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Abstract
X-ray crystallography has played an essential role in the field of molecular biology and biochemistry
as the protein structures obtained by this method provide a variety of information with which to
examine the interactions between proteins and ligands and consequently to help understand the
biological functions of the proteins. In this thesis, the structures and protein-ligand binding interactions
of two proteins, p-lactoglobulin (BLG) and cyclophilin 3 (CYP3), are studied by x-ray
crystallography.
BLG is a small globular protein, belonging to the lipocalin family. It is a commercially important whey
protein of nutritional value. However, the biological function is not yet clear. The structures of BLG in
three space groups have been solved. However, the refinement of the lattice Y structure has shown
problematic. In the current study, a new data set has been collected at low temperature (100K) and the
structure has been refined to 2.0A with the R-factor of 25.7% (Rfree=31.0%). The R-factor remains
around 26% although many methods have been tried to lower it. The possible reasons that hinder the
successful refinement are discussed.
In common with many of the other members of the lipocalin family, BLG binds a variety of
hydrophobic ligands. It appears possible that there are two distinct binding sites per monomer. By
comparison with other members of the family, there is a probable binding site in the central calyx of
the protein formed by the eight antiparallel (3-strands. In this thesis, cocrystallization of BLG with
palmitate has been successful and the structure of palmitate-bound BLG has been solved and refined at
a resolution of 2.5A to an R-factor of 20.4% (Rfree = 24%). The clear electron density map shows the
ligand binds inside the calyx and lies parallel to P-strand E. The palmitate adopts an almost fully
extended conformation with the hydrophobic tail stretching into the bottom of the calyx. The carboxyl
group of palmitate forms two hydrogen binds with Lys60 and Lys69 at the entrance of the calyx. This
the first direct observation of a ligand binding to BLG.
Cyclophilins are known as immunophilins as they can bind tightly to cyclosporin (CsA), which is a
immunosuppressant drug used to prevent organ rejection after transplant operations. The complex,
cyclophilin-CsA, can inhibit the activation of the immune cells. In addition, cyclophilins also possess
the peptidyl-prolyl cis-trans isomerase (PPIase) activity, which can catalyse the cis—>trans
isomerization of proline-containing peptide bonds and consequently accelerate the refolding of some
proteins in the cell. Recently, eleven cyclophilin isoforms have been cloned and sequenced from the
free-living nematode Caenorhabditis elegans (C.elegans). Cyclophilin 3 (CYP3) is one of the most
abundant expressed isoforms in this family. The structure of CYP3 has been refined to 1,8A with R-
factor of 20.8% (Rfree = 28.4%). The structure is similar to the well-characterised human cyclophilin A.
It contains a eight-stranded antiparallel p-barrel, similar to, but distinct from, BLG, capped with two
a-helices. However, CYP3 has an additional loop composed of seven residues (48KSGKPLH54),
which is absent in CYPA. This loop is held tightly by a specific network of hydrogen bonds from the
side chain of Glu83. The biological role of this additional loop is still unclear although it may provide
a distinctive recognition feature of the C.elegans-cyclophilin family as this inserted loop is particularly
common in this family.
X-ray data for 120mM Ala-Pro bound to CYP3 has been collected and refined at 1.9A resolution to an
R-factor of 18.3% (Rfree = 24.4%). The clear density map shows Ala-Pro binds in a groove on the
surface of the protein. The side chain of proline makes strong hydrophobic contacts with the
hydrophobic pocket of CYP3. In addition, there are seven strong hydrogen bonds involved in the
ligand-protein interactions.
Finally, the structure of CYP3 complexed with Ala-Pro has been used as a model to study the ligand
binding behaviour "in crystallo". Data from a series of native crystals soaked in solutions with
different concentrations of Ala-Pro have been collected. The complexed structures with different
ligand concentrations have been refined and the occupancy of Ala-Pro in each structure has been
determined. From the occupancy of Ala-Pro, the dissociation constant of Ala-Pro binding to CYP3 has
been calculated. The dissociation constant obtained by x-ray crystallography is 27.7mM, comparable




Arg62(L) Arg62 conformation with Ala-Pro binding to CYP-3
Arg62(N) Arg62 conformation without Ala-Pro binding to CYP-3
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BLGX the structure of BLG in the lattice X form
BLGY the structure of BLG in the lattice Y form
BLGZ the structure of BLG in the lattice Z form
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FABP fatty acid binding protein
hCYPA human cyclophilin A
Kdc dissociation constant "in crystallo"
PPIase peptidyl-prolyl cis-trans isomerase
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RBP retinol binding protein
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1. Introduction
This chapter describes the biological characteristics of p-lactoglobulin (BLG) and
cyclophilin 3 (CYP3), whose structures and ligand-protein binding interaction are
studied by x-ray crystallography in this thesis. The introduction to BLG will be given
in section 1.1 followed by the introduction to CYP3 in section 1.2. Finally, the aim of
this thesis will be described in section 1.3.
1.1 (3-Lactoglobulin (BLG)
1.1.1 Introduction
P-Lactoglobulin (BLG) is the major whey protein found in the milk ofmany
mammals and is expressed in the mammary gland during late pregnancy and lactation
(Larson, 1979). It is a small soluble protein and is remarkably acid stable. It remains
intact even at pH 2. The structure of the protein when crystallised at low pH is
similar to that at pH 7, with the exception of some loops which are disordered at low
pH (Ragona et al., 1997; Fogolari et al., 1998).
BLG has been detected in the milk of ruminants, for example, cows and sheep, and
also in non-ruminants, for example, pigs and dogs. However, it is absent from the
milk of humans, rabbits and mice. Since its isolation in 1934 (Palmer, 1934) and
mainly because of its abundance and ease of purification, bovine BLG has been
extensively studied using a variety of techniques and a lot of physico-chemical
properties have been investigated (Tilley, 1960; Townend et al., 1969; McKenzie,
1971; Green et al. 1979; Hambling et al., 1992).
In general, at room temperature and physiological pH, BLG exists as a dimer in the
milk of ruminants while it exists as a monomer in the milk of non-ruminant species.
However, ruminant BLG dissociates into monomers at pH values below 3 and above
8. Each monomer consists of 162 amino acids and has one free cysteine and two
disulphide bridges (Grosclaude et al., 1976). Generic variants appear to exist in all
species. In cows, the predominant forms are the A and B variants. The structure of
BLG contains a (3-barrel formed by eight antiparallel (3-strands, labelled as strand A,
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B, C, D, E, F, G, H. A 3 turn a-helix is on the outer surface of the p-barrel and is
followed by the ninth (3-strand, labelled as P-strand I.
BLG is a member of the lipocalin family (Flower, 1996). Many members of this
family are able to bind small hydrophobic molecules and BLG is no exception. It is
well known a variety of ligands can bind to BLG, for example, retinol (Fugate and
Song, 1980), fatty acid (Spector and Fletcher, 1970; Frapin et al., 1993), alkanes,
aromatic compounds and some biological molecules, such as heme-CO (Marden et
al., 1994). Flowever, the site of ligand binding and the mechanism of binding to BLG
have remained mysterious for many years. Other lipocalin members, such as retinol-
binding protein (Newcomer et al, 1984; Cowan et al, 1990), bilin binding protein
(Huber et al, 1987), odorant binding protein (Monaco et al., 1990) and fatty acid
binding protein (Hodsdon and Cistola, 1997a, b), bind ligands inside the calyx
formed from eight (or ten) antiparallel P-strands.
The biological function of BLG is unknown. The amino acid composition and
quantities present in ruminant species provide evidence to support a nutritional role.
However, the ligand binding properties that have emerged, coupled with the
structural similarity of BLG to retinol-binding protein and possibly even FABP, have
led to suggestions of its having a role in the transport of ligands like retinol or fatty
acids (Newcomer et al. 1984). The majority of the ligands that have been examined
are hydrophobic so that a transport role, in keeping with other lipocalins, is certainly
possible although no real proof of this has been published to date.
Moreover, it has been reported that bovine BLG increases the activity of ruminant
pregastric lipase (Perez et al. 1991). Since this enzyme is involved in the digestion of
milk lipid, it is assumed BLG may play an essential role in milk fat digestion in the
new-born animal by increasing the activity of pregastric lipase.
1.1.2 Distribution
The composition of milk varies from species to species. There are also seasonal
variations while the composition ofmilk changes in different seasons, presumably
implying the dairy habit of the animal. Some sensitive methods, such as the
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immunochemical cross-reaction between BLG and bovine BLG antiserum, have been
developed to detect the presence or absence of BLG in the milk of many species.
BLG has also been found in many ruminant species, such as, cow (Palmer, 1934),
sheep (Bell and Mckenzie, 1967), goat (Townend and Basch, 1968), water buffalo
(Lyster, 1972) and red and Virginian white-tailed deer (McDougall and Stewart,
1976). Not only in the milk of ruminant animals, BLG is also found in non-ruminant
animals, such as horse (Bell et al, 1981), red and eastern kangaroos (McKenzie et al,
1983), dolphins, manatees (Pervaiz and Brew, 1986) and cats (Halliday et al., 1993).
However, it is of interest to note that BLG in human milk is not detectable.
Alignment of the published sequences of BLG shows there is a very high degree of
homology throughout ruminant BLG. The sequence identity among ruminant BLG is
greater than 93%. However, the sequence identity is much lower among non-
ruminant BLG (Kolde, 1983). Some non-ruminant species, such as the pig I and
horse II BLG, shares only 37.7% identity with one another.
1.1.3 Genetic variants
Bovine BLG reveals heterogeneity and nine variants have been found so far. The
comparison of the amino acid sequence of different genetic variants of bovine BLG is
shown in Table 1-A.
BLG-A and BLG-B are the most abundant (Aschaffenburg and Drewry, 1955). These
two variants have two residue differences, residue 64 and residue 118. As shown in
Table 1-A, residues 64 of BLG-A and BLG-B are Asp and Gly, respectively while
residue 118 of BLG-A and BLG-B are Val and Ala, respectively. Therefore, variant
A is more negative than B so that they could be separated under the influence on the
applied electric field. BLG-C was identified in the milk of Jersey cows (Bell and
Mckenzie, 1967) and South Africa Nguni cattle (Osterhoff and Pretorious, 1966).
BLG-C reveals only one residue difference when compared to BLG-B. The residue
59 is Gin and His in BLG-B and BLG-C, respectively. BLG-D (Brignon et al., 1969)
is found in Danish Jersey cows and replaced by a single residue at position 45, Glu to
Gin, with respective to BLG-B.
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Three genetic variants E, F, G (Bell et al., 1981) were isolated from Bali cattle, Bos
javanicus. It has been suggested that the E variant appears to have the same sequence
as the BLG from yak milk, as position 11 in the latter is now thought to be Asp (Bell
et al., 1981) and not Asn (Grosclaude et al., 1976). BLG-E contains a single
substitution compared to BLG-B. The residue 158 is Gly in BLG-E instead of Glu.
BLG-F has one residue difference compared to BLG-E. Residue 50 is Ser and Pro in
BLG-F and BLG-E, respectively. However, there are two unidentified residues,
residue 129 and 130, in BLG-F. BLG-G also has one residue difference compared to
BLG-E. Residue 78 is Met and lie in BLG-G and BLG-E, respectively. BLG-W
(Godovac-Zimmermann et al., 1990; Krause et al., 1988) was isolated from a rare
breed of Bavarian and Murnau werdenfelder cattle. It has an electrophoretic mobility
close to that of the B variant but differs by a single lie to Leu substitution at position
56. Cross breeds of zebu and Australian Droughtmaster, were shown to produce
BLG-A, BLG-B and a new variant BLG-Dr. BLG-Dr is the only BLG known to be
N-glycosylated (Bell et al., 1970). These genetic variants are different in their
isoelectric points and can be separated using gel electrophoresis.
Other ruminant BLGs also exhibit genetic polymorphism. Red deer possess two
variants (McDougall and Stewart, 1976) while sheep have variants A, B (Bell and
McKenzie, 1967) and C (Erhardt et al., 1989).
1.1.4 Native structure
1.1.4.1 Crystalforms
A variety of crystal forms of BLG have been produced from a variety of different
conditions including pH, salt concentration and presence of ligand (Crowfoot and
Riley, 1938; Senti and Warner, 1948; Green et al., 1956; Aschaffenburg et al., 1965;
Bolognesi et al., 1979). In fact, there have been 18 crystal forms identified to date.
The majority of studies have concentrated on three salted-out crystal forms: lattice X
(Brownlow et al., 1997), lattice Y (Papiz et al., 1986) and lattice Z (Monaco et al.,
1987) as they are amenable to crystallisation at physiological pH. These crystal forms
were crystallised on either sides of the Tanford transition (Tanford et al., 1959),
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which occurs between pH 6 to 8. The details of the Tanford transition will be
discussed in section 1.1.7.
The Tanford transition is also known as the N —> R transition where N and R
represent the protein conformation at pH 6-6.5 and the conformation at pH 7.8,
respectively. Lattice X was crystallised at pH 6.5, corresponding to the N
conformation in solution while lattice Y was crystallised at pH 7.5, corresponding to
the R conformation in solution. Lattice Z was usually crystallised at a pH above 7
and sometimes this crystal form is found in the same drop with lattice Y. However, it
has been recently reported, lattice Z can be crystallised at a number of different pHs
including pH 6.2, pH 7.1 and pH 8.2 (Qin et al., 1998a). The space groups and unit
cell dimensions of these three crystal forms are summarised in Table 1-B.
Table 1-B. The space groups and unit cells of three crystal forms of BLG
Space group Unit cell pH Reference
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6.2 Qin et al., 1998a
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8.2 Qin et al., 1998a
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1.1.4.2 Recent history ofcrystallography studies on BLG
BLG has been studied by x-ray crystallography for many years since in 1979 when
the first BLG structures of X, Y, Z lattices were reported (Green et al., 1979). In
these 6A structures, BLG was shown to exist as a dimer. However, the positions of
the intramolecular disulphide bridges were unknown.
In 1986, a higher resolution structure was published by Edinburgh and Leeds groups
(Papiz et al., 1986). In this 2.8A resolution structure, the main fold of BLG was
recognised. 8 out of the 9 (3-strands form a [3-barrel and the 3 turn a-helix is outside
of the p-barrel. This special p-barrel motif is very similar to the previously solved
structure of retinol-binding protein (Newcomer et al., 1984). The positions of
disulphide bridges were easily recognised in this paper (Papiz et al., 1986). Cysl06
and Cysl 19 from strands G and H, respectively, form one disulphide bridge while
Cys66 from strand D and Cysl60 in the C-terminal form the other.
One year later, Monaco (Monaco et al., 1987) built a new structure model of lattice Z
at 2.5A resolution by obtaining the phases calculated from the multiple isomorphous
replacement (MIR). However, the model had poor geometry as reported by a
structure quality check program PROCHECK and unsatisfactory crystal contacts.
Therefore, the accuracy of this model is questionable.
In 1993, Joao Cabral re-collected the derivative data for lattice Z to 3A and re-solved
the structure by the MIR method (Cabral, 1993).
In 1997, Brownlow (Brownlow et al., 1997) used the new structure of lattice Z
solved by Cabral (Cabral, 1993) as the search model and solved the high resolution
structure of lattice X by molecular replacement to 1.8A. In this new model, the
overall fold is the same as the old lattice Y model. However, there are many
differences in the loops and there are four additional short a-helical turns that are
absent in the old lattice Y model. The most obvious difference is in the AB loop,
which extends 5 residues compared to the old model. The longer AB loop contributes
greatly to the stabilisation of the interface between the two monomers.
The shift of 5 residues in AB loop affects the position of 3 (3-strands (A, B, C) and
consequently results in shorter CD loop. The first residue in D strand was replaced
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back in register with the previous lattice Y model as a consequence of the shorter CD
loop.
1.1.4.3 Overall structure
The crystal structure of BLG reveals to be an eight-stranded antiparallel (3-barrel
arranged to form a conical central calyx or cavity in which the hydrophobic ligand is
expected to be located (Brownlow et al., 1997; Qin et al., 1998a). The overall
structure of BLG is shown in Figure 1-1. The secondary structure and corresponding
residues based on a monomer of BLG in lattice X form (BLGX) are listed in Table 1-
C.
Table 1-C. The secondary structure and corresponding residues of a monomer
ofBLGX
Residues range secondary Residues range secondary
structure structure
Gln5-Aspl 1 N-terminal Asn90-Thr97 Strand F
Ilel2-Vall5 3io Helix Asp98-Lysl01 FG loop
Alal6-Trpl9 Loop Tyrl02-Glul08 Strand G
Tyr20-Ala26 Strand A Asnl09-Glul 12 GH loop
Ser27-Asp28 AB loop Prol13-Glnl 15 3io Helix
Ile29-Leu31 3 io Helix Serll6-Leull7 GH loop
Leu32-Val41 AB loop Vail 18-Vall23 Strand H
Tyr42-Pro48 Strand B Argl24-Aspl29 Loop
Thr49-Asp53 BC loop Aspl30-Lysl41 Helix
Leu54-Trp61 Strand C Alal42-Hisl46 Loop
Glu62-Glu65 CD loop Ilel47-Serl50 Strand I
Cys66-Lys75 Strand D Phel51-Asnl52 Loop
Thr76-Ala80 DE loop Prol53-Leul56 3io Helix










Figure 1-1.Diagram of a monomer of BLGX. The nine strands are shown in red,
the helices are shown in blue and the joining loops are shown in yellow. Strand A,
I and loops are labelled. This diagram was prepared by MOLSCRIPT (Kraulis, 1991)
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The first four (3-strands (A, B, C, D) form one side of the calyx while the other four
p-strands (E, F, G, H) form the other. Strand A is bent through a right angle at Leu22
and contributes to both sides of the calyx. The 3-turn a-helix is located outside the (3-
barrel and is followed by p-strand I, which forms the dimer interface along with the
AB loop. There are twelve H-bonds at the interface, four of them occur in p-strand I
between two adjacent monomers. The other eight hydrogen bonds are formed in the
AB loop between the two adjacent monomers (Brownlow et al., 1997). In addition,
there are four short 3 io a-helix turns which occur in the N-terminus, AB loop, GH
loop and C-terminus.
There are five cysteine residues in BLG. Four of them form two disulphide bridges as
mentioned in section 1.1.4.2. The free cysteine, Cysl21, was found to be buried in
the interface of P-sheet and a-helix, which is consistent with the conclusion of
Townend (Townend et al., 1969).
1.1.5 Studies on specific amino acids
The environments of some specific amino acid of BLG have been studied under
various conditions using difference spectroscopy and chemical modification
(Townend et al., 1969). These specific amino acids include 4 tyrosines, 2 tryptophans
and the free cysteine. Four tyrosines (Tyr20, Tyr42, Tyr99 and Tyrl02) and two
tryptophans (Trpl9 and Trp61) will be discussed here. The free cysteine will be
discussed in section 1.1.7.
(a) Four tyrosines (Tyr20, Tyr42, Tyr99 and Tyrl02)\
BLG contains four Tyr residues per monomer and their accessibility has been studied
by titration with N-acetylimidazole and cyanuric fluoride (Townend et al., 1969). It is
found that the two tyrosines are able to acetylate with N-acetylimidazole at pH 7.5
whereas one tyrosine is totally unavailable for acetylation. The fourth tyrosine is
partially hindered and only becomes available after partial denaturation of BLG at pH
10.8. These four tyrosines can therefore be categorised as: two are exposed, one is
partially buried and the rest one is completely buried.
1-10
This categorisation is consistent with the structural analysis of BLG (Qin et al.,
1998a). By calculating the solvent accessibility of the sidechains of two tyrosines,
Tyr20 and Tyr99, are identified as the two exposed tyrosines with the solvent
accessibility of 40A2 and 30A2, respectively. Tyrl02 and Tyr42 are identified as the
partially buried and buried tyrosine with the solvent accessibility of 10A2 and OA2,
respectively.
(b) Two tryptophans (Trpl9 and Trp61):
There are two tryptophans in BLG, Trpl9 and Trp61. Trpl9, located at the bottom of
the calyx, is inaccessible to solvent while Trp61, in the extremely mobile loop at the
mouth of the calyx, is exposed.
Trpl9 is the only conserved residue throughout the lipocalin family, implying this
residue may play an important role shared by the lipocalin family. A study using site-
directed mutagenesis reported Trpl9 to be important in stabilising the protein
structure (Katakura et al., 1994). The concentration of guanidine hydrochloride (as a
denaturant) for the loss of CD intensity at 220 nm was 2.5M for wild-type BLG. As
for W19Y mutant, the denature concentration decreased to 1.2M, indicating W19Y
mutant was destabilised by this substitution.
Moreover, Cho et al (1994) genetically modified Trpl9 to Ala 19 and found, upon
binding of retinol, the association constant of the W19A mutant was decreased to
73% compared to the wild type. This result reveals the Trpl9 has also an effect on
ligand binding.
1.1.6 Binding studies by other methods
Since the late 1940's, many binding studies have been on BLG since 1946 when the
first compound, sodium lauryl sulphate(SLS), was reported to bind to the BLG (Bull
et al., 1946). As mentioned in section 1.1.1, There are a variety of ligands can bind to
BLG. In most cases, BLG binds 1 molecule of ligands per monomer with an
association constant varying from 107 to 102(M-1). Among them, retinol and fatty
acid have the strongest binding affinity and have been investigated extensively
because their binding indicates a possible biological function for BLG. Therefore, the
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binding of fatty acid and retinol to BLG will firstly be discussed, followed by some
other compounds.
1.1.6.1 Fatty acid
In 1970, fatty acid was first reported to bind to BLG by Spector and Fletcher (1970)
with an association constant around 105 (M"1).
The strength of binding depends on the length of the carbon chain. Caprylic acid
(C8:0) and capric acid (C10:0) do not bind (Frapin et al., 1993). If C>12, the
association constant is higher if the carbon chain is longer, which suggests the
binding process involves hydrophobic interactions. For C>16, the strength of
binding decreases as the carbon chain length increases. Conclusively, the strength
order is: C16:0> C18:0>C14:0> C20:0 > C12:0. From this order, it seems optimum
number of carbon atoms to fit into the binding pocket is 16. Furthermore, the binding
affinity of fatty acid to BLG decreases if the carboxyl group of fatty acid has been
removed or modified (Spector and Fletcher, 1970), indicating the polar interactions
are also important in the binding process. Therefore, it was proposed the binding site
for fatty acid contains a hydrophobic pocket with a positively charged amino acid at
the entrance of the pocket (Spector and Fletcher, 1970; Perez et al., 1989). This
hypothesis has been proven by the structural studies described in this thesis. The
complexed structure of palmitate binding to BLG reveals that palmitate binds inside
the hydrophobic pocket (calyx) formed by the [3-barrel. Lys60 and Lys69 at the
entrance of the calyx are hydrogen bonded to the carboxyl group of palmitate. The
detail of the complexed structure of palmitate binding to BLG will be discussed in
chapter 3.
Comparing saturated and unsaturated fatty acid binding, the unsaturated fatty acids
bind more weaker than the saturated ones. This indicates the structural constraints
caused by C=C bonds weaken their binding to BLG (Frapin et al., 1993).
Moreover, modifying BLG by alkylation and esterification also decreases the binding
affinity as methylation of lysine residues in BLG and methyl esterified BLG does not
bind palmitate at neutral pH (Frapin et al., 1993). This result shows the partial
change of BLG alters the fatty acid binding site.
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It has been reported that the binding of fatty acids to BLG increases its resistance to
proteolytic degradation and thermal denaturation (Puyol et al., 1994) as the
denaturation temperature of BLG-AB and BLG-AB bound with palmitic acid are
70.5° and 78.5° at pH 6.5, respectively. This result indicates fatty acids help to
stabilise the BLG structure.
1.1.6.2 Retinol
The first report of retinol binding to BLG was in 1972 by Futterman and Heller
(1972). Subsequently, the binding of retinol to BLG has been studied by a variety of
methods, for example, fluorescence (Fugate and Song, 1980), equilibrium dialysis
(Puyol et al., 1991), affinity chromatography (Jang and Swaisgood, 1990), etc. The
dissociation constant of retinol by different methods varies from 2.0x10"8 to 5.8x10"
7M.
From a solution study, Fugate and Song (1980) proposed that hydrophobic
interactions play an important role in the binding of retinol to BLG and the nonpoplar
part of retinol is mainly responsible for binding.
The binding affinity of retinol increases if chemically modifying BLG by methods
such as methylation, ethylation (Dufour and Haertle, 1990a, b), esterification or
alkylation (Dufour and Haertle, 1991). The increase of binding affinity may result
from the increase in the overall hydrophobicity of BLG and therefore strengthen the
binding interaction.
BLG from all species appears to bind retinol, but this ligand is not only found
associated with BLG but also with other milk proteins such as serum albumin and a-
lactalbumin (Puyol et al., 1991) indicating that this interaction seems to be rather
unspecific. Thus the functional relevance of retinol binding to BLG is also open to
question.
The location of the retinol binding site on BLG and the functional significance of
binding are still unclear. There are two divergent hypotheses on the retinol binding
site.
(a) The hypothesis of the internal calyx binding site:
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One hypothesis is from the modelling studies and proposes retinol is bound in the
central calyx formed by the eight antiparallel (3-strands (Papiz et al., 1986; Sawyer et
al., 1998). The position of retinol was modelled directly from that in retinol-binding
protein (RBP). In this model, the residues in the calyx make a variety of hydrophobic
interactions with retinol, which is consistent with the result from solution binding
studies which indicate that the binding of retinol to BLG mainly involves
hydrophobic interaction (Fugate and Song, 1980; Jang and Swaisgood, 1990).
Furthermore, the retinol hydroxyl group can make hydrogen bond contact with Lys69
and Trpl9 can make close contact with the P-ionone ring of retinol.
The hypothesis of the internal calyx binding site was supported by the work of Chen
et al (1993) and Cho et al (1994). Chen found that BLG with its a-helix removed by
proteolysis still bound to retinol in a manner similar to the intact BLG. Cho (1994)
found using site-directed mutagenesis that the residues of central calyx contribute to
the binding interaction. In his experiment, four separate mutants, W19A, K70M,
F136A and K141M were made where W19A or K70M mutated the residues in the
central calyx while F136A or K141M mutated the residues in the external groove. It
was shown that W19A and K70M mutants resulted in a dramatic decrease in the
binding of retinoic acid compared to that of the F136A, K141M and wild-type BLG.
(b) The hypothesis of the external groove binding site:
The other hypothesis is based on a difference density map that shows some electron
density found at a surface groove between the P-barrel and the a-helix and assigned
to the retinol (Monaco et al., 1987). In this model, the P-ionone ring of the retinol
interacts with the side chain of Phel36 while the retinol hydroxyl group is hydrogen
bonded to Lysl41. However, since the electron density for retinol is very weak and
ill-defined probably due to the poor data or low occupancy of the ligand and there is
an error in the crystallographic analysis, the result is questionable.
Therefore, full identification of the binding site of retinol will require the complex
structure to be solved by x-ray crystallography.
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1.1.6.3 Other compounds
In addition to retinol and fatty acids, many other compounds also bind to BLG and
most of them are hydrophobic in nature.
Many aliphatic and aromatic compounds, for example, butane, heptane, toluene and
trifluorotoluene are reported to bind to BLG although the binding strengths are much
weaker than those seen with retinol and fatty acids. These organic compounds are
believed to bind to the same site that is located in the interior of the protein because
this site is not affected by the state of dissociation from dimer to monomer (Papiz,
1982).
Some flavour compounds have been shown to bind to BLG and this property has
been applied in the food industry for food additives. (3-ionone (Dufour and Haertle,
1990b) and some alkanone flavours (O'Neill, 1987) are the examples.
(3-ionone binds to BLG strongly with an association constant of 1.6*10 (M1).
Modifying BLG by chemical or enzymatic treatment results in increasing the binding
affinity, which suggests changing the BLG conformation to alter its binding
properties and consequently to broaden its possible applications in the food industry.
1.1.7 Conformational Change
As observed by ORD (Optical Rotatory Dispersion), BLG reveals three pH-
dependant conformational transitions, which can be summarised as:
Conformational transition Q <-> N <-> R —> S
pH 4 6-6.5 7.8 > 8.5
The first transition assigned as Q<->N is reversible between pH=4 and 6 and is
observed in bovine BLGA, B and C (Timasheff et ai, 1966; Mckenzie and Sawyer,
1967). This transition is characterised by an increase in sedimentation coefficient
with an increase in pH. The increase in sedimentation coefficient seen is probably
related to the contraction of the protein.
The second one, N<->R, is observed between pH 6 and 8 and is known as the Tanford
transition (Tanford et al., 1959). Because this conformational transition occurs in
physiological conditions and is possibly associated with the biological function of
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BLG, it has been the focus ofmany researches. This transition is characterised by a
decrease in optical rotation ([a]o) from -25° at pH 6 to -48° at pH 8, indicating a
change in the environment of an optically active group. It was observed by Tanford
(Tanford et al., 1959) that this transition results in a carboxyl group buried at pH
below 7.0 becoming exposed at pH above 7.0. This transition is also detected by a
decrease in the sedimentation coefficient from 3.2 to 2.6s at 20°C (Pederson, 1936),
an increase in reactivity of a sulphydryl group with reagents containing Hg2+(Dunnill
and Green, 1965) and a change in the environment of tyrosines (Townend et al.,
1969). A decrease in the sedimentation coefficient is probably due to an expansion in
the volume of BLG (Tanford et al., 1959) or the dissociation of dimer to monomer
(Mckenzie and Sawyer, 1967). Moreover, it was found recently that the thermal
behaviour of BLG is also pH-dependent as a peak in the thermalgram (Qi et al.,
1995) disappears when the pH increases from 6.75 to 8.05.
After the project of this thesis started, the structures of BLG at pH 6.2, 7.1 and 8.2
have been solved by Qin (Qin et al., 1998a) and reveal the structural basis of the
behaviour of BLG during the Tanford transition. It has been shown that there is a
distinct movement of a loop, the EF loop, as the pH is raised. The anomalous
carboxyl group with pKa of 7.3 was probably identified as Glu89 by Brownlow et al
(1997) but confirmed convincingly by Qin et al (1998a). At pH below 7.0, the buried
Glu89 of the EF loop is hydrogen bonded to Serl 16 of the GH loop whereas, at pH
above 7.0, the hydrogen bond to Serl 16 is broken and Glu89 is exposed along with
° 2the movement of the EF loop. The solvent accessible area of Glu89 is 4A at pH 6.2,
116A2 at pH 7.1 and 136A2 at pH 8.2. A decrease in the sedimentation coefficient
can be explained as an overall increase in molecular volume or surface area. The
accessible surface area of BLG increases from 8240A2 at pH 6.2 to 8460A2 at pH 7.1
to 8670A2 at pH 8.2 (Qin et al., 1998a). An increase in reactivity of a sulphydryl
group with a positively charged reagent is because the environment of Cysl21
becomes more negatively charged and more susceptible to chemical modification.
When the pH increases from 6.7 to 7.2, the residues (LyslOl, Lysl35, Argl48,
Aspl29, Aspl37, Glul31 and Glul34) around Cysl21 become more negatively
charged and the average B factor of atoms with in 8A of Cysl21 increases from
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16.2A2 to 30.OA2 (Qin et al., 1998a). The increase in B-factor indicates these atoms
are more unstable and consequently more susceptible to chemical modification.
However, the structural study was unable to identify a dramatic change in the
environment of tyrosines observed by Tanford as the conformations of the residues
around these four tyrosines, Tyr20, 42, 99 and 102, are the same at pH 6.1, 7.1 and
8.2.
The last transition occurring above pH 8.5, assigned as R—>S, is an alkalic
denaturation. When the pH rises from 8 to 9, the dimer dissociates into monomer
reversibly but the protein will denature and aggregate irreversibly above pH=9.0
(Townend et al., 1960).
1.1.8 Sequence and structural homology within the proteins of
lipocalin family
BLG is a member of the lipocalin family. The name of lipocalin, firstly suggested by
Pervaiz and Brew (1987), comes from the Greek words "lipos" meaning fat and
"calin" meaning cup. There are more than 20 proteins in this family as identified
through sequence homology (Flower et al., 1996) with functions varying from insect
camouflage to small hydrophobic molecule transport typified by serum retinol
binding protein. The evolution of the lipocalin family from a common ancestor is
supported by work on gene sequences, which share common intron/exon patterns
among the members of this family (Ali and Clark, 1988). The crystal structures of
several members have been reported, for example, retinol-binding protein
(Newcomer et al, 1984; Cowan et al, 1990), BLG (Brownlow et al., 1997),
insecticyanin (Holden et al, 1987), bilin binding protein (Huber et al, 1987), odorant
binding protein (Monaco et al, 1990), mouse major urinary protein, rat a 2u-globulin
(Bocskei et al., 1992) and retinoic acid binding protein (Newcomer, 1993). The
crystal structures so far available reveal the typical lipocalin to be an 8-stranded
antiparallel (3-barrels arranged to form a conical central calyx or cavity in which the
hydrophobic ligand is located (Newcomer et al., 1984). There is an a-helix on the
outer surface of the P-barrel and the amino acid sequence contains 3 structurally
conserved regions (SCR's or sequence motifs) together with one or more disulphide
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bridges. The calycin super-family extends the family to include proteins like the fatty
acid binding proteins (FABP) which do not contain the second of these 3 sequence
patterns but which are also antiparallel (3-sheet proteins, though with 10 p-strands
rather than 8. However, in common with their distant lipocalin relatives, their
binding site is also within a central cavity.
Although there is low overall sequence identity throughout the lipocalin family,
typically as low as 10 or 20%, there are some regions where the sequence
conservation is very much greater. The three structurally conserved regions (SCRs)
found in lipocalins (North, 1989) are all located close to each other at the bottom
(closed end) of the (3-barrel. It has been proposed that these structurally conserved
regions probably consist of a receptor binding site (Yewdall, 1988; North, 1989).
These three regions are discussed below:
(a) The first SCR is located on strand A with a conserved sequence of h-a-x-x-b-h-x-
Gly-x-Trp-y-x-h-h around residue 20.
Where a is usually an acidic residue, b is usually a basic residue, h is a hydrophobic
residue, y is aromatic residue and x is any kind of residue.
(b) The second SCR is located on the FG loop with a conserved sequence of h-h-x-
Thr-Asp-Tyr-x-x-y-h around residue 100. It is very common feature that the main-
chain in this region adopts an unfavourable conformation and is stabilised by specific
sidechain-mainchain hydrogen bond from conserved threonines and aspartates. For
example in BLG, Tyr99 is in the disallowed region of the Ramachandran plot in all
BLG structure determined to date. There are also four mainchain-sidechain hydrogen
bonds formed in this region involved Asp98, Tyr99 and LyslOO (Brownlow et al.,
1997). Moreover, Tyr99 adopts a classic y-turn conformation that is common to
nearly all of the lipocalin structures. It has been suggested this y-turn may be
involved in some biological functions (North, 1989)
(c) The third SCR is located on the loop before a-helix with a conserved basic
residue at Argl24. Argl24 is at the centre of these three SCR regions and the side
chain of Argl24 lies parallel to the side chain of Trpl9, which is in the first SCR
region.
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1.1.9 The thermal denaturation of BLG
The effects on bovine milk of high temperature are very important in diary science
research as the processing ofmilk, for example, pasteurization, sterilisation and
dehydration, usually involves the use of high temperature processes.
The heat stability of BLG has been studied for a long time as BLG is involved in the
formation of fouling deposit from heated milk. Moreover, the binding of BLG to
casein upon denaturation increases the yield of cheese by increasing the amount of
protein. These and various other reactions must be well characterised in order to
improve the production of diary products without loss of an acceptable flavour.
Several methods have been used to study the thermal stability of BLG, for example,
optical rotatory dispersion (Sawyer et al., 1971), differential scanning calorimetry
(DSC) (Park and Lund, 1984), CD (Lapanje and Poklar, 1989). The most popular
method is differential scanning calorimetry (DSC).
BLG-A or BLG-B contains one cysteine and two disulphide bridges per monomer. It
has been suggested these cysteines are able to undergo sulphydryl oxidation of
disulphide interchange interaction (-SH/SS). These reactions result in the
denaturation of BLG. Briggs and Hull (1945) suggested there are two distinct stages
involved in the denaturation of BLG. The first step is dissociating dimer into
monomer and unfolding the polypeptide chain to a random-coiled conformation. The
second step is the unfolded protein undergoes -SH/SS exchange reactions to yield
irreversible aggregates.
The thermal behaviour of BLG in the presence of small molecule ligands and other
milk components has been investigated. Puyol et al (1994) have found binding of
palmitic acid to BLG increased significantly the denaturation temperature as
mentioned in section 1.1.6.1. The increase in the resistance to heat denaturation
indicates the binding of palmitic acid to BLG stabilised BLG structure. This
phenomenon is similar to the stabilising effect of other ligand bound to other milk
protein, e.g. fatty acid bound to bovine serum albumin (BSA) (Gumpen et al., 1979)
or Ca bound to a-lactalbumin (Relkin et al., 1993).
It is also found lactose stabilises BLG against thermal denaturation (Park and Lund,
1984).
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However, for BLG with bound retinol, the denaturation temperature (74.5°) is lower
than that of BLG with bound palmitic acid although the denaturation temperature is
still higher than that of native BLG (70.5°). This result indicates the binding the
retinol to BLG is probably a less important factor in the stabilising of BLG structure
compared to palmitic acid.
1.2 CYP3
1.2.1 Introduction
Cyclophilins are omnipresent, highly conserved proteins found in diverse prokaryotic
and eukaryotic organisms (Galat and Metcalfe, 1995). This protein has been found in
a variety of species ranging from bacteria to vertebrates, including human, plant, and
several parasitic species. The biological functions of cyclophilins include high
affinity binding to the immunosuppressant cyclosporin (CsA), possession of the
peptidyl-prolyl cis-trans isomerase activity (PPIase activity) and assisting in the
folding of several proteins in the cell.
Cyclophilin was first identified and purified from bovine thymus and human spleen
by Handschumacher et al (1984) and Harding et al (1986), respectively. This protein
has a high affinity for CsA with a of 46nM by tryptophan fluorescence (Liu et al.,
1990). CsA is a cyclic undecapeptide and is the principal immunosuppressant drug
used to prevent organ rejection after transplant operations (Beveridge and Calne,
1995). CsA also has therapeutic value in the treatment of autoimmune disorders,
including uveitis (Nussenblatt et al., 1983), type I diabetes (Stiller et al., 1984) and
encephalomyelitis (Hinrichs et al., 1983). Additionally, it has been reported that sub-
immunosuppressive levels of CsA have potent anti-parasitic activity on a wide range
of both helminth and protozoan parasites (Page et al., 1995a,b; Bell et al., 1996).
Moreover, non-immunosuppressive CsA analogues have been found to have an effect
on the malaria parasite (Bell et al., 1994). Recently, CsA has been shown to inhibit
the association of cyclophilin A and HIV-1 virions, consequently reducing the HIV-1
virion infectivity, as the binding of cyclophilin A to HIV plays an important role in
HIV-1 infectivity (Thali et al., 1994).
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Cyclophilins also have peptidyl-prolyl cis-trans isomerase activity (PPIase activity).
In independent studies, an enzyme isolated by Fischer et al (1984) and Lang et al
(1987) catalysed the cis—>tran isomerization of proline-containing peptide bonds.
This enzymatic activity was therefore named as peptidyl-prolyl cis-trans isomerase
(PPIase) activity. The first PPIase was purified and sequenced by Fischer et al
(1989a) and revealed that the PPIase isolated from pig kidney shared identity with the
cyclophilin from bovine thymus.
Therefore, cyclophilins are not only the receptors for the immunosuppressant drug,
CsA, but are also PPIases. Since the PPIase activity of cyclophilins can be completely
inhibited by CsA, it has been proposed that the binding site of CsA is identical to the
PPIase active site. This proposal has been confirmed by crystallographic studies as
both CsA and proline-containing peptides bind in the same place, at the surface of the
protein (Kallen et al., 1991; Pflugl et al., 1993).
Since the first structure, a tetrapeptide substrate, acetyl-Ala-Ala-Pro-Ala-
amidomethylcoumarin (acAAPAamc) bound with human cyclophilin (hCYPA), was
solved by Kallen in 1991 (Kallen et al., 1991), a number of structures of cyclophilin
complexed with different ligands have been solved in the past few years. All ligands
bind in a long and deep groove located on the surface of the protein. The liganded
structures will be discussed in sections 1.2.4 and 1.2.5. These liganded structures
could provide a starting point to reveal the immunosuppressive reaction and
understand the cis—>tran isomerization.
Cyclophilin usually exists as many distinct isoforms in a single species. For example,
there are at least four different cyclophilin isoforms in human (Galat and Metcalfe,
1995). Human cyclophilin A (hCYPA) consisting of 165 amino acids (17800 Da) is
the most abundant and well-characterised member in the cyclophilin family
(Handschumacher et al., 1984; Harding et al., 1986). Human cyclophilin B (hCYPB)
has 208 residues (22742 Da) and shares a sequence homology of 64% with hCYPA
(Price et al., 1991; Hasel et al., 1991). Human cyclophilin C (hCYPC) has 212
residues with molecular weight of 22795 Da (Thalhammer et al., 1992) while human
cyclophilin D (hCYPD) has 207 residues (Bergsma et al., 1991). These isoforms
show great similarity in overall folding and have a highly conserved CsA-binding
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domain (Taylor et al., 1997). Significant divergence occurs in the N- and C-terminal
regions. Compared to hCYPA, hCYPB and hCYPC contain an extra signal domain at
the N-terminus that directs them to the endoplasmic reticulum (ER). Human
cyclophilin D also has a signal domain at the N-terminus that directs it to
mitochondria. Moreover, a large cyclophilin, human cyclophilin 40 (hCYP40), with a
molecular weight about 40 kDa has been isolated and cloned from a human cell line
(Hoffmann et al., 1995a,b). Human CYP40 contains two domains; the N-terminal
cyclophilin-like domain reveals 40% sequence identify with hCYPA.
Recently, 11 cyclophilin isoforms (Page et al., 1996) have been cloned and
sequenced from the free-living nematode Caenorhabditis elegans (C. elegans). One
of these C. elegans cyclophilins, cyclophilin 3 (CYP3) is the main protein to be
discussed in this thesis. It contains 173 residues with molecular weight of 18550Ds.
Based on the sequence alignment, CYP3 reveals 67% sequence homology with
hCYPA. The overall structure of CYP3 is very similar to that of hCYPA with the
exception of the extra loop containing 7 inserted residues in CYP3. The structure and
biological characteristics of CYP3 will be discussed in chapter 4.
1.2.2 The family of Caenorhabditis elegans cyclophilins
All of the eleven isoforms of cyclophilins from C.elegans have been cloned and
expressed in Escherichia coli, except cyclophilin 7 (CYP7). CYP7 was excluded due
to its extremely high identity to cyclophilin 3 (CYP3); 87% identify over the entire
sequence and 100% identity over the CsA-binding domain. The sequence alignment
reveals that 7 of 11 of these isoforms in C. elegans contain a 7-8 amino acid insert
compared to hCYPA. The important features and possible functions of this insert are
discussed in section 5.1.3.
CYP1, 3, 5, 6, 7 have a conserved CsA binding domain (CBD) compared to CYPA
while CYP2, 4, 8, 9, 10 have one to four mutant residues in the CBD. The CsA
binding domain refers to the residues binding to CsA in human CYPA as will be
described in section 1.2.5. Based on the sequence comparison, CYP2, 3, and 7 most
closely resemble CYPA and are thus classified as CYPA-like isoforms.
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These isoforms reveal great divergence in the N-terminal and C-terminal regions. For
example, CYP1, 5 and 6 possess a signal domain in the N-terminal region. The 25
amino acid hydrophobic signal peptide found in CYP6 is similar to that seen in
human cyclophilin B and this protein is classified as a CYPB-like isoform. CYP1 and
CYP5 also contain a signal peptide at the N-terminus. However, these signal peptides
are more similar to human cyclophilin C, and hence classified as CYPC-like
isoforms. CYP4 is actually a three domain protein. These three domains consist of a
N-terminal domain (254 amino acids), a cyclophilin domain and a C-terminal domain
(220 amino acids). CYP8 and CYP9 contain two domains. One is a cyclophilin
domain and the other is an extended C-terminal domain. CYP4, 8 and 9 together with
CYP10 and CYP11 are classified as divergent cyclophilin isoform, or cyclophilin D
like isoforms. The similarity and difference between these 11 isoforms are
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CYP3 is the subject of part of this thesis (see chapter 5). It contains 173 amino acids
(18550Da) with a pi of 8.8. It is one of the most abundantly expressed isoforms.
Based on sequence alignment, this protein has the conserved CsA binding domain.
There are no signal peptides at the N-terminus and there are no extended N-terminal
and C-terminal domains. However, compared to hCYPA, CYP3 contained 7 inserted
residues starting from Lys48 in the CYP3 sequence.
1.2.3 Overall structure of human cyclophilin A (hCYPA)
The structure of cyclophilin A contains 8 antiparalleled p-strands and 2 a-helices
(Kallen et al., 1991; Ke et al., 1991). The overall shape of the structure is globular
with a dimension of approximately 34x33x30 (A3). These 8 antiparalled p-strands
form a P-barrel and 2 a-helices sit on the top and bottom of the p-barrel (Figure 1-2).
Cyclophilins share a common feature, "a P-barrel formed by antiparallel P-strands",
with the lipocalin family. However, cyclophilin is unique and distinct from the
lipocalin family in terms of topology and overall morphology of the structure.
The p-barrel of cyclophilin has a +1, -3, -1, -2, +1, -2, +3 topology, which is different
from the (+l)n topology found in the lipocalin family or the (-3, +1, +1) Greek key
topology frequently found in p-strand-predominated structures (Ke et al., 1992).
Inside the barrel of cyclophilin, a hydrophobic core contains most of the hydrophobic
residues. Other hydrophobic residues are found in the CsA binding site and the
contact region of the p-barrel and 2 a-helices. The residues contributing to the
hydrophobic core include seven aromatic residues (Phe8, Phe22, Phe36, Tyr48,
Phe53, Phel 12 and Phel29) and eight hydrophobic residues (Val6, Val20, Leu24,
Leu39, Ile56, Leu98, MetlOO and Ilel 14).
The major difference between cyclophilins and the lipocalin proteins is that no ligand
or substrate can bind to the hydrophobic core of the cyclophilins while the ligands do
bind inside the hydrophobic core of the lipocalins as discussed in section 1.1.8.
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N-term
Figure l-2.Diagram of the structure of hCYPA, produced by MOLSCRIPT
(Kraulis, 1991). The eight labelled beta-strands are shown in purple, the two
helices are shown in green and the joining loops are shown in orange.
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The reason why the hydrophobic core of cyclophilin is not accessible to the ligands is
because the barrel of cyclophilin is closed by the two helices, which block the entrance
to the core and consequently hinder the ligands to enter the core.
Moreover, inside the core, the hydrophobic residues pack tightly and consequently
exclude the possibility of ligand binding within the barrel. Actually, based on the
structural studies which will be discussed in section 1.2.4 and 1.2.5 of cyclophilin
complexed with a variety of ligands, all ligands bind in a long and deep groove located
on the surface of the protein between one face of the (3-barrel and the FG loop.
As can be seen, the binding sites of two proteins are significantly different due to
different arrangement and surroundings of the binding sites although they share the
similar motif.
1.2.4 Cyclophilin-ligand complex structures
Since the first complexed structure, a tetrapeptide substrate (acetyl-Ala-Ala-Pro-Ala-
amidomethylcoumarin) bound to hCYPA was solved by Kallen in 1991 (Kallen et al.,
1991), many studies have concentrated on the crystallographic study of cyclophilin in
order to understand the immunosuppressive reaction and the cis-trans isomerization
mechanism. As most complexed structures were studied with hCYPA and the major
protein studied in this thesis, CYP3, is a hCYPA-like protein in terms of sequence
homology and structure, the reviews of the complexed structures discussed in sections
1.2.4 and 1.2.5 are therefore focused on the hCYPA although several complexed
structures with hCYPB (Mikol et al., 1994), murine CYPC (Ke et al., 1993b) and E.coli
CYPA (Konno et al., 1996) have been published. Many complexed structures that have
been reported, include various proline-containing peptides (Ke et al., 1993a; Zhao et al.,
1996a,b), CsA (Mikol et al., 1993; Pflugl et al., 1993) and CsA derivatives (Kallen et
al., 1998). Recently, the structures of hCYPA complexed with a 25 amino acid fragment
of HIV-1 gag protein (Zhao et al., 1997) and hCYPA complexed with N-terminal
domain (151 residues) of the HIV-1 capsid protein have been solved (Gamble et al.,
1996).
The binding site is located on the surface of the protein and formed by the strands C, D
and F (see Figure 1-3). The detail of these complexed structures will be discussed later in
this section and in section 1.2.5. The close contact and hydrogen bond distances
between cyclophilin and a variety of substrates are summarised in Table 1-E.
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Figure l-3.Diagram of the molecular surface of hCYPA, prepared by
GRASP (Nicholls et al., 1991).The orientation of the model is similar
to that of Figure 1-2. The binding site is presented at the centre of the
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(a) The structure ofhCYPA comylexed with dipeptides:
Several complexed structures of dipeptide bound to CYPA have been determined and
refined at between 1.64A and 2.1A. The first structure reported was the Ala-Pro
binding to hCYPA by Ke (Ke et al., 1993a). The other three complexed structures,
Ser-Pro/hCYPA, His-Pro/hCYPA and Gly-Pro/hCYPA, were solved in 1996 by Zhao
(Zhao et al., 1996b). Comparison of these four structures shows proline-containing
dipeptides bind to cyclophilin in the cis form with an omega angle of between 5° and
-4°. The structure of Ala-Pro binding to hCYPA is shown in Figure 1-4 to illustrate
the interactions between dipeptide and cyclophilin.
Proline makes hydrophobic contact with the hydrophobic pocket of CYPA, which is
composed of Phe60, Met61, Phel 13, Ilel22 and Hisl26. The two C-terminal
oxygens form three hydrogen bonds with Arg55 and Glu63. The N-terminal nitrogen
forms a hydrogen bond with the carbonyl oxygen of Asnl02 while the carbonyl
oxygen forms a hydrogen bond with the NH nitrogen of Asnl02. The side chains of
the Xaa residue in the dipeptide of Xaa-Pro do not make strong contacts with
cyclophilin. The weak interaction of the Xaa residue with CYPA has indicated their
minor effect on the cis-trans isomerization and therefore explains the lack of
catalytic specificity of cyclophilin.
(b) The structure ofhCYPA complexed with tetrapeptides:
Two structures of human recombinant cyclophilin A complexed with a tetrapeptide
substrate have been reported. The structure of hCYPA complexed with acetyl-Ala-
Ala-Pro-Ala-amidomethylcoumarin was the first cyclophilin structure to be solved
(Kallen et al., 1991). The other is the structure of hCYPA complexed with succinyl-
Ala-Ala-Pro-Phe-p-nitroanilide (sAAPFna) (Zhao et al., 1996a). sAAPFna is a
substrate commonly used for the assay of peptidyl-prolyl cis-trans isomerization of
both cyclophilin and FK506 binding protein (FKBP). Both structures show the
tetrapeptides are bound to CYPA in the cis form. The structure of sAAPFna binding
to hCYPA is shown in Figure 1-5 to illustrate the interactions between tetrapeptide
and cyclophilin.
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Figure l-4.Stereodiagram of the binding site of hCYPA with bound Ala-Pro,
produced by MOLSCRIPT (Kraulis, 1991). The residues forming the
hydrophobic pocket are labelled. Some of the hydrogen bonds are marked by
broken lines. The carbon atoms of Ala-Pro are shown in green
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Figure l-5.Stereodiagram of the binding site of hCYPA with bound sAAPFna,
produced by MOLSCRIPT (Kraulis, 1991). The succinyl (Sue) and nitroanilide
(na) groups of sAAPFna are labelled and shown in magenta. The carbon atoms of
sAAPFna are shown in green.
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The cis proline makes hydrophobic contact with the hydrophobic pocket of CYPA.
The N-terminal nitrogen forms a hydrogen bond with the carbonyl oxygen of Asnl02
while the carbonyl oxygen forms a hydrogen bond with the NH nitrogen of Asnl02.
The other hydrogen bond is formed by the prolyl carbonyl oxygen with the side chain
of Arg55. These three hydrogen bonds are conserved in most structures of CYPA
complexed with a variety of substrates (refer to Tablel-E). Comparison of the
structures of tetrapeptides bound to cyclophilin and that of dipeptides bound to
cyclophilin reveals the major difference is the binding of Arg55. Arg55 adopts
different conformations in these two types of complexed structures. In the
tetrapeptide complexed structures, Arg55 adopts an identical conformation to that of
the native structure. However, the torsion angle around the CD-NE bond of the side
chain of Arg55 rotates from -140° in the tetrapeptide complexed structure to 70° in
the dipeptide complexed structure. The other difference between these two
complexed structures is the absence of a water molecule at the binding site in the
tetrapeptide complexed structure. The water is hydrogen bonded to the side chain of
Gln63 in the dipeptide complexed structure and was proposed to assist the cis-trans
isomerization in the "solvent-assisted mechanism". The details of "solvent-assistant
mechanism" will be discussed in section 1.2.6.
(c) The structure ofhCYPA complexed with HIV-1 cavsid protein:
The structure of hCYPA complexed with the N-terminal domain (residues 1 to 151)
of the HIV-1 capsid protein (CA151) was solved to 2.30A by Gamble in 1996
(Gamble et al., 1996). At the same time, the structure of a 25 amino acid peptide
(residues 81 to 105) of the HIV-1 capsid protein (25-mer) bound with recombinant
hCYPA was solved independently to a resolution of 1.8A by Zhao (Zhao et al., 1997)
with 12 of the 25 amino acids (Val86-Arg97) well-fitted into the density map while
the rest of the residues are disordered. Both structures show the capsid protein binds
at the active site on the surface of the cyclophilin. There are no large conformation
changes seen in either the cyclophilin or the capsid protein once the complex forms.
CA151 is a flat molecule with overall dimensions of 18A x 35A x 40A and contains 7
helices. The loop that connects helix 4 and 5 binds to the cyclophilin in an extended
conformation (see Figure 1-6).
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Helix 4
Figure 1-6.Ribbon diagram of the structure of hCYPA complexed with CA151
produced by MOLSCRIPT (Kraulis, 1991). The eight labelled strands of hCYA
are shown in purple, the two helices are shown in green and the joining loops are
shown in orange. The structure of CA151 are shown in lime green. The loop
(magenta) that connects helix 4 and 5 binds to cyclophilin in the binding site.
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Residues 85 to 93 of the capsid protein are involved in numerous hydrophobic
interactions and eight hydrogen bond interactions with hCYPA (refer to Table 1-E).
Pro90 of the capsid protein makes strong hydrophobic contacts with the residues in
the hydrophobic pocket of CYPA. However, Pro90 adopts the trans conformation, in
contrast to the cis conformation observed in other CYPA-peptide structures. In
addition, Gly89, the residue preceding Pro90, has a unfavourable backbone
conformation with 0=133° and \|/=160°. This unusual backbone conformation may be
adopted by Gly whereas it is inaccessible to other amino acids because of the
stereochemical constraints imposed by their side chains. Site-directed mutagenesis
has shown Gly89 is essential for binding as mutation of Gly89 to alanine inhibits the
CYPA-gag interaction (Colgan et al., 1996; Braaten et ai, 1996). It has been
proposed that cyclophilin plays a role as a chaperone or an essential functional
component instead of as a cis-trans isomerase in its interactions with HIV-1. The
reasons are as follows:
Firstly, the capsid protein binds to hCYPA in the trans form while the other proline-
containing peptides bind to CYPA in the cis form. Secondly, only Pro90 binds to
CYPA although there are three Proline residues (Pro85, Pro90 and Pro93) in the
binding interface between capsid protein and hCYPA. If cyclophilin is essential in
the folding of HIV-1 gag protein, it might be expected these three prolines would
bind equally to the active sites of CYPA. However, the complexed structure shows
only Pro90 binds to CYPA. Finally, a glycine residue preceding proline is essential
for the interaction between cyclophilin and gag protein while there is no specificity in
the requirement of the residue preceding proline in the other CYPA-peptide
complexes. This result indicates the binding of capsid protein and CYPA is sequence
specific.
In conclusion, the cis-trans isomerization activity of hCYPA may not be involved in
the interactions between cyclophilin and HIV-1 although whether Gly89-Pro90 can
undergo cis-trans isomerization by cyclophilin is still under investigation.
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1.2.5 The structures of CsA and CsA derivatives bound to hCYPA
(a)The structure ofhCYPA complexed with CsA:
Five structures of hCYPA complexed with CsA have been reported. Three were
solved by X-ray crystallography, each with a different crystal form (Mikol et al.,
1993; Pflugl et al., 1993; Ke et al., 1994) while the other two were determined by
NMR in solution (Wuthrich et al., 1991; Weber et al., 1991; Spitzfaden et al., 1992;
Theriault et al., 1993). All these structures show CsA binds at the PPIase active site,
which is located at the surface of cyclophilin (see Figure 1-7).
13 residues (Arg55, Phe60, Met61, Gln63, Gly72, AlalOl, Asnl02, Alal03, Glulll,
Phel 13, Trpl21, Leu 122 and His 126) form the CsA binding pocket and are within
4A of the bound CsA (see Figure 1-8).
Arg55, Ansl02 and Gln63 make five hydrogen bond contacts with CsA. In addition,
five rigid water molecules mediate hydrogen bond interactions between CsA and
CYP. CsA is a cyclic undecapeptide which has 7 of the 11 peptides N-methylated
(see Figure 1-9).
Analysis of the hCYPA-CsA complex structure shows residues 1, 2, 3, 9, 10 and 11
of the CsA are in contact with hCYPA (see Figure 1-8). MeVall 1 makes the most
strong contact with hCYPA although residues 1, 2, 3, 9 and 10 also contribute to
binding. When compared to the structures of proline-containing peptides bound to
CYPA, MeVall 1 occupies the position usually taken by proline in the binding
pocket. The remaining residues, 4, 5, 6, 7 and 8 are exposed on the CYPA surface
(see Figure 1-8) and are proposed to have specific interactions with calcineurin (Liu
et al., 1992), a key protein in the T cell activation pathway. The role of MeVall 1 in
binding to cyclophilin is supported by site-directed mutagenesis studies. Mutation of
MeVall 1 to MeAlal 1 or MeLeul 1 resulted in a decrease in cyclophilin binding and
immunosuppressive activity (Mikol et al., 1993). CsA adopts a significantly different
conformation when bound to hCYPA. Free CsA in solution has a tightly folded
conformation with four intramolecular hydrogen bonds (Loosli et al., 1985).
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Figure l-7.Diagram of the structure of hCYPA with bound CsA,produced by
MOLSCRIPT (Kraulis, 1991). The eight labelled strands of hCYPA are shown in
purple, the two helices are shown in green and the joining loops are shown in
orange. The 70s loop (residues 67 to 76) is shown in magenta. The carbon atoms of
CsA are shown in black.
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Figure l-8.Stereodiagram of the CsA docked into the binding site of hCYPA. The
carbon atoms of residues 1, 2, 3, 9, 10 and 11 of CsA, which are in contact with
hCYPA, are shown in magenta while the carbon atoms of residues 4, 5, 6, 7 and 8,
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Figure 1-9. Chemical structure of CsA. Abbreviations: MeBmt for (4R)-4-[(E)-
2-butenyl]-4-N-dimethyl-L-threonine; Abu for L-a-aminobutyric acid; Sar for
sarcosine; MeLeu for N-methylleucine; MeVal for N-methylvaline
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Moreover, there is one cis peptide bond between MeLeu9 and MeLeulO. However,
when bound to cyclophilin, CsA adopts a loose folded conformation without any
intramolecular hydrogen bonds. Additionally, all peptide bonds are present in the
trans conformation. In contrast to CsA, cyclophilin does not undergo dramatic
structural change upon ligand binding (Mikol et al., 1993).
(b) Structures ofhCYPA complexed with 11 CsA derivatives'.
A total of 11 structures of CsA and CsA derivatives bound to hCYPA have been
refined at resolutions between 2.2k and 1.76A with R-factors varying from 15% to
19% (Kallen et al., 1998). The formulae of 11 CsA derivatives and their biological
activities are summarised in Table 1-F.
Comparison of these 11 structures (Kallen et al., 1998) shows that the conformation
of the cyclophilin is very similar. The maximum rms deviation among all structures
is only 0.2A. Apart from the flexible N- and C-terminal regions, the only region that
reveals dramatic difference is the 70s loop (residues 67 to 76) (see Figure 1-7). The
movement of this loop results from the binding of the CsA analogues to the protein.
Comparison of CsA derivatives with CsA shows that the large difference occurs in
residues 4 to 8 of CsA. This region (residues 4 to 8) is suggested to have specific
interaction with calcineurin as mentioned before. In addition, the intermolecular
hydrogen bond and hydrophobic interactions between cyclophilin and different CsA
derivatives are conserved. This indicates that the binding site of hCYPA has a very
conserved conformation even when different ligands bind.
As seen in Table 1-F, chemical modification of residues 1, 2, and 3 changes the
ability of CsA to bind cyclophilin without affecting the immunosuppressive activity
dramatically. Conversely modification of residue 4 decreases the immunosuppressive
activity dramatically without reducing the binding affinity. This result is in agreement
with the structural study where residues 1, 2, and 3 are responsible of the binding to
cyclophilin while residue 4 affects the interactions with calcineurin. Residue 4 of
CsA is a key site in the recognition of CYPA/CsA complex by calcineurin. A slight
modification of the side chain of residue 4 is enough to essentially abolish the
calcineurin inhibitory.
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(2) The CYPA value in column 6 gives a measure of the strength
of the binding the derivative relative to CsA as determined using
an ELISA assay (Quesnizus et al., 1988)
(3) The number given is column 7 is the measure of the effect of
supressing the production of interleukin-2 relative to CsA in a
whole cell assay (Fliri et al., 1993; Bollinger et al., 1990)
(4)a) : IC50 (derivative)/IC50 CsA





































The ability to decouple the cyclophilin inhibitory property from its
immunosuppressive activity by such modification is of potential value in developing
non-immunosuppressant derivatives which prevent cyclophilin being incorporated
into the HIV protein coat. It has been shown that MeIle4-CS (211811) is a potentially
useful HIV inhibitor which blocks viral replication (Rosenwirth et al., 1994).
1.2.6 PPIase (peptidyl-prolyl cis-trans isomerase) activity
The torsion angle of a peptide bond can be either cis (0°) or trans (180°). Cis
peptides are rarely found in native structures of proteins. The rotational energy
barrier of the peptide bond from trans to cis form has been calculated to be
21kcal/mol (Jorgensen and Gao,1988), except the Xaa-Pro peptide bond. Xaa-Pro has
a higher probability (10% -30%) of forming a cis peptide bond while other peptide
bonds have a probability of 10"3. The higher probability of Xaa-Pro in cis peptide
bond is due to a lower rotational energy barrier of 17kacl/mol (Fischer et al., 1994).
Cyclophilin is known as a PPIase since their enzymatic activity can reduce the
rotational energy barrier and speed up the cis-trans isomerization. The PPIase activity
of cyclophilin plays an important role in the cell since it could accelerate the
refolding of other proteins. Some studies have shown the cis-trans isomerization of
the Xaa-Pro peptide bond is the rate-limiting step in the refolding process (Brandts et
al., 1975; Lang et al, 1987). The rate of refolding of RNAase was accelerated in the
presence of cyclophilin at a concentration as low as 0.1 (J.M (Schonbrunner et al.,
1991). When the concentration of cyclophilin increased to 30|iM, which is the
approximate concentration of some cyclophilins in vivo, RNAase was instantly
refolded (Harding et al., 1986). Addition of PPIase has also been shown to accelerate
the refolding process on human carbonic anhydrase II (Fransson et al., 1992). The
half-time for recovery of enzymatic active of carbonic anhydrase II on refolding was
reduced to 4min in the presence of PPIase compared to 9min in the absence of
PPIase. Moreover, studies have been reported which illustrate the involvement of
cyclophilins in the folding of several proteins: collagen or procollagen (Bachinger,
1987; Davis et al., 1989; Steinmann et al., 1991), chymotrypsin inhibitor 2 (Jackson
and Fersht, 1991) and ribonuclease (Lang et al., 1987; Kiefhaber et al., 1990a,b,c).
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The cis-trans isomerization can be considered as a two-step reaction (Ke et al.,
1993a). The first step is the rotation of the C-N peptide bond. The second step is the
release of the N- or C-terminal residues of peptides or substrates from the PPIase.
Since the C-N peptide bond has partial double bond character which results in the
restriction of the rotation of C-N bond, the cis-trans isomerization needs to overcome
the energy barrier. Therefore, any factors which can weaken the double bond
character of the C-N peptide bond might be expected to accelerate the rate of
isomerization.
Several mechanisms have been proposed for the cis-trans isomerization catalysed by
cyclophilins. They will be discussed as follows:
(a) Catalysis by formation ofa covalent tetrahedral intermediate (Fischer et al.,
1989a,b):
In this mechanism, it was suggested that a tetrahedral intermediate,
hemithioorthoamide, was formed by the nucleophilic addition of a cysteine or
nucleophilic residue to the carbonyl carbon of the Xaa-Pro peptide bond. The
formation of the covalent intermediate is then followed by rotation about the C-N
peptide bond and finally, collapse of the tetrahedral intermediate to release the
isomerized Xaa-Pro peptide. However, the structural study revealed no cysteine or
nucleophilic residue close to the carbonyl carbon (Ke et al., 1991). Additionally, a
site-directed mutagenesis study also disagreed with this mechanism as the mutation
of cysteine to alanine has no effect on the cis-trans isomerase activity (Liu et al.,
1990).
(b) Catalysis by distortion (Harrison and Stein, 1990a, b):
In this mechanism, the C-N peptide bond is rotated and this distorted intermediate is
stabilised by the noncovalent interaction with cyclophilin. The energy that is required
to distort the peptide bond out of planarity and therefore destroy the resonance
stabilisation of the amide linkage, is provided by the binding interaction between
cyclophilin and substrate in the transition state. This mechanism is supported by the
kinetic isotropic study and the solvent deuterium isotropic effect (Harrison and Stein,
1990a,b). However, from structural studies, all proline-containing peptides and
substrates bind to CYPA in the cis form, except the HIV-1 capsid protein (Gamble et
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al., 1996). Therefore, the distortion binding mechanism is not proven by the
structures of cyclophilin complexed with a variety of proline-containing peptides as
no distorted peptides in the transition state bind to cyclophilin.
( c) Protonation of the nitrogen ofC-N peptide bond (Kofron et al., 1991):
The mechanism proposes the side chains of serine, threonine or tyrosine protonate or
form a hydrogen bond to the lone pair of nitrogen atom of C-N peptide bond. It has
been proven by molecular orbital calculation that the protonation reaction of amide
nitrogen atom can reduce the energy barrier of the cis-trans isomerization as it can
deconjugate the C=0-N peptide bond and thus weaken the double bond character of
the C-N bond (Armbruster and Pullman, 1974). However, this mechanism is not in
agreement with structural results. In the structure of Ala-Pro binding to hCYPA,
there are no proton-donor groups such as serine, threonine or tyrosine close to the
amide nitrogen. Therefore, this mechanism is questionable and requires further
investigation.
(d) Catalysis by desolvation (Radzicka et al., 1992; Eberhardt et al., 1992):
This mechanism suggests the desolvation of the proline-containing peptides or the
substrates by binding to the PPIase may be the first step in the cis-trans
isomerization. Further actions, such as hydrophilic interactions between the PPIase
and substrates are required to complete the cis-trans isomerization. This mechanism
is supported by the results that the rate of cis-trans isomerization was significantly
accelerated in nonpolar solvents (Radzicka et al., 1992; Eberhardt et al., 1992). In
addition, this mechanism is also supported by the structural analysis of cyclophilin
complexed with a variety of substrates as the proline residue of the substrate makes
strong hydrophobic interactions with the hydrophobic pocket of the cyclophilin.
(e) Solvent-assisted mechanism (Ke et al., 1993a):
This mechanism is based on the structure of Ala-Pro binding to hCYPA. Ala-Pro is
firstly desolvated in the ground state by binding to the hydrophobic pocket of the
active site. Then, the C-N peptide bond of Ala-Pro is oscillated by thermodynamic
fluctuation or thermal movement. Once this C-N peptide bond is rotated to an angle
between -50° to -90°, a water molecule, which is conserved in the unliganded
structure of hCYPA and complexed structure of dipeptide binding to hCYPA, can
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form a hydrogen bond with the carbonyl oxygen atom of Ala-Pro and consequently
stabilise the intermediate in the transition state. This solvent-assisted mechanism is
supported by the structure of dipeptide binding to hCYPA. However, this mechanism
is inconsistent with the structure of cyclophilin complexed with sAAPFna (Zhao et
al., 1996a) as this water is displaced by the oxygen of the succinyl group. The
absence of the water molecule in the tetrapeptide complexed structure raises the
question whether the dipeptide and tetrapeptide have different cis-trans isomerization
mechanisms or whether solvent-assistant mechanism is wrong. Further experiments
using NMR or kinetic method are required in order to answer this question.
1.2.7 Functions
Many functions have been attributed to the cyclophilins
(a )Immunophilin:
The most well-known function of cyclophilin is its immunosuppressive activity,
which has been facilitated to prevent organ rejection after transplant operation. In
order to initiate the immunosuppressive activity, CsA is required to bind to
cyclophilin. Neither cyclophilin nor CsA alone can effect this activity. The
mechanism of the immunosuppressive activity is complicated. Firstly, cyclophilin
forms a tight complex with CsA and this complex will then bind to calcineurin and
inhibit its phosphatase activity (Liu et al., 1991, 1992; Clipstone et al., 1994).
Calcineurin is a phosphatase and plays an essential role in the regulation of T
lymphocyte activation and proliferation. Inhibition of calcineurin will inactive the
dephosphorylation of a lymphocyte-specific transcription factor, NF-ATp, and
therefore prevent the movement of NF-ATp from the cytoplasm to the nucleus where
it binds to the promoter of the interleukin-2 gene and stimulates expression of the
gene in the T-cell activation pathway (Loh et al., 1996; Luo et al., 1996).
(b)The PPIase activity.
The other important function of cyclophilin is its PPIase activity. Cyclophilin can
catalyse the cis-trans isomerization of peptidyl-prolyl amide bonds and consequently
accelerate the rate of refolding of certain proteins in the cell. The characteristic of
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PPIase activity and its influence on several proteins in vitro have been discussed in
section 1.2.6.
(c) The incorporation ofcyclophilin A into HIV-1 virions:
Recently, it has been reported cyclophilin A forms a tight complex with HIV-1
capsid protein and the binding of cyclophilin to HIV-1 capsid protein is required for
the infectious activity of HIV-1 virion (Franke et al., 1994; Thali et al., 1994).
Therefore, any factors that disrupt the interaction between capsid protein and
cyclophilin will then inhibit the replication of HIV-1. For example, CsA, the high
affinity substrate of cyclophilin, significantly inhibits the incorporation of cyclophilin
into HIV-1 virions and thus reduces the HIV-1 infectivity. As can be expected, if the
inhibitory property of CsA can be decoupled from its immunosuppressive activity by
chemical modification, this modified non-immunosuppressive CsA analogue could
block HIV-1 virion replication without initiating the immunosuppressive reaction.
Recently, it has been reported that MeIle4-CS, a non-immunosuppressive CsA
analogue, is a potentially useful HIV virion inhibitor (Rosenwirth et al., 1994).
Furthermore, crystallographic and genetic studies propose that the CYPA plays a role
as a chaperone or essential functional component instead of a cis-trans isomerase in
HIV-1 infectivity as discussed in section 1.2.4.
(d) The application in the field ofparasitology.
Cyclophilins have an important role in the field of parasitology as a large and
increasing number of conserved and divergent cyclophilins have been purified and
isolated in both protozoan, helminth and nematode species (Page et al., 1995a,b; Bell
et al., 1996). Moreover, CsA, the well-known substrate of cyclophilin, has been
shown to have anti-parasitic effects against a variety of parasites, such as, nematode
species (Page et al., 1995a,b). The mode of action of CsA or its analogues against
parasites is still unknown. However, it has been proposed that the anti-parasitic
properties of CsA are involved in producing structural damage to tegumental and gut
surface of the parasites and is likely to be related to the inhibition of the folding of
some proteins which are catalysed by PPIase under normal conditions (Page et al.,
1998).
(e) Other important functions ofsome divergent cvclophilins:
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Some divergent cyclophilins have been shown to have the distinct functions,
separated from the immunosuppressive function. The cyclophilin homology ninaA
gene product from Drosophila melanogaster has been shown to form a tight complex
in vivo with rhodopsin and this 26 kDa cyclophilin homologue is likely to be a
transporter transferring rhodopsin from the rough endoplasmic reticulum through the
cytoplasm to the cell surface. The ninaA gene is also probably to involve in the
folding of an eye-specific rhodopsin class in Drosophila melanogaster. The
inhibition of this folding has resulted in impaired vision (Colley et al., 1991; Schmidt
et al., 1994). In addition, two cyclophilin-like proteins together with other proteins
have been shown to chaperone the opsin molecule of the visual pigment of
vertebrates (Ferreira et al., 1996).
Moreover, hCYPB together with a heat shock protein (hsp47) has been reported to
transport procollagen from endoplasmic reticulum to pre-golgi intermediate (Smith et
al., 1995).
Recently, it has been reported that cyclophilin 40 together with other proteins, forms
the avian progesterone receptor (PR) (Johnson and Toft, 1994). This receptor is a
large multiprotein complex containing CYP40, P23, two heat shock proteins (hsp70
and hsp90) and two FK506-binding proteins, FKBP54 and FKBP52. In the absence
of hormone, PR has been shown to bind and respond to progestin.
1.3 Thesis rationale
The work described in this thesis involves the examination of the structure and ligand
binding interactions of BLG and CYP3.
The determination of the structure of BLG in the lattice Y form (BLGY) has not
progressed smoothly since it was first reported in 1979 at low resolution (Green et
al., 1979). An initial goal of this thesis was to collect a good quality data set at low
temperature and to achieve a successful refinement of the BLGY structure (chapter
3).
The ligand binding properties of BLG are ill-understood at the molecular level
although the protein has been shown to bind a variety of hydrophobic small
molecules by solution studies. Therefore, one of the main goals of this thesis was to
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provide a detailed picture of the binding site and consequently to understand the
interaction between a ligand and BLG using x-ray crystallography (chapter 4).
Similar to BLG, cyclophilin 3 (CYP3) is a small globular protein with molecular
weight around 18000Da. Superficially, CYP3 shares a similar structural motif to
BLG as both proteins contain a [3-barrel formed by the eight antiparalled p-strands.
However, the ligand binding characteristics and biological features of CYP3 are very
different from that of BLG. A further aim of this thesis was to refine the CYP3
structure and to examine the ligand binding interactions of the protein by x-ray
crystallography. Finally, by using the structure of CYP3 complexed with the
dipeptide, Ala-Pro, as a model system, x-ray crystallography was applied to a
dynamic study of ligand binding "in crystallo". It has been shown that it is possible
to obtain the dissociation constant by x-ray crystallography (chapter 5).
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2. Materials and Methods
This chapter will describe the methods applied to BLG and CYP3. First, the materials
used in the project (section 2.1) followed by the purification (section 2.2) and
crystallisation conditions (section 2.3) will be reported. Next, the crystallographic
data collection (section 2.4) and data processing (section 2.5) will be described.
Finally, the theory and programs used in molecular replacement and refinement will
be discussed in section 2.6 and 2.7, respectively.
2.1 Materials
• Bovine (3-lactoglobulin variant B (Lot 13H7150) was purchased from Sigma
Chemical Company.
• Phastgel Homogeneous 12.5 (Code 17-0623-01) was a 12.5% polyacylamide gel
(PAGE gel) supplied by Pharmacia Biotech (Uppsala, Sweden)
• Phastsystem was supplied by Pharmacia. It consists of a separation and control
unit and a development unit.
• The crystallisation screen I (HR-CS1) was supplied by Hampton research.
• Immersion oil (Type B) was supplied by Cargille Inc.
• Palmitic acid (Lot 105F00232) was 99% purity and supplied by Sigma Chemical
Company
• Ammonium sulphate was > 99% purity and supplied by Sigma Chemical
Company
• HEPES (Lot 10077840W) was 99% purity and supplied by BDH
• MPEG5000 was supplied by Sigma Chemical Company
• Ala-Pro was supplied by Sigma Chemical Company




The BLG used in this work was obtained in two ways. One batch was purchased
from Sigma. The other one was purified at the Hannah Research Institute.
2.2.1.1 Genetic typing of the Hannah Herd
Two genetic variants but three possibilities, BLG-A, BLG-B and BLG-AB, are found
in the milk of Hannah herd. Therefore, it was necessary to type genetically the milk
of several cows in order to identify individuals producing the pure A and pure B
variants. Fresh milk was collected from the Hannah dairy in the morning. Analysis of
all samples started within 3 hours ofmilking.
Genetic typing involved two stages. First, the whey protein was isolated from the
whole milk. The second stage used "Ultrathin layer gel electrophoresis" to identify
the variants. Ultrathin layer gel electrophoresis is very similar to the conventional gel
electrophoresis but a smaller gel is used in the ultrathin layer gel electrophoresis.
This method is faster than conventional gel electrophoresis and is supposed to give
high resolution. The protocol used was as follows:
(a) Isolation of the whey protein'.
First, fat was removed by skimming the milk. The milk was centrifuged at 40g for 25
mins and then cooled down in a refrigerator to solidify the fat layer. After 40 mins, a
slightly yellow fat layer was evident at the top of the centrifuge tube. Skimmed milk
was in the lower layer and some impurity was precipitated at the bottom of the tube.
The fat layer was removed with a spatula. 50ml skimmed milk was taken out of tube
with the volumetric pipette without disturbing the impurity at the bottom.
In the next step, casein was separated from whey protein by precipitation at the
isoelectric point. 1M HC1 was slowly added to 50ml skimmed milk to reduce the pH
from 6.6 to 4.6, the isoelectric point of casein. Casein started to precipitate when the
pH fell below 5.0. The cloudy solution was filtered through a 13mm polypropylene
Millipore filter unit (0.45pm poresize). After filtering, the slightly cloudy solution
containing whey protein was collected and stored in the refrigerator for further use.
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(b) Identification of the variant by ultrathin layer gel electrophoresis
Buffer containing 1 ImM Tris and 53mM glycine at pH 8.6 was prepared. A pre-cast
homogeneous 12.5% polyacylamide gel was soaked in approximately 100ml
Tris/Glycine buffer for at least 1 hour before use. After soaking, the gel was removed
and stood upright to drain on a tissue for around 10-15 mins. The gel was ready for
use in the Phast system. The buffer strips to connect the gel to the electrodes were
prepared according to the following protocol, lg Agarose was dissolved in 50ml
Tris/Glycine buffer using a hot plate and stirred with a thermometer until the
temperature reached ~ 85°C. The solution was clear at this stage. Then, the clear
solution was allowed to cool down to 58 °C and poured into the moulds using 2.4 ml
per mould. The strips were covered with parafilm and stored in the refrigerator.
The Pharmacia Phast system was thermostated at 15°C before use and the base of the
separation plate was cleaned with alcohol and wiped dry. Then distilled FbO =~
200pl was put in the centre of the base plate. The gel was placed carefully on the
separation plate to avoid bubbles between the plate and the gel. After that, the buffer
strips were carefully placed in the appropriate position. The electrode plate was then
put down making sure that the electrodes were in contact with the buffer strips.
Meanwhile, the sample solutions were prepared according to the following protocol.
Since the approximate quantity of BLG in milk was 3g BLG/ per litre milk, in order
to load a protein concentration of approximately 500p,g/ml, the whey protein was
diluted 6 times before being applied to the gel. This was achieved by dilution of 20|ll
of whey protein with 110|Ltl of the Tris/Glycine buffer and lOfll bromophenol blue
solution.
Sample solutions were then loaded into the gel according to the manufactory
instructions to start gel separation procedure, which took around lOmins.The protein
was stained with coomassie blue. Because variant A was more negative than B, it
moved faster under the applied electric field which consequently separates these two
variants.
The result of genetic typing of some of the Hannah herd is summarised in Table 2-A
and a photograph of the gel is shown in Figure 2-1.
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Table 2-A. Ihe variants ofBLGinnilk fromHannahHerd
Cbwnurrber Lactation number Lactation date Genetic variant
64 3rd 12/95 AB
158 2nd 8/8/95 A
167 2nd 29/8/95 AB
181 2nd 29/8/95 AB
186 2nd 2/8/95 AB
257 1st 9/95 A
259 1st 307/95 AB
260 1st 8/95 A
384 1st 1095 A
386 1st 1095 B
387 1st 11/95 B
Figure 2-1. Photograph of the gel used for genetic typing.













64 158 167 181 186 257 259 260 384 386 387
2-4
2.2.1.2 Purification ofBLG
The "salting out" method (Armstrong, 1967) was chosen to purify BLG. The
purification procedure involves four stages:
the removal of fat, the removal of casein, fractionation of whey protein and the final
purification of BLG. The milk of cow no.386 (variant B) and cow no.384 (variant A)
were chosen to be purified. The protocol was as follows:
(a) First ammonium sulphate Precipitation:
Ammonium sulphate (264g/per litre of milk) was slowly added at room temperature
over 40 mins. The solution was left to stir for 2 hours and then filtered through a
Whatman 113V fluted filter paper. If the solution was still cloudy, it was then filtered
through No. 42 filter paper overnight in the cold room to remove fat and some of the
casein.
(b) Acid precipitation:
The faintly cloudy solution was taken from the cold room and brought to room
temperature. 1M HC1 (38 ml/per litre milk) was slowly added to reduce the pH from
7.04 to 3.5. The casein started to precipitate when the pH was below 5.0. The
solution was left to stir for 1 hour and then centrifuged at 70g over 40 mins at 16°C
using a Mistral 6000 centrifuge. After centrifuging, the supernatant was carefully
poured off and filtered through No 42 filter paper. 1M NH4OH was added to re¬
adjust the pH of supernatant to 6.0.
(c) SecondAmmonium Sulphate Precipitation:
Ammonium sulphate (262g/per litre of the supernatant obtained from the previous
step) was gradually added with stirring. The procedure was done very slowly in order
to get a high yield. White BLG precipitated at this stage. The solution was left to stir
overnight in the cold room to allow complete precipitation of BLG. Then, the milky
solution was centrifuged at 80g in room temperature for 30 mins. After the
supernatant was poured off carefully, the white precipitate was collected with a
spatula and the tube was washed with a minimum amount of supernatant. The
precipitate was mixed with a small amount (~2ml) of acetate buffer for dialysis.
(d) Dialysis:
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Before dialysis, a suitable length of Visking tubing (18/32" diameter) was boiled for
one hour in Na2C03 in order to remove the plasticizer and any heavy metals. The
precipitate of BLG was packed to the tubing and dialysed against 0.12M sodium
acetate/0.04M acetic acid buffer, pH 5.2 overnight. The buffer was changed 4 times
at 4 hourly intervals. Next morning, there was some black impurity, a-lactoferrin,
precipitated at the bottom of tubing. The solution was centrifuged at room
temperature for 30 mins by Sorvall centrifuge using the SS34 rotor. After removing
a-lactoferrin, the supernatant was dialysed against phosphate buffer at pH 6.7 (0.02M
Na2HPC>4/ O.lMNaCl).
(e) Gel Filtration:
A column of length 100cm and diameter 2.5cm was packed with Sephadex G-75,
equilibrated in 0.02M Na2HP04/ 0.1M NaCl and 0.02% azide, pH 6.7 over 72 hours.
The buffer was de-gassed before use. Before loading into column, the concentration
of protein in the dialysed sample was determined using £icm =9.6 ml/mg*cm at
278nm by measuring its UV absorbance. Where the concentration was too high, the
sample was diluted with phosphate buffer to ~ 30mg/ml. The flow rate was set to
0.4ml/min and the BLG eluted within approximately 270ml.
(f) Freeze-Dried the protein'.
The fractions with high absorbance UV value was collected and dialysed against de-
ionised H20 for one day. Then the solution was freeze-dried for storage. The protein,
which looked like white cotton after freeze-drying, was stored in the freezer until
required. The purity of the final sample was checked by ultrathin layer gel
electrophoresis. A photograph of the gel is shown in Figure 2-2
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2.2.1.3 Result
(a) By weighting the BLG after freeze-dried, the yield obtained was as follows:
BLG-A: 326mg (326mg/lL milk)
BLG-B: 2500mg (lOOOmg/lLmilk)
(b) Figure 2-2. Photograph of the gel used to check the purity of BLG after
purification. The numbers represent the numbers of cows labelled in the
Hannah herd.
384 386 386 386 386 386
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2.2.2 BLG-palmitate complex
Bovine BLG-AB complexed with palmitate was prepared by Puyol in Spain. The
procedures are included for completeness.
The procedure was according to Puyol et al (1994) and BLG-AB was delipidated by
charcoal treatment at pH 3 as described by Chen et al (1967). Palmitic acid at a molar
concentration ratio of 2:1 with respect to the protein dimer was dissolved in
chloroform in a glass tube. After the organic solvent was evaporated under nitrogen,
a solution of delipidated BLG, dissolved in 0.29 M NaCl, 2.5mM KH2PO4, 16mM
K2HPO4 pH 7.4 was added and the mixture incubated overnight at 37 °C. The
saturated protein solution was then dialysed against distilled water and freeze-dried.
Analysis by gas chromatography showed that the complex had about 1 mol palmitate
bound to 1 mol of dimeric protein.
2.2.3 CYP3
CYP3 was cloned by Dr. Page in Glasgow University and was purified by Miss
Jacqueline Dornan in the laboratory in Edinburgh. The procedures are included for
completeness.
2.2.3.1 Cloning ofCYP3
CYP3 was cloned by Dr. Page (Page et al., 1996) using the reverse transcriptase
polymerase chain reaction (RT-PCR) method. The RT-PCR conditions were as
follows: lOpmol of each primer (CYP3F/Nde
GCGAATTCTTATGCCTTGAGTTGTCCACAG), Buffer ( 45mM Tris pH 8.8; 1 ImM
ammonium sulphate; 4.5mM MgCl2; 6.7mM 2-ME; 4.4|iM EDTA pH=8; ImM of
each; 113|ig/ml non-acetylated BSA), 2pl of mixed stage cDNA and lp.1 Taq
polymerase. All of the above solution were mixed together and cycled 20 times at
94°C for 30secs (denaturation), 60°C for lmin (annealing) and 72°C for lmin
(extension) in 100|ll. Plasmid DNA was isolated (Plasmid Kit, Qiagen) and the insert
was sequenced in both directions to check that no mutations had been generated by
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the RT-PCR procedure. The plasmid DNA was then transformed into BL21 (DE3
pLysS) cells (Promega) for recombinant protein expression. After expression, the
protein extract containing recombinant CYP3 was subject to purification.
2.2.3.2 Purification ofCYP3
CYP3 was purified by Jacqueline Dornan in the laboratory in Edinburgh. First,
protein extract was loaded into a SP Sepharose cation exchange column. Two buffers
were used in sequence- Buffer A: 50mM HEPES, 5mM EDTA, 5mM [3-Me at
pH6.8; Buffer B: Buffer A mixed with 0.5M NaCl, pH=6.8. Column fractions were
tested by 15% SDS-PAGE gel. The fractions that contained CYP3 were collected and
dialysed against buffer A overnight. After filtering through a 0.2p,m filter, the
solution was loaded into a Resource S ion exchange column. CYP3 was eluted within
75ml by the following buffer— Buffer 1: 20mM HEPES at pH=6.8; Buffer 2: Buffer
1 mixed with 0.5M NaCl.
2.3 Crystallisation
2.3.1 Introduction
2.3.1.1 The theory ofcrystallisation
Crystallisation is a multiparametric process and involves three steps: nucleation,
growth and cessation (Stura and Wilson, 1992).
First, crystallisation starts by nucleation, in which the macromolecule (protein) free
in solution forms the first ordered aggregates. In order to achieve nucleation, the
protein solution is brought into a supersaturated state, which is a metastable
condition where more protein is in solution than is in thermodynamic equilibrium. A
supersaturated state is thermodynamically unstable and may return to equilibrium by
forming a crystalline or amorphous phase. Once the nucleation has occurred, the
crystallisation goes on to the second step, crystal growth. Crystal growth is a process
where protein is converted from the solution phase to the crystalline phase. In this
step, protein is crystallised by the slow precipitation of the protein onto an ordered
crystal lattice. When the crystals are formed by the addition of protein molecules onto
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the growing faces of the crystal lattice, the degree of supersaturation is decreased as
well.
Cessation of crystal growth can occur for many reasons. The most obvious is due to
accumulation of impurities in solution, which results in growth defects, poisoning of
the faces or ageing of the macromolecules.
There are various parameters responsible for the solubility of a protein and
consequently they will affect the crystallisation process. These parameters (Blundell
and Johnson, 1976), such as precipitant type and concentration, pH, ionic strength,
temperature and the presence of additives (e.g. organic solvent) which change the
dielectric constant of the solution need to be explored to optimise the crystallisation
conditions. Because a variety of parameters need to be considered, in order to reduce
the number of experiments and the consumption of protein, a more practical
approach using sparse matrix screens is usually carried out (Jancarik and Kim, 1991).
In the sparse matrix screening method, the crystallisation conditions have been
chosen based on a data base of successful protein crystallisation. These conditions
include reagent combinations as well as the pH ranges which are most frequently
reported in the literature. The concept of sparse matrix screening has become widely
accepted and these crystallisation conditions are now commercially available as kits
(Crystal Screen, Hampton Research).
Once success in a sparse matrix screen has been achieved, a grid screen should be
performed to optimise the crystallisation conditions in order to obtain better crystals.
Grid screens generally screen a single precipitant concentration versus a range of pH
based on the information obtained from the sparse matrix screen. Grid screens are
useful to fill in pH and reagent gaps missed with sparse matrix screens.
Four methods (Weber, 1997) are commonly applied to the crystallisation of
macromolecules: vapour diffusion, free interface diffusion, batch and dialysis
methods. The vapour diffusion method is used for the work described in this thesis.
The vapour diffusion technique is the most popular method for the crystallisation of a
protein as it is easy to set up, cheap and most important, it consumes little protein.
Therefore, vapour diffusion is extensively used in screening for the suitable
crystallisation conditions. Typically, the drop, either a hanging or sitting drop,
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containing the 1:1 mixture of protein and precipitant is suspended and sealed over a
well or reservoir solution, which contains the precipitant at the target concentration.
The principle of vapour diffusion is straightforward. Since the drop contains a lower
precipitant concentration than the reservoir, in order to reach equilibrium, water
moves from the drop to the reservoir. As water leaves the drop, both the protein and
precipitant concentration increase to achieve the supersaturated state and therefore
lead to crystallisation.
2.3.1.2 The theory ofsoaking and co-crystallisation
Inhibitors, activators, substrates, or heavy atoms can be introduced into a crystal to
bind to the protein in two ways (Stura and Chen, 1992). One is to soak native crystals
of protein in the mother liquor containing ligand or reactant solution. Because a
protein crystal has a high solvent content (between 27-95%), apart from a small
amount of the solvent which is tightly bound with the protein, most solvent is weakly
bound and can be replaced by ligand. The maximum size of the ligand that may be
diffused into the crystal depends on the size and environment of the channels within
the crystal. For most small molecules, these channels are large enough to allow their
diffusion to any part of the surface of the protein except for the regions involved in
crystal contacts. However, if the ligand is large or hydrophobic, diffusion into the
crystal becomes inefficient. In these cases, co-crystallising ligand with protein is an
alternative way to introduce the ligand into the crystal. Compared to the soaking
method, co-crystallisation sometimes can produce crystals which are totally non-
isomorphous with the native crystal, e.g. different space group, and this makes the
structure determination more complicated.
2.3.2 BLG
2.3.2.1 Crystallisation ofBLGY
Initial trials of crystallising Lattice Y used ammonium sulphate according to the
existing recipes (Brownlow et al., 1997, Hambling, 1990). However, they failed to
produce good crystals suitable for X-ray diffraction when either the batch method or
the vapour diffusion method were tried. Only amorphous precipitate appeared.
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However, in some drops, microcrystals were obtained. After optimising the
crystallisation conditions by varying protein concentration, pH, salt concentration and
temperature, the best crystals obtained only diffracted to 3.5A. Therefore, the crystal
screen kit (Hampton research, HR-CS1) was used to screen for alternative
crystallisation conditions. Six lattice Y crystals with a size around 0.5mm were
obtained in reagent No.38, whose composition was 1.4M sodium citrate dihydrate,
0.1M HEPES, pH 7.5. The crystals diffracted to a resolution better than 3A. Then,
the crystallisation conditions were refined by varying the sodium citrate dihydrate
concentration, pH, protein concentration. After several trials, good crystals that
diffracted to 2A were obtained by the following procedure:
Bovine BLG-B was dissolved in distilled H2O to a concentration of 40mg/ml and
crystallised at 16°C by the sitting drop method using 1.34-1.40M sodium citrate as
precipitant and 0.1M HEPES adjusted with 1M NaOH to pH 7.5 as buffer. 0.02%
azide was also added to prevent microorganism growth. Distilled H20 was used
through the whole experiment. A microbridge was placed in 1.0 ml of precipitant
solution, the reservoir, in a 24-well Linbro tissue culture plate. For a sitting drop, 4(il
protein solution was added to 12jil reservoir solution. After the well was sealed with
a glass cover-slip and immersion oil, the whole tray was left in the 16°C crystal
growth room. After 4-5 days, lattice Y crystals with size 1.0x0.8x0.9 mm, had grown
from the clear drops (see Figure 2-3, top left).
BLG-A and BLG-AB were also crystallised using the same conditions as above.
However, the quality of crystals, as judged both by the size and diffraction pattern,
was not as good as those of the BLG-B variant. The BLG purified at the Hannah
Institute herd was tried as well. Crystals with dimensions around 1mm were obtained
from the same conditions. However, compared to the chunky crystals from the Sigma
protein, the crystals were long and thin, which resulted in the elliptical spot shape in
the diffraction pattern. Furthermore, the overall quality of the data was worse than
that for Sigma BLG. The reason why the more pure protein from the Hannah herd
produced worse crystals than the protein from Sigma is unknown. One possibility is
that some low level impurity maybe plays the role of an additive to improve the
crystal quality.
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Figure 2-3. Photograph of a crystal of BLGY Figure 2-3. Photograph of a
crystal of BLGZ co-crystallised
with palmitate
Figure 2-3. Photograph of a crystal of CYP3
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2.3.2.2 Co-crystallisation ofBLG with palmitate
Once native crystals were available, the soaking experiments were carried out to
introduce ligands into the crystals. However, crystals tended to crack easily in the
soaking solution, which contained 5%-10% organic solvent (for example, ethanol) in
the mother liquor to help dissolve the hydrophobic ligand. Apparently, the additional
organic solvent disturbs the interaction between molecules at the crystal contact in
the lattice which results in cracking of the crystal. If the content of organic solvent
was decreased below 5%, the crystals sometimes survived. However, this reduced
the amount of palmitate available to diffuse into the crystal to bind to the protein
since there was no promising electron density observable in the difference maps.
Therefore, soaking experiments were abandoned and the alternative method, co-
crystallisation, was used to try to introduce the palmitate into crystals.
BLG-B crystallisations were set up as described in 2.3.2.1, but 0.4|il lOOmM palmitic
acid in 100% ethanol was added to the drop to give a molar ratio of 10 palmitic acids
per protein dimer, and mixed by pipette before the well was sealed with the glass
cover-slip. Since the palmitic acid was super-saturated with respect to the aqueous
phase, a white precipitate appeared in the drop. After 4-5 days, the white precipitate
had disappeared and trigonal lattice Z crystals, with size 0.4x0.3x0.5 mm, grew from
the clear drops (see Figure 2-3, top right).
The pH of the crystals was assumed to be 7.5, although it was not directly measured.
It is interesting to notice that, in a control experiment, with the same conditions but
no added ligand solution, lattice Y rather than lattice Z crystals appeared in the drop.
2.3.2.3 Crystallisation ofBLG complexed with palmitate
The freeze-dried complex prepared by Puyol (refer to 2.2.2) was dissolved in distilled
H2O to a concentration of 40mg/ml and crystallised as a sitting drop (4p) protein
solution + 12|il well solution) over a well solution of 1.4M sodium citrate, 0.1M
HEPES at pH 7.5 and 0.02% azide. Crystals, also of the trigonal lattice Z form, grew
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in a few days and appeared identical to the crystals from the co-crystallisation
preparation.
2.3.3 CYP3
Crystallisation and ligand soaking of CYP3 were done by Miss Jacqueline Dornan in
the laboratory in Edinburgh. The methods are included for completeness.
2.3.3.1 Crystallisation ofCYP3
CYP3 purified by the procedure outlined in section 2.2.3 was crystallised at 16°C by
the hanging drop vapour diffusion method. The well solution contains 29-31%
MPEG5000 as precipitant and 0.1M sodium citrate adjusted by citrate acid to pH 5.6.
For a hanging drop, 2|il 7.0mg/ml CYP3 in 20mMHEPES/0.5MNaCl buffer was
added to 2pl well solution.
Tetragonal bipyramidal crystals of size 0.2x0.3x0.3 mm appeared after 1-2 weeks
(see Figure 2-3).
2.3.3.2 Soaking ofCYP3 with Ala-Pro
The conditions of the native CYP3 crystals soaked in solutions with different
concentrations of Ala-Pro are summarised in Table 2-B.
Table 2-B. The conditions of the native CYP3 crystals soaked in solutions with
different concentrations of Ala-Pro
Ala-Pro
Concentration(mM)
Soaking Vol. ((il) Soaking time
1.2 10 27 hours
6 10 20 hours
18 10 20 hours
36 10 18 hours
60 10 20 hours
120 10 17 hours
2.4 Data Collection
The goal of data collection is to collect all unique reflections for a specific space
group. Additionally, because crystals could decay in the x-ray beam due to reactive
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free radicals generated by the radiation, protein crystallographers have to use an
efficient data collection strategy to collect data as rapidly and precisely as possible. It
is also highly advantageous to collect as many as symmetry equivalents as are
accessible with in the limits of the experimental set up.
2.4.1 Preparing a crystal for data collection
Traditionally, crystals are mounted in a capillary with mother liquor to keep them
from drying out during the x-ray experiment. However, crystals usually decay quickly
at room temperature before a complete data set can be collected. This problem has
been overcome recently by suddenly cooling the crystal in liquid nitrogen to a
temperature around 100K, and thereafter keeping the crystal in the stream of gaseous
liquid nitrogen during data collection.
This flash freezing method has been shown to increase crystal lifetime significantly,
in some case even making crystals survive indefinitely (Dewan and Tilton, 1987).
Moreover, the advantage of this method is that it is rather easy and there is very little
mounting material and surrounding mother liquid to cause a significant radiation
background. Recently, it has been found some protein crystals can be frozen first and
unfrozen later for several rounds to collect more than one type of data set from the
same crystal. Surprisingly, the mosaicity of the crystal decreased during this
procedure (Yeh and Hoi, 1998).
A suitable cryoprotectant is essential for the success of the flash freezing method.
The function of the cryoprotectant is to prevent the crystal cracking when the
disordered water and solvent in the crystal freeze as an amorphous glass. Some
chemicals, such as ethylene glycol, glycerol or PEG400, at concentrations between
15-25% in mother liquor are frequently used as cryoprotectants. There are several
ways to introduce the crystal into the cryoprotectant: direct transfer into the final
concentration of cryoprotectant for a few seconds, sequential transfer into increasing
concentrations of cryoprotectant and co-crystallisation with cryoprotectant (Garman,
1996).
The flash freezing procedures for BLG and CYP3 were as follows:
(a)BLG:
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A crystal about 0.8mm in length was mounted in a 1.0mm cryoloop
(Hampton Research, Inc.), dipped briefly (2-3 seconds) in immersion oil (TypeB,
Cargille) and frozen by plunging into liquid N2. The frozen crystal was then
transferred to a magnetic goniometer head in a stream of N2 at 100K (Cryostream,
Oxford Cryosystems).
(b) CYP3 :
The composition of cryoprotectant required for CYP3 was: 0.2ml glycerol, 0.7ml
mPEG5000, 0.1ml 0.1M sodium citrate/citric acid (pH 5.6). A crystal about 0.3mm
in length was mounted in a 0.2-0.3mm cryoloop (Hampton Research, Inc.), dipped in
cryoprotectant for a few seconds and frozen by plunging into liquid N2. The frozen
crystal was then transferred to a magnetic goniometer head in a stream of N2 at 100K
as for BLG.
2.4.2 Optimising data collection parameters
Although the quality of crystal is the most important factor that determines the
quality of data, other factors also affect the success of data collection. It is impossible
to fully satisfy all of the factors at the same time. Thus, any data set is usually the
result of compromise.
These factors will be discussed below:
(a) Detector distance:
The crystal-to-detector distance is the first parameter to decide upon since it
determines the spot separation and hence the maximum resolution that can be
collected.
Spot separation = 1/L * D * X
where L: the length of one of unit cell axes, normally the longest
D: detector distance
X : wavelength
Therefore, the distance between spots depends linearly on the detector distance. The
further the detector distance, the better the separation. However, if the detector
distance is too far, the reflections can be beyond the edge of the detector and
consequently the high resolution data will be missed out. A rule of thumb is to move
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the detector back until the highest resolution reflections just reach the edge of the
detector. This reduces radiation background and uses the detector surface most
efficiently.
(b) Oscillation width per frame:
The permissible oscillation width per frame without spot overlap depends only on the
maximum resolution and cell dimension parallel to the beam direction (Dauter,
1997).
Ac() = (180/ti) (d/a)
where d: the resolution limit
a: cell dimension parallel to the beam direction
Because crystals often have different cell dimensions in different directions, the
maximum allowed rotation range may also change when the crystal rotates from
image to image. However, the cell dimension along the spindle axis will never lie
along the beam since the crystal is rotated around this axis. Thus, if a crystal has one
cell dimension much longer than the other two, it is best to align this longest axis
along the goniometer spindle axis.
(c) The required, oscillation range:
How many degrees need to be collected in order to get a complete data set depends
upon the crystal symmetry and the choice of the proper rotation start and end
positions. The required oscillation range varies from 30° to 180° (Dauter, 1997) but
assumes that the crystal is perfectly aligned. Usually, because the crystal is
misaligned in practice, the required oscillation range is larger.
(d) Slit size:
The bigger the slit size, the stronger is the x-ray beam that will radiate the crystal and
consequently, the spot intensity will be stronger. However, the background radiation
also increases. Also, the spot size will be bigger with a wider slit and this may result
in spot overlap. Thus, ideally, the slit size should be set equal to or smaller than the
crystal size.
(e) Exposure time:
The longer the crystal is irradiated in the X-ray beam, the stronger reflections are
recorded in the detector. Therefore, if the high resolution reflections are too weak, it
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is sometimes useful to increase the exposure time in order to get stronger reflections.
However, if the exposure time is too long, the low resolution reflections will start to
overload. Thus, how to choose a reasonable exposure time is a result of compromise
between the collection of low and high resolution data.
The other alternative way is to decrease the oscillation width per frame with the same
exposure time. With the Mar detector, it is sensible not to have a maximum pixel
intensity on any frame greater than 45000 although the intensity up to 105000 is
processible (DENZO default number).
2.4.3 Summary of the optimised parameters for data collection
All diffraction data with the exception of the data from the native BLGY crystal were
collected on a 300mm MarResearch imaging plate system mounted on an ENRAF
Nonius FR571 rotating anode generator operating at 40kV, 80mA and producing Cu-
Ka radiation from a graphite crystal monochromator. The pixel size of the Mar
detector is 150pm x 150p.m. The data of native BLGY was collected on a 180mm
MarResearch imaging plate using the synchrotron source in Daresbusy 7.2 station.











Native* 83.9 0.2 1.4 120 0-182
j
Palmitate 180 0.35 1.5 1500 0-132
Palmitate2 160 0.30 1.5 1200 0-67.5
native*: data was collected in Daresbusy using small mar detector
palmitate': data collection of BLG co-crystallised with palmitate (first preparation, section 2.3.2.2)
palmitate2: data collection of BLG complexed with palmitate (second preparation, section 2.3.2.3)
Table 2-D. The summary of data collection parameters for CYP3
Ligand Distance Slit size Oscillation Exposure Oscillation
(mm) (mm) width (°) time (sec) range (°)
Native 120 0.3 1.2 1200 0-48
1.2mM Ala-Pro 145 0.3 1.2 1200 0-79.2
6mM Ala-Pro 135 0.3 1.2 1200 0-72
18mM Ala-Pro 130 0.3 1.2 1200 0-52.8
36mM Ala-Pro 130 0.3 0.9 1800 0-63.9
60mM Ala-Pro 140 0.3 1.25 1200 0-76.8
120mM Ala-Pro 135 0.3 1.2 1200 0-108.75
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2.5 Data Processing
Data processing is a procedure to analyses, integrate, scale and merge the diffraction
data obtained from data collection. The aim of this procedure is to index the recorded
reflections, properly integrate the intensity and assess the quality of data set
statistically.
2.5.1 Data processing protocol
Program DENZO (Otwinowski and Minor, 1997) was used to process the data. The
program consists of the three subprograms: DENZO, XDISPLAYF and
SCALEPACK. Subprogram DENZO separates the background from the reflection
and writes these integrated reflections into a file containing hkl indices, intensity and
estimates of the errors. XDISPLAYF is a program to display the diffraction image in
order to monitor the data processing procedure. SCALEPACK is to scale the
integrated reflections from DENZO and merge the symmetry-related reflections to a
symmetry-unique set of reflections.
The protocol is as follows:
(a) Autoindexing the diffraction pattern:
The first step is to search for a number of well separated and medium intensity
reflections to be used by autoindexing. Then, autoindexing is performed to search for
all possible indices of all reflections picked from the peak search step by fast Fourier
Transform (FFT) method. After the search for all possible indices is complete, the
three linearly independent vectors with minimal unit cell volume are obtained. These
three linearly independent vectors are able to index all of the observed reflections and
form a basis for the determination of the true unit cell. The output of autoindexing in
DENZO is the lattice and unit cell distortion table, and the crystal orientation
parameters. The lattice and unit cell distortion table show the 14 Bravais lattices in
decreasing order of symmetry, with primitive cubic being the highest symmetry and
primitive triclinic being the lowest symmetry. Along with each lattice is a percentage
value which represents the distortion of the unit cell parameters in order to fit the
lattice. From the table, the lattice of highest symmetry with minimal distortion is
chosen from among 14 Bravais lattices.
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(b) Optimisation ofspot size and mosaicity:
The spot size and shape were chosen to fit the reflection as closely as possible. It
could be slightly bigger than the actual reflection size, but must not overlap the
neighbouring reflections. The background size was chosen 0.1mm larger than the
spot size.
Mosaicity is optimised to give more or less the same number of predicted reflections
as are observed reflections. However, it is better to give slightly higher mosaicity to
be sure of picking all the spots.
(c) Refinement of the crystal orientation and detector parameters:
Because the approximate orientation of the crystal and initial detector parameters
given from the autoindexing step were imprecise, the crystal and detector parameters
had to be refined in order to get an accurate prediction of the spot position.
Minimisation of the deviation of the reflections from their predicted positions was
essential for obtaining precise integrated reflection intensities. This least-squares
refinement is applied in DENZO and the %" value, a measure of the difference
between predicted and recorded reflections, should be near 1.0 if the refinement has
converged. However, a value of 2 or even 3 is still acceptable. In the early stages
of refinement, %2 values will be high, but when the orientation of the crystal, the
detector parameters and the unit cell parameters start to be refined, the % values
should decrease gradually and end up below 2. The predicted decrease is a measure
of the convergence of the refinement. When the predicted decrease is near zero, the
refinement has converged and further refinement will have no effect.
(d) Integrating the reflection intensity:
A profile fitting method was applied in DENZO to integrate the intensity. This
method makes the assumption that the profile of the reflections is independent of the
intensity, which means the strong and weak reflections have the same profile.
Therefore, the strong reflections can be used to determine the profile and then this
profile is applied to the weak reflections. Once the profile was derived from the
strong reflections, this profile was fitted to each reflection as closely as possible and
the area under the profile was counted as intensity. The rest of the area outside the
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profile was then considered as background. The background must be subtracted from
the intensity to get the correct measurement.
The profiles of the observed reflections vary over in the diffraction pattern as the
profiles of the reflections at the centre of the diffraction pattern are more circular than
that at the edges because the incident beam is more oblique at the edge of the
detector. Thus, several profiles were usually used in the different parts of one
particular image. In DENZO, each profile was derived from 10-50 strong reflections.
(e) Scaling and mersins the integrated reflections:
Scaling data means to put all reflections on the same scale. Merging data means to
find reflections with symmetry-related indices and transfer them to a symmetry-
unique set of reflections. Therefore, the program SCALEPACK consists of three
parts:
(1) calculate the single isotropic scale and temperature factor for each image or batch
in order to scale all data to the same level
(2) reject the outliers and analyse for systematic errors
(3) average the symmetry-related reflections and merge them to a unique set data
2.5.2 Space group determination
The space group was determined by the following steps:
(1) The lattice type with highest symmetry and lowest distortion was selected from
the distortion table in DENZO
(2) The data were scaled first in SCALEPACK by the lowest symmetry Laue group
in the Bravais lattice selected from step (1). Then, the Laue group with higher
symmetry was tested by the same procedure and the % was compared with the
previous one from the lowest symmetry Laue group. The %2 from the SCALEPACK
statistics output was the criterion to decide the Laue group. If % was significantly
higher, the previous Laue group was the correct one. If % was almost the same, the
next higher Laue group was tried. The procedure was repeated until the Laue group
of highest symmetry with similar %2 was found.
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(3) After the Laue group was determined, the systematic absences in the output log
file were checked. Once the systematic absences were confirmed, the space group can
subsequently be determined. However, some space groups have the same systematic
absences, for example, the enantiomeric space group, P3i21 and P3221. In these
cases, scaling and merging of reflections can not distinguish between these
enantiomeric pairs and hence these space groups have to be determined from the
translation function in molecular replacement or by some other procedures.
2.5.3 Assessment of data quality
The quality of the data can be assessed from the SCALEPACK output statistics.
There are two ways to justify the data quality:
(a) The ratio of intensity to the sigma of intensity, i.e. I/O:
The sigma (estimated standard deviation) of an intensity is an estimate of how
accurate the individual reflection is. It is calculated from the counting statistics,
background height and the number of times the reflection was measured. The bigger
the sigma, the more imprecise the reflection. Therefore, the bigger the I/a, the better
the data quality. Moreover, I/g is also used as a criterion for resolution cut-off.
(hiRmergfi'
Rmerge is a measure of the difference between symmetry-related reflections that should
have theoretically identical intensity.
Rmerge = 11- <I> I / 2h 111
<I> is the mean intensity of all observations of reflection, h=hkl
Traditionally, if the Rmerge is < 5%, the data are considered as good. If the Rmerge is
between 5%~10%, the data are still useful. But if the Rmerge is > 10%, the data require
further investigation, which may just mean reprocessing. However, Rmerge is not a
very sensitive criterion of the data quality. As the redundancy goes up, the final
averaged data quality is improved, but the Rmerge also goes up. Furthermore, if the
space group has high symmetry, the Rmerge is bigger although the data quality is the
same as that of a lower symmetry space group.
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Furthermore, Rmerge can be manipulated by rejecting weak reflections, cutting the
higher resolution data off and omitting the partially recorded reflections. In these
cases, the quality of data becomes worse although the Rmerge seems to improve.




Table 2-E. Data processing parameters for BLG and CYP3
(1) BLG






Native 0.652 (0.45, 0.45) 30 (16.2,-118.4, -98.9)
Palmitate1 0.689 (0.5, 0.5) 27 (-19.53, 144.20, -80.32)
a
Palmitate" 0.328 (0.5, 0.5) 27 (0.20,8.81,24.75)
palmitate1: data collection of BLG co-crystallised with palmitate (first preparation, section 2.3.2.2.)
palmitate2: data collection of BLG complexed with palmitate (second preparation, section 2.3.2.3.)
(2) CYP3






Native 0.607 (0.45, 0.45) 27 (70.3, 50.48, -145.0)
1,2mM Ala-Pro 0.757 (0.45, 0.40) 27 (-74.7, 166.3, -169.9)
6mM Ala-Pro 0.614 (0.45, 0.5) 27 (112.7,-168.2,-162.4)
18mM Ala-Pro 0.610 (0.50, 0.45) 27 (-117.3,-28.4, 171.48)
36mM Ala-Pro 0.827 (0.50, 0.45) 27 (-113.8, 33.3, -178.2)
60mM Ala-Pro 1.283 (0.45, 0.45) 27 (149.0, 156.0, 162.1)
120mM Ala-Pro 0.612 (0.45, 0.40) 27 (122.9, 20.7, -23.4)
2.5.4.2 Space group determination
(1) BLGY
(i) Lattice selection:
Lattice P cubic I cubic F cubic P rhombohedral P hexagonal P tetragonal I tetragonal
distortion
index (%)
30.72 31.84 30.83 34.81 3.80 9.05 9.03
Lattice P orthorhombic C orthorhombic I orthorhombic F orthorhombic p
monoclinic
C monoclinic P triclinic
distortion
index (%)
9.05 0.06 9.02 8.20 0.05 0.04 0.00
P: Primitive I : I centred F : F centred C: C centred
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From the table above, it is shown that the lattice type is C orthorhombic
(ii) Laue group determination:
Laue class C222,
r 0.996
From the table above, it is shown that the Laue group is C222}
(iii) Systematic absence:
The systematic absence of the data of BLGY is listed in the appendix 2-1. It is shown
the reflection condition of BLGY is (0 0 2n).
Therefore, from (i) (ii) and (iii), it is known that the space group is C222i.
(2) BLG co-crystallised with palmitic acid
(I) Lattice selection:
Lattice P cubic I cubic F cubic P rhombohedral P hexagonal P tetragonal I tetragonal
distortion
index (%)

















7.81 0.08 4.22 4.42 0.07 0.05 0.00
P: Primitive I : I centred F : F centred C: C centred
From the table above, it is shown that the lattice type is P hexagonal
(ii) Laue group determination:
Laue class P3, P3j 12 P3X21 P6i P6]22
x2 1.020 21.865 1.025 21.890 20.58
From the table above, it is shown that the Laue group is P3]21
(iii) Systematic absence:
The systematic absence of the data of BLG co-crystallised with palmitic acid is listed
in the appendix 2-1. It is shown the reflection condition is (0 0 3n).




Lattice P cubic I cubic F cubic P rhombohedral P hexagonal P tetragonal I tetragonal
distortion
index (%)
56.63 31.23 33.82 9.79 8.12 0.10 6.87
Lattice P orthorhombic C orthorhombic I orthorhombic F
orthorhombic




0.05 0.07 6.87 7.32 0.04 0.06 0.0
P: Primitive 1 : I centred F : F centred C: C centred
From the table above, it is shown that the lattice type is P tetragonal
(ii) Laue group determination:
Laue class P4i P4A2
x2 1.080 1.003
From the table above, it is shown that the Laue group is P4i2]2
(iii) Systematic absence:
The systematic absence of the data of CYP3 is listed in the appendix 2-1. It is shown
the reflection conditions are ( 0 0 4n ) and ( 2n 0 0 ).
Therefore, from (i) (ii) and (iii), it is known that the space group is P4(2[2 or P432i2
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2.5.4.3 Data processing results
Table 2-F. Data processing results of BLG and CYP3
(l)BLGY
Data collection statistics BLGY native




Number of reflections measured 131207
Number of unique reflections 10343
Completeness 99.1%
Multiplicity 12.68
( outer shell) 5.1% (20.8%)
I/O (I) (outer shell) 27.22 (6.30)
(2) BLG complexed with palmitate
Data collection statistics Palmitate1 Palmitate2
Space group, P3221 a = b = 53.48 A a = b = 53.52 A
c= 111.64A c = 111.37A
a = (3 = 90°, y = 120° a= (3 = 90°, y= 120°
Resolution range 20-2.5 A 25-2.3 A
Number of reflections measured 97142 48843
Number of unique reflections 6888 8763
Completeness 99.9% 97.8%
Multiplicity 14.1 5.57
Rmerge ( outer shell) 7.3% (36.6%) 6.3% (37.6%)
I/g (I) (outer shell) 21.2 (3.95) 17.38 (2.57)
palmitate1: data collection of BLG co-crystallised with palmitate (first preparation, section 2.3.2.2.)
palmitate2: data collection of BLG complexed with palmitat (second preparation, section 2.3.2.3.)
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(3) CYP3
Data collection statistics Native 1.2mM Ala-Pro 6mM Ala-Pro
Space group, P4r2i2 a = b = 60.60 A a = b = 60.87 A a = b = 60.74 A
c= 123.lA c = 122.99A c = 122.72A
a = (3 = y = 90° a = (3 = y = 90° a = (3 = y = 90°
Resolution range 20-1.8 A 25-2.1 A 25-2.0 A
Number of reflections measured 145422 165474 189319
Number of unique reflections 22053 14262 16311
Completeness 97.0% 98.9% 99.7%
Multiplicity 6.59 11.60 11.60
Rmerge ( outer shell) 8.3% (27.8%) 9.9% (36.2%) 8.1% (31.5%)
I/a (I) (outer shell) 11.7 (2.60) 12.50 (3.36) 14.88 (3.62)
Data collection statistics 18mM Ala-Pro 36mM Ala-Pro 60mM Ala-Pro
Space group, P4j2i2 a = b = 61.03 A a = b = 61.42 A a = b = 61.05 A
c = 122.7A c = 122.47A c — 122.67A
a = (3 = y = 90° S 11 "CO II II SDO0 8 II "CO II II SO00
Resolution range 20-1.9 A 20-1.9 A 25-2.0 A
Number of reflections measured 146663 224150 270345
Number of unique reflections 19030 19185 16443
Completeness 98.6% 99.5% 95.8%
Multiplicity 7.70 11.60 16.44
Rmerge ( outer shell) 6.7% (34.6%) 7.2% (31.3%) 7.1% (33.2%)
I/a (I) (outer shell) 13.88 (2.34) 14.89 (2.90) 14.44 (2.09)
Data collection statistics 120mM Ala-Pro
Space group, P4i2i2
Resolution range
Number of reflections measured
Number of unique reflections
Completeness
Multiplicity
Rmerge1 ( outer shell)
I/a (I)2 (outer shell)
a = b = 61.03 Ac = 122.66A









Rmerge=^h 1I- <I> 1/ 2Lh III, where <I> is the mean intensity of all observation of reflection h=hkl
2




Molecular replacement (MR) has been proven to be an efficient method to solve
protein structures by using knowledge of similar structure. This method is based on
the theory that two similar structures in different crystallographic environments, e.g.
different space groups, would be expected to have similar diffraction patterns albeit
sampled differently. Molecular replacement compares the Patterson function of an
unknown structure with the calculated and rotated/translated Patterson function of a
search model. Electron density maps calculated with phases with the rotated search
model and the unknown structure factors should then reveal the unknown structure.
The aim of molecular replacement is to determine the position of the search model
within the crystal unit cell. The position of the search model is defined by six
parameters, three rotational and three translational parameters. The rotational
parameters are specified in terms of Eulerian angle (a, P, y) while the translational
parameters are specified by fractional coordinate (x, y, z). The rotational parameters
take values within the range: 0° < a < 360°, 0° < P < 180°, 0° < y < 360° while the
translational parameters take values within the range: 0 < x < 1, 0 < y < 1, 0 < z < 1.
The mathematical expression of molecular replacement is as follows:
r = Rr° +T
where
R is the rotation matrix
T is the translation vector
r, specified by the atomic vectors, is the current position of the search model
r°is the initial position of the search model. Conventionally, the initial position is
placed where the centre mass of the model is at the origin and the principal axes of
the model are parallel to the orthogonal axes. Therefore, by default, r°=0.
The rotation function determines the rotational parameters by comparing the
Patterson function of diffraction data with that of the model. The translation function
determines the vector necessary to translate the oriented model obtained from the
rotation function in order to obtain the best fit with the diffraction data. The standard
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procedure of molecular replacement is firstly to calculate the rotation function
followed by the translation function.
The success of molecular replacement depends on several factors: completeness and
accuracy of the model, quality and completeness of diffraction data, similarity
between model and the actual structure and the selected resolution range of the data.
In this thesis, AMoRe (Navaza and Saludjian, 1997) was used in molecular
replacement calculations and will be the main program discussed. Other molecular
replacement packages are available, for example, X-PLOR (Brunger, 1990a) and are
reviewed by Tickle and Driessen (1996).
2.6.2 The rotation function
The rotation function is based on the principle that similar molecules will have
similar sets of intramolecular vectors. Therefore, the orientation of the model with
respect to the actual structure could be determined by overlapping these two
intramolecular vector sets.
The rotation function was first developed by Rossmann and Blow (1962) with the
mathematical expression:
RF (£2) = lu Pcry(r) X Pmodel r]JV Equation (1)
where Pcry is the Patterson function of the actual molecule
Pmodel is the Patterson function of the search model
£2 is the 3 x 3 rotation matrix described by three angles (e.g. Euler angle)
r is the integration variable
U is the region of integration, usually spherical, centred at the origin.
The criterion of fit of the rotation function is defined by the product between these
two Patterson functions, Pcry and Pm0dei. Therefore, the maximum value of RF (£2) is
the most likely solution for the rotation function as the best fit of Pcry and Pmodei will
give the maximum RF (£2).
The region of integration should include the maximum number of intramolecular
vectors and the minimum number of intermolecular vectors. In order to make the best
use of the mathematical properties of the rotation group, the region of integration is
usually spherical. The radius of the integration sphere is commonly 75-80% of the
model diameter.
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The rotation function can be calculated in real space or in reciprocal space. In the real
space rotation function (equation (1)), the Patterson function of the search model is
presented as a map of an array of intramolecular vectors and is compared with the
Patterson function of diffraction data. In the reciprocal space rotation function
(equation (2)), the Fourier transform of the model is compared with diffraction data.
RF (Q) = I IFcry(h)l2IFmodei (Q'h)l2 Equation 2
where Fcry is the structure factors from the diffraction data
Fmodei is the calculated structure factors of the search model
h =hkl is the indices of the diffraction pattern
Q1 is the reverse of the rotation matrix Q
These two rotation functions are, in principle, equivalent. The reciprocal space
rotation function could be converted from the real space rotation function by Fourier
transform and application of Parseval's theorem.
2.6.3 The translation function
The translation function was first introduced by Crowther and Blow (1967) with a
similar mathematical expression to that of rotation function:
TF (v) = Jv Pcry(u) Pmodei (u,t) du Equation 3
where Pcry is the Patterson function of the actual molecule
Pmodei is the Patterson function of the search model
v is the intermolecular vector between the two symmetry-related molecules
u is the integration variable
V is the region of integration
t is the unknown translation vector of the search model
Again, the maximum value of TF(v) is the most likely solution for the translation
function as the best fit of Pcry and Pmodeiwill give the maximum TF(v).
Once the rotation parameters have been obtained from the rotation function, the
oriented search model has to be translated to the optimal position in the crystal unit
cell by calculating the translation function.
Similar to the rotation function, the translation function is to determine the
translational parameters by comparing the Patterson function of diffraction data with
that of the model. However, intermolecular vector sets are used in the calculation of
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the translation function whereas the intramolecular vector sets are used in the
calculation of the rotation function.
2.6.4 Molecular replacement using AMoRe
AMoRe (Navaza and Saludjian, 1997) is an automated molecular replacement
program implemented in CCP4. It consists of five steps: format of the input data for
use in later steps, fast calculation of structure factors by continuous Fourier transform
of the model electron density, calculation of the rotation function, calculation of the
translation function and rigid-body refinement of the orientated model obtained from
molecular replacement. These five steps were performed in order by the following
programs:
(a) Sorting:
The program SORTING is to sort and pack the input data (H, K, L, Fobs) to an
AMoRe readable format. Usually, data with a low resolution cut-off to 10A are used
as data lower than 10A mainly contains information about solvent.
(b) Tabling'.
The program TABLING is used to translate the model so that the centre of mass is at
the origin and performs fast computation of structure factors of the search model. In
AMoRe, a very efficient algorithm is applied to calculate the structure factors of the
model in terms of the continuous Fourier transform. The output from running
TABLING produces the Fourier coefficient of the search model which is used as the
input into the programs ROTING and TRAING which will be discussed later.
(c) Rotins:
The program ROTING is used to calculate the rotation function. A modified fast
rotation function is used in AMoRe. The fast rotation function was introduced by
Crowther (1972) and is an expansion of reciprocal space Patterson function in terms
of spherical harmonics. By this method, the entire rotation function could be
calculated by a single Fourier transformation and consequently the calculation of
rotation function is faster.
The output of this program is the rotational solution given in terms of the Eulerian
angles (a, (3, y).
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(d) Trains:
The program TRAING is used to calculate the translation function. The translation
function devised by Crowther and Blow is applied in AMoRe. The input is the
rotation solution specified by Eulerian angles. After calculation of translation
function, the translation solutions in terms of fraction coordinate (x, y, z) along with
correlation coefficient and initial R-factor are given. Good solutions will have high
correlation coefficients and low R-factors. The correlation coefficient is a measure of
the difference between the structure factors calculated from the model and those
obtained from the experiment. Therefore, the correlation coefficient is a measure of
the agreement of the model and actual structure. The higher the correlation
coefficient, the better agreement between the model and the actual structure.
(e) Rigid-body refinement:
After translation function, the oriented model is subject to rigid-body refinement in
order to obtain the maximum correlation coefficient and consequently, the optimum
position.
2.7 Refinement and Model building
2.7.1 Introduction
As the structures solved by MIR (multiple isomorphous replacement) and MR
(molecular replacement) are usually inaccurate and contain a large number of errors,
refinement of the structure is necessary to bring observed and calculated intensities or
structure factor amplitudes as close as possible. Refinement is the process of
adjusting the model to improve the agreement between the observed and calculated
structure factors. For successful least squares refinements, the number of the
observed reflections should be significantly greater than the number of parameters.
However, in protein structures, the ratio of observed reflections to refinable
parameters (x,y,z,B) is usually very low because of the loss of high resolution data
due to disorder in the crystal and high solvent content in the crystal. In order to
overcome this problem, constraints or more usually nowadays restraints are applied
in the refinement procedure (Glusker et al., 1994a). Constraints reduce the number of
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parameters by expressing several parameters in terms of a single parameter. For
example, a single set of parameters (x,y,z, 0i, 02,63) is used to represent the position
and orientation of the whole group of atoms. Restraints can be considered as
additional observed information usually derived from the stereochemical information
such as bond length, bond angle, torsion angle, bond planarity and non-bonded
information such as van der Waals interactions. Thus, the restraint refinement will
not only increase the number of observations in calculations but also help ensure that
the stereochemistry of the molecule is correct. Therefore, the overall function being
minimised contains two terms: the crystallographic term defined as the square of the
difference between the observed structure factor amplitude (IF0I) and calculated
structure factor amplitude (IFCI) and the stereochemical term defined as the square
difference between the actual value and ideal value of the geometric parameters, like
bond length and bond angle (McRee, 1993). These ideal values are obtained from the
highly refined small molecule structures.
Etotal = ®aEEcryStallographic + G)b21Estereochemical
Ecrystllographic= [ IF0(hkl)l -Fc(hkl)l f
Estereochemical = ^bond lentgh( A-A0) + Ebond angle ( B-B0) + 2 torsion angle( C-C0)
+ Enon_bonded contacts (D-D0)2+ Eplanar groups ( E-E0)~ + E chiral volumes( F-F0)
where
A, B, C, D, E, F : the actual value
A0 B0 C0 D0 E0 F0 : the ideal value
coa and (Ob are the weights of the crystallographic term and stereochemical term,
respectively. A good refinement program should be able to apply the appropriate
weighting scheme in the refinement procedure as the weight can affect the result of
the refinement dramatically. If the weight of the crystallographic term is too high, the
stereochemical geometry of the structure will be distorted. If the weight of the
stereochemical term is too high, it will slow down the convergence of the refinement
and result in a poor fit to the observed x-ray data.
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A least squares refinement program aims to minimise the overall function by
calculating the shift in coordinate or temperature factor that will give the lowest
value.
Because the least squares process calculates a shift from an input position, if that
position is far from the true one, no satisfactory shift can be determined and no
improvement result. In other words, least squares refinement requires a reasonably
accurate input model. To overcome this short-coming, following each round of
refinement, an electron density map is generated and displayed in the computer
graphic system to ensure the model is well-fitted in the density map. Manual model
building, including moving atoms, changing conformation, insertion of amino acids
and addition of ligands may be required if the fit is poor. Two types of electron
density map are usually used for model building, (2Fo-lFc) and (Fo-Fc) maps. (2Fo-
lFc) (or (3Fo-2Fc)) map is like as the sum of the electron density of a model and a
difference electron density map. It is usually used to check if each part of the model
fits well into the map (Glusker et al., 1994b). The other one is the (Fo-Fc) map, the
so-called difference map. It is used to highlight the errors in a trial structure, to find
out parts of the structure that have not yet been identified or located and to recognise
the movement of residues. Once the native structure has been solved, the difference
map is also a very important tool in studies of complexed structures since it can be
used to identify the location of a ligand or substrate soaked into a crystal or co-
crystallised with the protein.
Several algorithms have been established to refine the protein structures. In general,
they can be classified into conjugate gradient minimisation (Jack and Levitt, 1978),
constrained or restrained least-square refinement (Hendrickson, 1985) and simulated
annealing (Brunger et al., 1987). Conjugate gradient minimisation and simulated
annealing were used in X-PLOR to refine the macromolecule structures. Least-square
refinement and conjugate gradient minimisation were applied in SHELX97 to refine
the small molecule and macromolecule structures, respectively. These two programs




X-PLOR (Brunger et al., 1992) was initially used for the refinement of the native
BLGY structure and structure of palmitate bound to BLG.
This program contains a variety of refinement protocols, including rigid-body
refinement, positional refinement, B-factor refinement and simulated annealing. An
energy minimisation procedure was used in X-PLOR where the crystallographic and
stereochemical terms are treated as functions of energy.
(a)Rigid-body refinement'.
In rigid-body refinement, the structure of protein is broken into several rigid bodies.
These rigid bodies can be domains, polypeptide chains or monomers. Three
rotational and three translational parameters are assigned to each rigid body and these
parameters are then refined to minimise the total energy function. The molecular
conformation of each rigid body remains the same when the six rotational and
translational parameters for each are refined. In rigid-body refinement, the ratio of
observed reflections to refinable parameters is high as only six parameters have to be
refined for each rigid body.
The data of lower resolution, i.e. lower than 3A, was used in order to increase the
radius of convergence. The radius of convergence is d/4 in theory, where d is the
highest resolution data included in the refinement procedure (Jack and Levitt, 1978).
(b)Positional refinement.
In X-PLOR, the conjugate gradient minimisation method (Jack and Levitt, 1978) is
used in conventional positional refinement. The overall energy function is minimised
by shift in coordinates to get the lowest energy. As mentioned in section 2.7.1, it is
essential to use the appropriate weight to balance the contribution from the
crystallographic term and stereochemical term. In XPLOR, the program CHECK can
determine the appropriate weight by running a molecular dynamics calculation.
(C)B-factor refinement:
B-factor refinement is performed independently from positional refinement in X-
PLOR. There are three types of B-factor refinements in X-PLOR: an overall B-factor,
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a grouped B-factor and individual B-factor refinement. A single B-factor is
calculated for the entire molecule in overall B-factor refinement and this single B-
factor is an indicator of the mobility of the whole molecule. In grouped B-factor
refinement, single B-factor is applied to the atoms of the same group while, in
individual B-factor refinement, individual B-factor is calculated for each atom. The
choose of the type of B-factor refinement used depends on the resolution of the data.
Usually, overall B-factor refinement or grouped B-factor refinement is used in the
early stage of refinement whereas individual B-factor refinement is used when higher
resolution data is included in the latter stage of refinement.
(d)Simulated annealing:
Simulated annealing has a wider radius of convergence than least-square refinement
and conjugate gradient minimisation. Therefore, simulated annealing can reach
global minima whereas least-square refinement or conjugate gradient minimisation is
easily trapped in a local minimum. In simulated annealing, the structure is heated to
high temperature, usually 2000K to 3000K, and then annealed the structure by slowly
reducing the temperature. The "temperature" here is a control parameter that
determined whether the structure can escape the local minima instead of a physical
temperature. Therefore, very high temperature maybe has to be used if the barriers
between local minimum are rather large.
2.7.2.2 Refinement procedure
The input PDB file was subjected to a program call GENERATE (also in X-PLOR)
and two output files were then obtained. One is the coordinate file with a header in
the beginning of the file. The other is the structure file (.psf file) containing structural
and stereochemical information, for example, bond length, bond angle, etc.
5% of all reflections randomly selected by the program SETUP FREE R to monitor
the refinement procedure in order to avoid over-refinement are flagged as Rfree set
and excluded in all refinement.
Prior to any refinement, the program CHECK should be used to calculate the
appropriate weight. This program also calculates an initial R-factor before refinement
was carried out.
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Rigid-body refinement was performed firstly and was followed by simulated
annealing. Before simulated annealing using the program SLOWCOOL, the program
PRESTAGE was used to minimise the energy of structure. Following simulated
annealing, positional refinement and then B-factor refinement were performed.
After each round of refinement, electron density map was calculated and displayed in
O (Jones et al., 1991). The map generated in X-PLOR has to be converted into O
format by a program called MAPPAGE (Jones, 1992) from the RAVE suite.
2.7.3 Refinement program—SHELX97
2.7.3.1 Introduction
SHLEX97 (Sheldrick and Schneider, 1997) is a multi-program used to carry out
refinement of all of the structures discussed in this thesis. This program uses a
conventional structure factor calculation rather than a FFT (fast Fourier transform)
summation usually applied in other programs, like X-PLOR. The FFT method
involves small approximations whereas the conventional structure factor calculation
method is more accurate although it takes more CPU running time. The other
difference in SHELX97 is this program always refines against the square of the
structure factor amplitude (IFI2) instead of the structure factor amplitude (IFI) since
from experience with small molecules, the refinement against IFI is better than IFI.
SHLEX97-SHELXL is an easy-to-use program, special for macromolecules, even at
moderate resolution around 2.5A and only two input files are required. One is the
reflection data file (.hkl) containing h,k,l,F2 and a (F2) while the other is the
instruction file (.ins) including the appropriate stereochemical restraints. The
reflection file from DENZO and the instruction file from PDB format file are
generated in SHELXPRO, an interactive program interfacing with the other protein
structure programs.
2.7.3.2 Refinement procedure
In SHELXL, positional and B-factor refinement are performed in the same cycle.
Usually, the data between 10A to the highest resolution are used for refinement. 5%
of all reflections randomly selected by SHELXPRO to monitor the refinement
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procedure in order to avoid over-refinement are flagged as the Rfree set and excluded
in all refinement and map calculation. Following each round of refinement, (2Fo-
lFc) or (Fo-Fc) map is generated in SHELXPRO and displayed in the model building
program O. H20 molecules are added by SHELXWAT, an automatic H20 adding
program implemented in SHELX97. After checking H20 generated by SHELXWAT,
H20 molecules with high B-factor and unfavourable geometry relationship with
protein are deleted.
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3. Structure determination of BLGY
This chapter will describe the crystallographic work on the BLGY structure. Section
3.1 is to determine and refine the structure. Section 3.2 is to examine the detail of the
structure. Section 3.3 and 3.4 is to compare the BLGY structure with the BLGZ and
BLGX structures, respectively. Section 3.5 is to discuss the problems encountered in
the BLGY structure.
3.1 Molecular replacement
The first lattice Y structure was solved to 6.0A resolution by Green and co-workers
in 1979 (Green et al., 1979). Later, in 1986, a higher resolution structure to 2.8A
resolution was published by Papiz et al (1986). However, successful refinement of
this structure could not be achieved. Therefore, in 1990, Hambling collected much
higher resolution data to 1.8A (Hambling, 1990) and tried to refine the structure
o
solved by Papiz. This data, phased to 2.8A resolution, was used to calculate an
electron density map and this map appeared better than that obtained by Papiz
although the density for residues 55 to 69 and 150 to 162 was still ill-defined. A
model was rebuilt into the 2.8 A (2Fo-Fc) map and this rebuilt model was then
subject to further refinement. However, further refinement of this model failed as the
R-factor fluctuated around the mid 40's to 2.8A resolution and this refined model had
unusual geometry with many residues in the disallowed regions of the Ramachandran
plot. One year later, manual-building of the Hambling model, with geometry
restraints being applied regularly, was carried out by McAlpine (1991). The R-factor
reduced to 34% to 2.8A resolution and acceptable geometry was obtained. However,
further refinement failed to reduce the R-factor below 34% although many
approaches were tried. After McAlpine, Dr. Igor Polikarpov in Edinburgh collected a
new data set in collaboration with Dr. Sean McSweeney in Daresbury and tried to re¬
solve the lattice Y structure by molecular replacement using the lattice X structure,
which was later published by Dr. Brownlow in 1997 as mentioned in section 1.1.4.2.
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However, this structure also revealed some problems as the two terminal regions and
several loops had extremely high B-factors and questionable geometry (Polikarpov,
1995)
After the project of this thesis started, independently, Dr. Maria Bewley in professor
Ted Baker's laboratory in New Zealand re-collected the data of lattice Y form at
o
1.8A and re-solved the structure by multiple isomorphous replacement.
The newly solved structure, requiring further refinement was kindly provided by Dr.
Maria Bewley and used as the initial model for the further refinement described in
this thesis. This original model had some missing residues in the N-terminus and the
GH loop: residue 1 to 2 in the N-terminus and residue 111 to 114 in the GH loop.
3.1.1 Molecular replacement using the lattice Y model provided by
Dr. Maria Bewley
The structure solved by Dr. Maria Bewley was from data collected at room
temperature. However, data used for the work in this thesis were collected at low
temperature (100K). This resulted in a decrease of the unit cell dimensions from
a=55.5A, b=82.lA, c=66.8A to a=55.19A, b=79.72A, c=66.68A, a contraction
largely along the b axis, which is also the molecular dyad. Thus, molecular
replacement and rigid-body refinement were performed firstly to ensure the position
of the model in the unit cell.
The model (space group C222j; a=55.5A, b=82.lA, c=66.8A, a=P=y=90°) was
subjected to molecular replacement using the program AMORE. It is noted that the
space group here is the standard setting C222i instead of permuted cell, B22]2, used
by Green et al (1979) and Papiz et al (1986). The input values for variables used with
AMORE are listed in Table 3-A.
Table 3-A. Input values for variables used with the AMORE program
Resolution (A) 10-4
PI box size (A,°) (75, 75, 75, 90, 90, 90)
Radius of integration (A) 18
Angular step (°) 1.0
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The top six peaks of the rotation function are listed in Table 3-B.
Table 3-B. The top six peaks of the rotation function using the model from Dr.
Maria Bewley as the search model
Peak (a, P, Y) Correlation
coefficient (%)
Sigma (a)
1 (359.00, 0.00, 0.00) 36.2 7.24
2 (179.00, 0.00, 0.00) 36.2 7.24
3 (0.00, 180.00, 179.00) 36.2 7.24
4 (0.00, 180.00,-1.00) 36.2 7.24
5 (73.60, 169.22, 101.54) 19.4 3.88
6 (106.40, 10.78,281.55) 19.4 3.88
After checking with the CCP4 program ROTMAT (Dodson,1997), which generates
the symmetry equivalents, it became apparent that peaks 1,2, 3 and 4 are symmetry
equivalent.
The maximum peak (7.24a) in the rotation function and next highest peak (3.88a)
were used to calculate the translation function. After the translation search, the
maximum peak (a=359.00, P=0.00, y=0.00) gave a distinct solution with a high
correlation coefficient of 64.3% and a low R-factor of 38.8%. The next solution has a
lower correlation coefficient of 45.3% and a higher R-factor of 46.5%.
The top five solutions of translation function using this maximum peak are listed in
Table 3-C.
Table 3-C. The top five solutions of translation function using the maximum
peak obtained from rotation function (a=359.00, P=0.00, y=0.00)
Solutions of Fractional coordinates Correlation R-factor
translation function (Tx, Ty, Tz) coefficient (%)
(%)
1 (0.2429, 0.1517,0.3556) 64.3 38.8
2 (0.2433, 0.3976, 0.3556) 45.3 46.5
3 (0.2400, 0.2690, 0.3528) 42.5 47.7
4 (0.4854, 0.4036, 0.3517) 41.6 49.1
5 (0.2452, 0.0190, 0.3566) 41.5 47.3
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The packing of the molecules in the unit cell was checked by the program PACMAN
(Kleywegt et al., 1996) and also displayed in O (Jones et al., 1991). Both programs
showed that the packing of the first solution was reasonable with no symmetry-
related molecules clashing into each other.
It was obvious that the first solution was correct since it had a significantly higher
sigma value, higher correlation coefficient and lower R-factor when compared to the
second solution. The packing of this solution was also reasonable.
As well as peak 1 of table 3-B, peak 5 (a=73.60, P=169.22, 7=101.54) obtained from
the rotation function was used to calculate the translation function. However, unlike
peakl, it failed to give a distinct solution. In addition, the solutions that it did give
had much lower correlation coefficients (approximately 21%), and much higher R-
factors (approximately 55%).
Following the translation function, rigid-body refinement of the optimum molecular
replacement solution was performed. This increased the correlation coefficient
significantly from 64.3% to 72.1% and reduced the R-factor from 38.8% to 32.9%
The Eulerian angles and fractional coordinates shift to a=359.57, P=-0.24, 7=1.01,
Tx=0.2422, Ty=0.1555, Tz=0.3535.
3.1.2 Molecular replacement using a monomer of lattice X
A monomer of the crystal structure of dimeric BLG refined at 1.8A resolution in
triclinic Lattice X (space group PI; a=37.8A, b=49.6A, c=56.6 A, a=123.4°, p=97.3°,
7 = 103.7°; PDB ID 1BEB) was also used as the search model (Brownlow et al., 1997)
in the structure determination of the lattice Y crystal form.
Following the same procedure as in section 3.1.1 and using the same input variables
as were applied in section 3.1.1, the rotation function gives the maximum peak
(a=33.93, P=119.03, 7=333.81) of 6.04a and the next highest peak (a=42.60,
P= 16.08, 7=342.53) of 3.92a. Both were used to calculate the translation function.
After the translation search, the maximum peak (a=33.93, P=119.03, 7=333.81) gave
the best solution with a correlation coefficient of 49.0% and an R-factor of 44.8%
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while the next solution had a correlation coefficient of 36.6% and an R-factor of
49.5%. The top five solutions of translation function are listed in Table 3-D.
Table 3-D. The top five solutions of translation function using the maximum
peak obtained from rotation function (a=33.93, p=119.03, y=333.81)
Solutions of Fractional coordinates Correlation R-factor
translation function (Tx, Ty, Tz) coefficient (%)
(%)
1 (0.2411,0.1520, 0.3584) 49.0 44.8
2 (0.2413,0.3941,0.3556) 36.6 49.5
3 (0.2523,0.0112, 0.3607) 33.8 50.2
4 (0.2483, 0.3230, 0.3594) 33.2 51.1
5 (0.4784, 0.1476, 0.3573) 31.7 50.2
The packing of the molecules in the unit cell was checked by the program PACMAN
(Kleywegt et ai, 1996) and also displayed in O (Jones et al., 1991). Both programs
showed that the packing of the first solution was reasonable with no symmetry-
related molecules clashing into each other.
The first solution was taken as correct since it had a higher sigma value, higher
correlation coefficient and lower R-factor when compared to the second solution. The
packing of this solution was also reasonable.
The next highest peak (a=42.60, (3=16.08, y=342.53) of the rotation function gave no
significant solution and all other solutions had a lower correlation coefficient around
18.0% and a higher R-factor around 55.0%.
Although correct, the best solution obtained using the lattice X structure as the search
model was poor compared to that obtained using the lattice Y model provided by Dr.
Maria Bewley as the solution from lattice X structure has much lower correlation
coefficient and much higher R-factor. Therefore, the molecular replacement solution
using the lattice X structure was discarded and further refinement work in this thesis
focuses on the lattice Y model provided by Dr. Maria Bewley.
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3.1.3 Molecular replacement using the lattice Z model
The recently solved structure of BLG refined at 2.24A resolution in lattice Z form
(space group p3221; a=b=53.96A, c= 112.41 A, a=P=90.0°, y=120.0°; PDB ID
1BSY) was also used as the search model (Qin et al., 1998a) in the structure
determination of the lattice Y crystal form to examine whether better molecular
replacement solutions could be obtained from this model.
Following the same procedure as in section 3.1.1 and using the same input variables
as were applied in section 3.1.1, the rotation function gives the maximum peak
(a= 172.51, [3=48.63, y=153.15) of 5.72a and the next highest peak (a=154.07,
[3=10.71, y=214.44) of 3.67a. Both were used to calculate the translation function.
After the translation search, the maximum peak (a=172.51, P=48.63, y= 153.15)
gave the best solution with a correlation coefficient of 47.1% and an R-factor of
46.0% while the next solution had a correlation coefficient of 29.8% and an R-factor
of 53.3%. The top five solutions of translation function are listed in Table 3-E.
The packing of the molecules in the unit cell was checked by the program PACMAN
(Kleywegt et al., 1996) and also displayed in O (Jones et al., 1991). Both programs
showed that the packing of the first solution was reasonable with no symmetry-
related molecules clashing into each other.
Table 3-E. The top five solutions of translation function using the maximum
peak obtained from rotation function (a=172.51, P=48.63, y=153.15)
Solutions of Fractional coordinates Correlation R-factor
translation function (Tx, Ty, Tz) coefficient (%) (%)
1 (0.2571,0.1537,0.1424) 47.1 46.0
2 (0.0801,0.1594, 0.1444) 29.8 53.3
3 (0.2540, 0.1518,0.0306) 29.5 51.9
4 (0.2486, 0.1515,0.4861) 28.4 53.1
5 (0.3502, 0.0328, 0.4727) 28.2 52.8
The first solution was correct since it had a higher sigma value, higher correlation
coefficient and lower R-factor when compared to the second solution. The packing of
this solution was also reasonable.
3-6
The next highest peak (oc=154.07, (3=10.71, y=214.44) of the rotation function gave
no significant solution and all other solutions had a lower correlation coefficient
around 18.4% and a higher R-factor around 55.7%.
The best solution obtained using the lattice Z structure as the search model was poor
compared to that obtained using the lattice Y model provided by Dr. Maria Bewley
although this solution was also correct. Therefore, the molecular replacement
solution using the lattice Z structure was discarded and further refinement work in
this thesis focuses on the lattice Y model provided by Dr. Maria Bewley.
3.1.4 Refinement and model building
Following rigid-body refinement, the model was subjected to simulated annealing
using data between 10A to 2.0A resolution. The slow cooling protocol for refinement
by simulated annealing was used (Brunger et al, 1990b). Firstly, the model was
heated to 2500K, followed by 50 steps of molecular dynamics integration performed
with a time step of 0.5fs. After each molecular dynamics calculation, the temperature
was decreased by steps of 25K to the final temperature of 250K. The R-factor
decreased from 34% to 32.1% (Rfree from 42.1% to 40.4%) after simulated annealing.
The initial electron density map, (3Fo-2Fc) map, calculated in X-PLOR (Brunger,
1992) and converted in MAPPAGE (Jones, 1992) was displayed in O. The main
chains of the core region of BLG were covered by the density map. The core region
contained a [3-barrel formed by 8 antiparallel [3-strands and a a-helix outside the (3-
barrel. However, the density of the main chains of N-terminus, C-terminus and some
disordered loops, such as the AB, CD and GH loops, was rather poor. There was no
continuous density to allow the tracing of the main chains of the CD loop and C-
terminus. Following simulated annealing, positional refinement and individual B-
factor refinement were performed using X-PLOR. This resulted in a slightly decrease
of the R-factor from 32.1% to 31.0% (Rfree from 40.4% to 39.3%). However, there
were no improvements in the density of these disordered loops. Therefore, the
decision was taken to re-build manually these disordered loops using the program O.
The AB loop was re-built firstly since the density of the AB loop was clearer than
others. (3Fo-2Fc) and (Fo-Fc) maps were both used to re-build this loop. The (Fo-Fc)
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map was used to monitor the movement of the main chain while the (3Fo-2Fc) map
was used to identify the orientation of the side chain. The (3Fo-2Fc) map was shown
in Figure 3-1.
Manual rebuilding of the AB loop involved the movement of the main chain from
residue 32 to 36, the flipping of some peptide bonds and the alteration of some side
chain rotamers. Following rebuilding, the model was subjected to positional
refinement. After 200 cycles of refinement, the R-factor decreased from 31.0% to
29.7% (Rfree from 39.3% to 36.1%). The density map was also improved and most
atoms of AB loop were fitted into density although the density of some side chains
was still very weak. Following refinement, an attempt was made to re-build manually
the GH loop. This loop was omitted in the original model. However, in the (3Fo-2Fc)
and (Fo-Fc) maps, this loop was identifiable although the density was rather poor.
Careful inspection allowed tracing of the main chain through continuous density.
After rebuilding, positional and individual B-factor refinement was again performed.
However, there was no improvement in the density map. In particular, the density
map of the side chains was ill-defined. The geometry of this loop was also poor as
the main chains of Pro 113 and Serl 16 and the side chain of Glul 14 and Glnl 15
adopted unfavourable conformations. Furthermore, there was no significant decrease
of the R-factor.
The rebuilt model was subject to further refinement with SHELX97-SHELXL
(Sheldrick and Schneider, 1997). After 5 cycles of positional and B-factor
refinement, H2O molecules were added using SHELXWAT. The positions of H2O
were checked manually in O firstly to ensure the location was appropriate and
secondly that the H20 made a reasonable hydrogen bond contact with the protein. A
(2Fo-lFc) map was calculated using SHELXPRO and displayed with O. The
refinement and addition of H2O resulted in a dramatic decrease in the R-factor from
29.7% to 25.9% (Rfree from 36.1% to 31.5%) and also greatly improved the density
map. The density of main chains and side chains of the core region was now well-
defined. The density maps of both AB and GH loops were clearer, especially that of
the AB loop. The (2Fo-lFc) map of the AB loop is shown in Figure 3-2.
However, the density maps around the CD loop and the C-terminal regions were still
ill-defined.
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Figure 3-1.The (3Fo-2Fc) electron density map, contoured at 1.2 sigma, of the
AB loop. The map was calculated by XPLOR (Branger, 1992) after
simulated annealing refinement and displayed in O (Jones et al., 1991).
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Figure 3-2.The (2Fo-lFc) electron density map, contoured at 1.2 sigma, of the
AB loop. The map was calculated by SHELXPRO (Sheldrick and Schneider, 1997)
after refinement in SHELX and displayed in O (Jones et al., 1991). This
density map shows the great improvement in density of AB loop after the
refinement in SHELX compared to Figure 3-1.
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The improved density map allowed the GH loop to be built properly. After rebuilding
and positional refinement, the main chains of the GH loop were fitted into density.
The geometry was better although the density maps of some side chains, such as
Glul 12, Glul 14, and Glnl 15, were very weak. However, there was no significant
decrease in the R-factor and the B-factors of atoms in this region were rather high,
the average B-factor being 85A2.
It was very difficult to build the CD loop and the C-terminus (see Figure 3-3) since
the density was still rather poor.
Several methods were tried to overcome this problem. Firstly, removal of the poorly
defined residues was tried. The residues 60 to 66 of the CD loop and residues 152 to
160 of the C-terminal region were removed from the original model and this partial
model was then subjected to positional and B-factor refinement. After 15 cycles of
positional and B-factor refinement, the R-factor had increased from 25.9% to 27.1%
as expected.
Moreover, both (2Fo-Fc) and (Fo-Fc) maps showed no obvious improvement around
these two regions. The removed residues were therefore replaced back since
removing them seemed to have no beneficial effect on the overall structure.
Secondly, residues from 60 to 66 and from 152 to 160 were converted to be alanine
in an attempt to reduce the effect of the side chain atoms in these two regions. After
15 cycles of positional and B-factor refinement, a (2Fo-Fc) map was again generated.
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Figure 3-3.The (2Fo-lFc) electron density map, contoured at 1.0 sigma, of the part of
the C-terminus. The map was calculated by SHELXPRO (Sheldrick and Schneider, 1997)
after refinement in SHELX and displayed in O (Jones et al., 1991).
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However, there was still no improvement in the density map. Since there was little
effect seen from converting these residues to alanine, the side chains of these residues
were replaced into their original positions.
The other approach was to build the C-terminus of the lattice Y structure by using the
C-terminal region from residues 152 to 160 of the lattice Z structure (the structure of
BLG complexed with palmitate, which will be discussed in chapter 4) as the C-
terminus in the lattice Z form was well-fitted into the density (see Figure 3-4)
However, the trial also failed since the main chains were out of the density. This
result indicated that the C-terminus of the lattice Y structure adopts an alternative
conformation to that seen in the lattice Z structure.
Further rebuilding and refinement failed to produce an improved density map and the
R-factor continued to fluctuate around 26%.
The current R-factor is 25.7% and Rfree is 31.0% for all reflections to 2.0A resolution.
The result of the final round of refinement is summarised in Table 3-F.
Table 3-F. Summary of the refinement statistics of BLGY structure.
Summary of the refinement statistics BLGY structure
o
Resolution range (A) 10-2.0
Rfinal (F>4tf) 25.7% (25.1%)
Rfree (F>4g) 31.0% (30.2%)
rms deviations from ideal geometry
Bond lengths (A) 0.005
Angle distance (A) 0.018
mean B-factor (A ) 50.0
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Figure 3-4.The (2Fo-lFc) electron density map, contoured at 1.5 sigma, of the
part of the C-terminus in BLGZ. The map was calculated by SHELXPRO
(Sheldrick and Schneider, 1997) after refinement in SHELX and displayed in O
(Jones et al., 1991). The density map of this region in BLGZ is much clearer
than that of in BLGY (see Figure 3-3).
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The solvent content of the crystal is 38.15 %, with the Matthews number 2.0 A3/Da.
There are 8 molecules in the unit cell, with 1 molecule per asymmetric unit. The most
complete model comprised 158 residues. Two residues (residue 1 and 2) at the N-
terminus and two residues (residue 161 and 162) at the C-terminus are omitted as
there is no density around these regions. The electron density map of the 9 (3-strands
and the a-helix is very clear. However, as mentioned before, the N-terminus, C-
terminus and some loops that connect (3-strands have ill-defined density, especially
the C-terminus and the CD loop. The AB loop, EF loop and GH loop have rather
high B-factors although they were fitted into the density. These disordered loops are
commonly found in BLG structures (Brownlow et al., 1997; Qin et al., 1998a). These
loops are around the open end of the (3-barrel and are flexible, which resulted in
difficulty in interpretation of the electron density map. However, it is as a direct
result of the flexibility in these regions that the ligand is able to access the calyx
without obstruction.
The structure has good geometry as reported by SHELX97 with rms deviation of
bond length and angle distance, 0.005A and 0.018 A, respectively. The average B-
factor for all protein atoms is quite high, 50.OA2, but is in keeping with the values
usually obtained for BLG.
The stereochemical quality of the structure was checked by CCP4 program














Residues in most favoured regions [A,B.L] 110 76.4%
Residues in additional allowed regions [a,b,l,p] 33 22.9%
Residues in generously allowed regions [~a,~b,~l,~p] 0 0.0%
Residues in disallowed regions 1 0.7%
Number of non-glycine and non-proline residues 144 100.0%
Number of end-residues (excl. Gly and Pro) 2
Number of glycine residues (shown as triangles) 4
Number of proline residues 8
Total number of residues 158
Figure 3-5. Ramachandran plot of the BLGY structure, produced by
PROCHECK (Laskowski et al., 1993). Square symbols represent the non-
glycine residues while triangles represent the glycine residues
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Essentially, all residues are in the allowed regions, except Tyr99. Tyr99, which
adopts a typical y-turn conformation common to many lipocalin structures with the
sequence of TDY, is well defined in the density map and is also in the disallowed
region in the lattice X structure (Brownlow et ai, 1997), the lattice Z structure (Qin
et al., 1998a) and in other lipocalins.
PROCHECK was also used to assess agreement between the main-chain and side-
chain parameters of the lattice Y structure with those of well-refined structures at a
similar resolution (See Figure 3-6 and Figure 3-7). In Figure 3-6 and Figure 3-7, the
lattice Y structure is represented by a solid square, while other reference structures
are represented by the dark band. The central line is a least-squares fit to the mean
trend as a function of resolution and the width of the band corresponds to a variation
of one standard deviation about the mean.
Figure 3-6 shows 6 plots calculated from the BLGY model. Plot (a) presents the
quality of Ramachandran plot. This property is indicated by the percentage of the
protein's residues that are in the most favoured regions of the Ramachandran plot.
Plot (b) shows the peptide bond planarity. This property is measured by calculating
the standard deviation of the omega torsion angle. The smaller the value, the closer
the ideal value, 180 degrees. Plot (c) presents the bad non-bonded interactions. This
property is measured by the number of bad contacts per 100 residues. The bad
contact is defined as the distance less than 2.6A between two atoms. Plot (d) shows
the CA tetrahedral distortion. This property is measured by calculating the standard
deviation of the "Zeta torsion angle", which is defined by the following 4 atoms: CA,
N,C,CB. Plot (e) is the standard deviation of the main-chain hydrogen bond energies
calculated using the method of Kabsch and Sander (1983). Plot (f) is the overall G-
factor. The G-factor is a measure of the normality of the stereochemical parameters,
like bond length, bond angle, torsion angle, compared to the other structures. The
overall G-factor is calculated from an average of the different G-factors for each
residue in the BLGY model.
The structure was of acceptable quality as the stereochemistry is in good agreement
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Figure 3-6. Plots of the comparison of the main chain parameters of BLGY
with those of other structures solved to a similar resolution, produced by the
program PROCHECK (Laskowski et al., 1993).
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a. Chi-1 gauche minus b. Chi-1 trans
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Figure 3-7. Plots of the comparison of the side chain parameters of BLGY with
those of other structures solved to a similar resolution, produced by the
program PROCHECK(Laskowski et ah, 1993).
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3.2 Overall structure
The overall structure of BLG in lattice Y form (BLGY) is very similar to the
structures of two other crystal forms, lattice X (BLGX) and lattice Z (BLGZ) as
shown in Figure 1-1.
The core region of BLGY is identical to that of BLGX and BLGZ. However, the N-
terminus, the C-terminus and some loops that connect the p-strands adopt different
conformations in these three crystal forms, especially the AB, CD, EF and GH loops.
These loops are highly flexible and rather disordered as mentioned in sections 3.1.
Similar to the BLGX and BLGZ structures, the BLGY structure also contains two
disulphide bridges. Since the CD loop and C-terminus in the lattice Y structure are
very disordered and the density maps around these two regions are rather poor, the
disulphide bridge, 66-160, appears mobile and the density of this disulphide bridge is
very weak.
BLG exists as a dimer in physiological conditions and at room temperature. In the
lattice Y structure, the asymmetric unit in the crystal contains only a single monomer
and the dimer is created by a crystallographic 2-fold axis. The dimer therefore has
exact 2-fold symmetry. Strand I and AB loop form the dimer interface. The
interactions that occur at the dimer interface of BLGY are similar to those of BLGX
(Brownlow et al., 1997) with the exception of the absence of one hydrogen bond
(N/Ala34 —>ODl/Asp33) in the BLGY structure. However, the hydrogen bonds
between the adjacent AB loops at the dimer interface are weaker than these in BLGX
and BLGZ structures because of longer separation between the adjacent AB loops.
This movement of the AB loop will be discussed in section 3.3.
One end of the p-barrel is open to ligand binding as the EF lifts up to open up the
entrance to the calyx in the same manner as in the complexed structures of palmitate-
bound BLG, which will be discussed in chapter 4. This important feature of the EF
loop is discussed further in section 4.5. Furthermore, the flexibility of the CD, EF,
GH loops at the open end of the P-barrel allows the ligand to enter the calyx without
hindrance.
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3.3 Comparison of BLGY and BLGZ structure
In sections 3.3 and 3.4, the BLGY structure will be compared with the BLGZ and
BLGX structures, respectively. The most complete BLGY structure contains residues
3 to 160. However, as mentioned in section 3.1.4, the density maps of the CD loop
and the C-terminus are very poor and these two regions are not well-fitted into the
density. Therefore, the difference of the CD loop and C-terminus in the BLGY
structure compared to the BLGZ and BLGX structures remains questionable as these
two regions in the BLGY structure have not yet been proven to be correct.
The superimposition of the structures of BLG in the lattice Y (BLGY) and the lattice
Z (BLGZ) forms is shown in Figure 3-8.
The structures of BLGY (at pH 7.5) and BLGZ (pH 7.1; PDB entry 1BSY) are very
similar, the exception being the GH, AB, CD loops, the loop before the a-helix and
C-terminus. The rms between corresponding backbone atoms of 116 residues in
BLGY and BLGZ structures is 0.737A with the GH, AB, CD loops, the loop before
the a-helix and C-terminus excluded.
The GH loop, a hairpin loop held by the strand G and H, is at the open end of the
calyx and is very flexible with high B-factors seen in both structures. Comparison of
the BLGY structure with the BLGZ structure shows that the divergence of the GH
loop begins at Asnl09 and ends at Serl 16. Moreover, this loop in BLGY moves
toward the entrance of the binding site with the maximum shift of 5.0A at the CA
atom of Glul 15. However, it seems that this movement has no effect on the access of
ligands, at least for fatty acid, as there is still enough space to allow the ligands to
entry. The AB loop is located at the dimer interface. In BLGY, this loop moves
slightly toward the mouth of the calyx. This movement results in the adjacent AB
loops in the dimer interface moving further apart. Therefore, the hydrogen bonds
between these two adjacent loops are weaker as the bond distances are longer. This
weakening of the hydrogen bonds is probably related to the observation that the
dimer dissociates into monomer more readily as pH increases (Georges and Guinand,
1960). However, it is highly possible the different relative disposition of the
monomer in these two crystal forms is a result of the different crystal packing forces.
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Loop before the alpha-helix
Figure 3-8.Diagram of the superimposition of the BLGY (yellow) and BLGZ
(cyan) structures, prepared by MOLSCRIPT (Kraulis, 1991). By comparison,
the differences of these two structures occur at the AB, GH loops and the loop
before the alpha-helix. The problematic regions of BLGY, the CD loop and the
C-terminus, are shown in red.
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The other divergent loop is the loop before the a-helix. Comparison of these two
structures reveals divergence begins at Pro 126 and ends at Asp 130 with the
maximum shift, 3.87A, at the CA atom of Vail28. This loop is well-defined in the
density map and is rather rigid in the BLGY structure. The movement of this loop is
probably a consequence of the different crystal packing force. In the BLGY structure,
the other symmetry related molecule is nearby and the shift of this loop makes better
hydrophobic contacts and hydrogen bond contacts with the other symmetry related
molecule.
There are two short 3io helix turns at the C-terminus of the BLGZ which are absent
in the BLGY structure. However, as mentioned before, the structure of the C-
terminus in the BLGY structure is doubtful. Therefore, the absence of these two 3io
helical turns cannot be taken as definite.
3.4 Comparison of BLGY and BLGX structure
The superimposition of the structures of BLG in the lattice Y (BLGY) and the lattice
X (BLGX) crystal forms (Brownlow et al., 1997) is shown in Figure 3-9. The rms
between corresponding backbone atoms of 113 residues in BLGY and BLGX
structures is 0.692A with the EF, GH, AB, CD loops, the loop before the a-helix and
C-terminus excluded.
Comparison of BLGY (pH 7.5) and BLGX (pH6.5) reveals the most distinctive
difference is in the movement of the EF loop. The EF loop is folding toward the
calyx in the BLGX structure whereas the EF loop in the BLGY structure is folding
back to open up the entrance to the calyx. Since lattice X and lattice Y are
crystallised at the two ends of the Tanford transition (Tanford et al., 1959), the
BLGY structure confirmed the important role of the EF loop in the Tanford transition
as discussed in the section 1.1.7. Moreover, in the BLGY structure, Glu89 buried in
the BLGX structure at pH 6.5 is exposed in the BLGY structure along with the
movement of the EF loop. This is consistent with the observation in the BLGZ
structure at pH 7.1 (Qin et al., 1998a) and the structure of palmitate-bound BLG,
which will be discussed in chapter 4.
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Loop before the alpha-helix
Figure 3-9.Diagram of the superimposition of the BLGY (yellow) and BLGX
(blue) structures, prepared by MOLSCRIPT (Kraulis, 1991). By comparison,
the differences of these two structures occur at the AB, EF, GH loops and the
loop before the alpha-helix as labelled. The problematic regions
ofBLGY, the CD loop and the C-terminus, are shown in red.
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Recently, it has been reported (Qin et al., 1999) that the EF loop adopts different
conformations at pH 7.1 in the structures of different genetic variants. In BLGA
structure (pH 7.1), the EF loop adopts the open conformation whereas in BLGB
structure (pH 7.1), this loop adopts the close conformation, the same as the structures
in the lattice X form (Brownlow et al., 1997) and in the lattice Z form (Qin et al.,
1998a) at pH about 6.5. However, it has been noted by the author of this paper (Qin
et al., 1999) that it is not clear whether the conformational difference of the EF loop
is actually due to different generic variants or other uncertain reasons. This
observation of the alternative conformation in the EF loop at pH 7.1 is contradiction
with the result discussed above where the BLGY structure was obtained from the B
variant (pH 7.5) and the EF loop was in the open conformation. Since the conclusion
of the conformational difference of the EF loop because of different genetic variants
can not be taken as definite, the reasons resulting in the contradiction between two
structures require further investigation.
The other divergent loops are the AB, GH ones and the loop before the a-helix. The
differences in these loops are also found between the BLGY and BLGZ structures as
discussed in section 3.3. It seems these loops are located in a different position in the
BLGY structure while these loops are in the same position in BLGX and BLGZ
structures. It is therefore proposed the dispositions of these loops are due to the
different crystal packing force instead of the influence of pH as BLG X is crystallised
at pH below 7.0 while BLGX and BLGY are crystallised at pH above 7.0.
3.5 Discussion
The refinement of the BLG structure in lattice Y form has been a problem for many
years. Many studies have been focused on the lattice Y structure (Papiz et al., 1986;
Hambling, 1990; McAlpine. 1991; Bewley et al., 1997) since the first structure was
solved in 1979 by Green (Green et al., 1979). However, successful refinement of
BLGY structure has not really been achieved although a variety of methods have
been tried. The problems are either the disagreement between the model and the data
or the poor geometry of the refined model.
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Each of these data sets was collected independently under different system and
crystals were crystallised under different conditions. This maybe the cause of some of
the problems encountered in the refinement.
Although the core region of these models was identical, the loops varied from model
to model. The most problematic regions occur in the CD loop and the C-terminus.
The C-terminus, which is well-defined in the lattice Z form, has rather weak density
and is poorly defined in the lattice Y structure. The much greater flexibility of the C-
terminus in BLGY is probably the consequence of the weaker crystal packing force in
the lattice Y form. The CD loop is commonly disordered in all BLG structures
published. These two regions probably have some effects in hindering refinement.
Although a variety of approaches have been tried, the successful refinement still can
not be achieved. For example, the residues from 60 to 66 (CD loop) and 152 to 160
(C-terminus) were firstly removed and this partial model was then subjected to
refinement. However, (Fo-Fc) map calculated after refinement fails to show
continuous main chain density in these disordered regions. Secondly, the re-built
model subjected to simulated annealing has proven no more successful in decreasing
the R-factor and after stimulated annealing, the model was out of the density. In
addition, the possibility of using the structure of C-terminus in the lattice Z form to
locate the same area in lattice Y form was considered but failed as the main chain
does not fit into the density properly and so reflects a clear difference in these two
crystal forms at this point. Moreover, the rebuilding of these disordered regions fails
to reduce the R-factor and some residues were being pulled back toward the position
that they had occupied before the rebuilding.
The other possibility is that the problem may lie in the quality of the X-ray data. The
data were assessed carefully using DENZO. As summarised in Table 2-F, 131207
reflections between 23.0 to 2.0A resolution were measured and the completeness was
99.7% with the multiplicity of 12.68. The overall I/a(I) is 27.22 while the I/a(I) of
the outer shell (2.03A to 2.00A) is 6.30. The high I/a(I) indicates the reflections are
strong even at high resolution. The overall Rmerge is 5.1% while the Rmerge of the outer
shell (2.03A to 2.00A) is 20.8%. The low Rmerge shows the intensities of symmetry-
related reflections are in a good agreement of each other.
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The overloading problem has also been considered. Since the data set was collected
at the Daresbury synchrotron, there were a few reflections (approximately 20
reflections) at low resolution that were overloaded due to strong beam intensity and
long exposure time needed for the collection of the high resolution data. After the
high resolution data set was collected, the detector was moved further away the
crystal to collect the low resolution data. Careful data collection strategies, such as
decreasing the exposure time, were taken to avoid the overloading of any reflection.
The high resolution data with the overloaded reflections excluded and the low
resolution data were then merged together. The final Rmerge was 5.1%. The low
merging R-factor shows these two data sets scaled well. This merged data set was
used for the refinement is this thesis. The statistics, including low Rmerge(5.1%), high
l/o(I) (27.22) and high completeness (99.7%), show the quality of the data is good.
Therefore, it would appear that the difficulty of refinement does not come from the
quality of the data.
Moreover, the possibility of the alternative space group with lower symmetry has
also been examined. The same data set was processed in the space group C2. The
date processing results are as follows: a=79.73A, b=55.18A, c=66.68A, a=y=90°,
(3=89.99°; the completeness was 99.0% with the multiplicity of 6.99. After data
processing, molecular replacement with the program AMORE was performed. In the
space group C222i, there is a monomer in an asymmetric unit while there is a dimer
in an asymmetric unit in the space group C2. In other words, the dimer of BLG is a
crystallographic dimer in C222i while it is non-crystallographic dimer in C2.
Therefore, a dimeric search model was used for molecular replacement in the space
group C2. The dimeric model, generated in O, consists of two symmetry equivalent
molecules (monomers) which are related by a crystallographic 2-fold axis along the b
axis (the molecular dyad) in the space group C222j. After rotation and translation
functions with AMORE, a solution (a=0.00, [3=180.00, "p-90.00, Tx=0.3452,
Ty=0.0000, Tz=0.2500) with a high correlation coefficient (70.7%) and a low R-
factor (33.2%) was given. Following molecular replacement, the dimeric model was
subject to refinement with SHELX97 by performing the same procedures as
mentioned in section 3.1.4. However, the refinement result did not achieve any more
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success as the R-factor is 27.8%, which was worse than that obtained from the space
group C222i. Thus, it confirms that the space group C222i is correct.
An other approach to the problem was to collect data from another crystal grown in a
different plate and different drop to investigate if the crystal quality has effects on the
refinement. This data set was collected using home source. 77480 reflections
between 20.0 to 2.0A resolution were measured and the completeness was 99.0%
with the multiplicity of 7.46. The overall I/g(I) is 16.00 while the I/g(I) of outer shell
(2.03A to 2.00A) is 2.43. The overall Rmerge was 5.4% while the Rmerge of outer shell
(2.03A to 2.00A) is 32.7%. These data were refined against the model with the same
procedure as described in section 3.1.4. However, the refinement did not show any
improvement since the R-factor fluctuated around 26%, the same as the previous data
set.
In conclusion, the refinement problem probably does not lie in the quality of the data
set and the crystal quality. It is therefore tempting to speculate that the unsuccessful
refinement was due to the difficulty in building the disordered regions, such as C-
terminal and the CD loop, although the actual reasons resulting in hindering the
refinement require further investigation.
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4. Structure determination of BLGZ
complexed with palmitate
This chapter will describe in four parts the structural studies of BLG complexed with
palmitate. The first part is to determine and refine the complexed structure (section
4.1). The second part is to examine the complexed structure and the interactions
between palmitate and BLG (sections 4.2 to 4.4). The third part is to compare the
structure of palmitate-bound BLG with the other structures (sections 4.5 to 4.8).
Finally, the possibility of the existence of the second binding site will be discussed
(section 4.9).
4.1 Molecular replacement
4.1.1 Molecular replacement using a monomer of lattice X
The structure was solved by molecular replacement using AMORE (Navaza and
Saludjian, 1997). Data within the resolution range 10-4A and an integration radius of
18 A were used to calculate the rotation and translation functions.
A monomer of the crystal structure of dimeric BLG refined at 1.8A resolution in
triclinic Lattice X (space group PI; a=37.8A, b=49.6A, c=56.6 A, a=123.4°, (3=97.3°,
y=103.7°; PDB ID 1BEB) was used as the search model (Brownlow et al., 1997) in
the structure determination of the Lattice Z crystal forms containing the palmitate.
Although the 3.0A lattice Z structure (Brownlow et al., 1997) could have been used,
the higher resolution lattice X structure was preferred as the best starting model.
The input values for variables used with the AMORE program are listed in Table 4-
A.
Table 4-A. Input values for variables used with the AMORE program
Resolution (A) 10-4
PI box size (A,°) (75, 75, 75, 90, 90, 90)
Radius of integration (A) 18
Angular step (°) 1.0
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The top six peaks of the rotation function are listed in Table 4-B.
Table 4-B. The top six peaks of the rotation function using the lattice X
monomer as the search model
Peak (a, p, y.) Correlation
coefficient (%)
Sigma (a)
1 (78.12, 26.87, 206.14) 22.2 4.86
2 (41.88, 153.13,26.14) 22.2 4.86
3 (95.93, 140.45, 121.85) 16.9 3.70
4 (24.07, 39.55, 301.85) 16.9 3.70
5 (92.25,65.18,96.91) 16.5 3.16
6 (27.75, 114.82, 276.91) 16.5 3.16
After checking with the CCP4 program ROTMAN (Dodson,1997), it became
apparent that peaks 1 and 2 are symmetry equivalent.
The maximum peak (4.86a) in the rotation function and next highest peak (3.70a)
were used to calculate the translation function. After the translation search, the
maximum peak (a=78.12 p=26.87 y=206.14) gave a distinct solution with a high
correlation coefficient of 60.8% and a low R-factor of 38.9%. The next solution has a
lower correlation coefficient of 34.2% and a higher R-factor of 49.8%.
The top five solutions of translation function using this maximum peak are listed in
Table 4-C.
Table 4-C. The top five solutions of translation function using the maximum
peak obtained from rotation function (a=78.12 p=26.87 y=206.14)
Solutions of Fractional coordinates Correlation R-factor
translation function (Tx, Ty, Tz) coefficient (%)
(%)
1 (0.3317,0.2440, 0.3664) 60.8 38.9
2 (0.6639, 0.9092, 0.2827) 34.2 49.8
3 (0.9969, 0.5724, 0.3675) 32.6 50.7
4 (0.3338,0.2454, 0.1586) 32.5 50.1
5 (0.6617,0.9109,0.4085) 32.2 51.4
The packing of the molecules in the unit cell was checked by the program PACMAN
(Kleywegt et al., 1996) and also displayed in O (See Figure 4-1). Both programs
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showed that the packing of the first solution was reasonable with no symmetry-
related molecules clashing into each other.
It was obvious that the first solution was correct since it had a significantly higher
sigma value, higher correlation coefficient and lower R-factor when compared to the
second solution. The packing of this solution was also reasonable. As well as peak 1,
peak 3 (a=95.93 (3=140.45 •y= 121.85) obtained from the rotation function was used
to calculate the translation function. However, it failed to give a distinct solution like
peak 1. In addition, the solutions that it did give had much lower correlation
coefficients (approximately 20.0%), and much higher R-factors (approximately
55.5%).
The space group P3i21 was also confirmed by the translation function. The rotation
function in space group P3121 give the same solutions as in space group P3221.
However, when the translation function was calculated using peak 1 (a=78.12
(3=26.87 y=206.14) of the rotation function, no distinct solution was found in space
group P3i21. The top five solutions of translation function in space group P3i21
using peak 1 are listed in Table 4-D.
Table 4-D The top five solutions of translation function in space group P3i21
using the peak 1 obtained from rotation function (a=78.12 (3=26.87 y=206.14)
Solutions of Fractional coordinates Correlation R-factor
translation function (Tx, Ty, Tz) coefficient (%)
(%)
1 (0.3862, 0.2952, 0.3666) 26.8 53.1
2 (0.9620, 0.8709, 0.3658) 26.7 52.5
3 (0.7393, 0.6586, 0.3669) 26.4 52.6
4 (0.3383, 0.6133, 0.2000) 26.0 53.2
5 (0.0209, 0.9375,0.3671) 25.7 53.4
The best solution in P3121 gave a lower correlation coefficient of 26.8% and a higher
R-factor of 53.1% whereas the best solution in P3221 gave a correlation coefficient of
60.8% and an R-factor of 38.9%.
Following the translation function, rigid-body refinement of the optimum molecular
replacement solution was performed. This reduced the R-factor slightly from 38.9%
to 38.0% and the Eulerian angles and fractional coordinates shift slightly to a=78.28
(3=26.50 '7=206.33 Tx=0.330 Ty=0.246 Tz=0.3663.
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Figure 4-1.Packing diagram of the molecular replacement
solution, prepared by O (Jones et al., 1991).
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4.1.2 Molecular replacement using lattice Y model
The BLG Lattice Y structure (space group C222j; a=55.5A, b=82.lA, c=66.8, a=[3=7
=90°) was also used as a search model in the structure determination of the lattice Z
crystal form containing palmitate. Following the same procedure as in section 4.1.1
and using the same input variables as were applied to the lattice X monomer, the
rotation function gives the maximum peak (a=97.74, [3=47.43 7^=352.49) of 5.41a
and the next highest peak (a=96.09, [3=12.78 7^=136.42) of 3.94a. Both were used to
calculate the translation function. After the translation search, the maximum peak
(a=97.74, [3=47.43 7^352.49) gave the best solution with a correlation coefficient of
38.3% and an R-factor of 48.6% while the next solution had a correlation coefficient
of 28.0% and an R-factor of 52.3%. The top five solutions of translation function are
listed in Table 4-E.
Table 4-E. The top five solutions of translation function using the maximum
peak obtained from rotation function (a=97.74, (3=47.43 y=352.49)
Solutions of Fractional coordinates Correlation R-factor
translation function (Tx, Ty, Tz) coefficient (%)
(%)
1 (0.6686, 0.9090, 0.3007) 38.3 48.6
2 (0.6697, 0.9090, 0.2582) 28.0 52.3
3 (0.6679, 0.9093,0.0731) 27.2 53.2
4 (0.3371,0.2411,0.3425) 26.6 53.0
5 (0.6714, 0.9107,0.1160) 26.3 53.4
The packing of the molecules in the unit cell was checked by the program PACMAN
(Kleywegt et al., 1996) and also displayed in O. Both programs showed that the
packing of the first solution was reasonable with no symmetry-related molecules
clashing into each other.
The first solution was correct since it had a higher sigma value, higher correlation
coefficient and lower R-factor when compared to the second solution. The packing of
this solution was also reasonable.
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The next highest peak of rotation function (a=96.09, (3=12.78 136.42) gave no
significant solution and all solutions are with a lower correlation coefficient around
17.0% and a higher R-factor around 56.0%.
The solutions obtained using lattice Y as the search model were generally poor and
therefore the solution obtained from molecular replacement using lattice X as the
search model was used for further refinement and discussed in this thesis.
4.1.3 Refinement and model building
Following rigid-body refinement, the model was subjected to simulated annealing
using data between 10A and 2.5A. The slow cooling protocol for refinement by
simulated annealing was used (Brunger et al., 1990b). Firstly, the model was heated
to 3000K, followed by 50 steps ofmolecular dynamics integration performed with a
time step of 0.5fs. After each molecular dynamics calculation, the temperature was
decreased by 25°K to the final temperature of 250°K. The R-factor dropped to 34%
(Rfree=38.1%) after simulated annealing. The electron density maps, (3Fo-2Fc) and
(Fo-Fc), calculated in X-PLOR and converted in MAPPAGE (Jones, 1992) were
displayed in O. In the (3Fo-2Fc) map (see Figure 4-2), some density appeared in the
proposed binding site inside the calyx (Cho et al., 1994).
Although the electron density was not clear enough to fit the entire palmitate, it
looked promising as the shape of the density is elongated, like an extended carbon
chain. Actually, this part of the density was confirmed as the tail of the palmitate at
the final refinement stage. The density of the head of the palmitate was missing in the
(3Fo-2Fc) map. However, in the (Fo-Fc) map (see Figure 4-3), some density
appeared around the mouth of the calyx near to the CD loop.
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Figure 4-2.The (3Fo-2Fc) electron density map around the bound palmitate
with the refined structure superimposed. The map, contoured at 1.2 sigma, was
calculated by XPLOR (Brunger, 1992) after simulated annealing
refinement and displayed in O (Jones et al., 1991). The density of tail of the
palmitate appears in the binding site.
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Palmitate
Figure 4-3 .The (Fo-Fc) electron density map around the bound palmitate with
the refined structure superimposed. The map, contoured at 2.0 sigma, was
calculated by XPLOR (Brunger, 1992) after simulated annealing
refinement and displayed in O (Jones et al., 1991).
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The density was very weak, therefore little could be said about the location and
orientation of palmitate at this stage. Following simulated annealing, 600 cycles of
positional refinement were carried out. Individual B-factors were also refined after
positional refinement. This resulted in a decrease of the R-factor from 34% to 29.8%
(Rfree from 38.1% to 33.8%). However, the density of palmitate was still not
significantly improved. Following individual B-factor refinement, H20 molecules
were added using the programWATERPICK supplied in X-PLOR. The positions of
H20 were checked manually in O firstly to ensure the location was appropriate and
secondly that the H20 made a reasonable hydrogen bond contact with the protein.
The R-factor decreased to 25.2% (Rfree=29.0%).
From the density map (see Figure 4-4), it was obvious the EF loop adapts the
alternative conformation compared to the original model (BLGX model). Therefore,
the decision was taken to re-build manually the EF loop in order to clarify this
region. The density in this region was weak, however careful inspection allowed
tracing of the main chain through continuous density. As the (3Fo-2Fc) map (see
Figure 4-4) was more clear than the (Fo-Fc) map, it was used to re-build EF loop.
Following rebuilding, further positional and B-factor refinement resulted in a
reduction of the R-factor to 24.4% (Rfree=28.8%) and enhanced clarity in the density
map around the bound palmitate (see Figure 4-5).
The broken density seen in Figure 4-2 had joined together and stronger density
appeared around the open end of the calyx. The rebuilt model was subjected to
further refinement with SHELX97-SHELXL. After 5 cycles of positional and B-
factor refinement, more H20 molecules were added using SHELXWAT. A (2Fo-lFc)
map (see Figure 4-6) was calculated using SHELXPRO and displayed with O. The
refinement and addition of H20 in SHELXL improved the density sufficiently to








Figure 4-4.The (3Fo-2Fc) electron density map of the EF loop with the refined
BLGZ structure superimposed. The EF loop of the original model (BLGX) is
shown in green. The map, contoured at 0.8 sigma, was calculated by XPLOR
(Brunger, 1992) after the addition of the water molecules and displayed in
O (Jones et al„ 1991).
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Palmitate
Figure 4-5.The (3Fo-2Fc) electron density map around the bound palmitate
with the refined structure superimposed. The map, contoured at 1.0 sigma, was
calculated by XPLOR (Branger, 1992) after rebuilding the EF loop and
displayed in O (Jones et al„ 1991).
4-11
Figure 4-6.The (2Fo-Fc) electron density map around the bound palmitate with the
refined structure superimposed. The map, contoured at 1.3 sigma, was calculated by
SHELXPRO (Sheldrick and Schneider, 1997) after refinement in SHELX and
displayed in O (Jones et al., 1991). Compared to Figure 4-2, this density map shows
the improvement in the density of palmitate after the refinement in SHELX.
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The model of palmitate was taken from the well-refined structure of palmitate
binding to fatty acid binding protein (PDB ID: 1MDC) and built into the density with
O. The tail of palmitate was built towards the bottom of the calyx, the head being
located near the mouth of the calyx. 14 out of 16 carbon atoms were able to be fitted
into the density with the exception of two carbon atoms near the head of palmitate
(C2 and C3). After palmitate was modelled into the density, 10 cycles of positional
and B-factor refinement were performed. A (2Fo-Fc) map was again calculated. The
ligand density was very clear at this stage (See Figure 4-7).
All atoms were fitted into the map and the density of the -COOH group was well-
defined. Following ligand building, the protein structure was completed by inserting
three residues (Ile2-Thr4) into the N-terminal region, and two residues (Hisl61-
Ilel62) into the C-terminal region. These residues were unclear in the lattice X
structure and had been omitted.
The final R-factor is 20.4% and Rfree is 24.0% for all reflections to 2.5A. resolution.
The result of the final round of refinement result is summarised in Table 4-F.
Table 4-F. Summary of the refinement statistics of BLG complexed with
palmitate structure
Summary of the refinement statistics Palmitate/BLG structure
Resolution range (A) 10-2.5
Rfinal (F>4<7) 20.4% (19.7%)
Rfree' (F>4a) 24.0% (23.7%)
Rms deviations from ideal geometry
Bond lengths (A) 0.004
Angle distance (A) 0.018
mean B-factor (A2) 47.17
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Figure 4-7 .The (2Fo-Fc) electron density map around the bound palmitate with
the refined structure superimposed. The map, contoured at 1.3 sigma, was
calculated by SHELXPRO (Sheldrick and Schneider, 1997) after building
palmitate into the density and displayed in O (Jones et al„ 1991). The density of
palmitate is well defined.
4-14
The solvent content of the crystal is 50.78 %, with the Matthews number 2.52 A3/Da.
There are 6 molecules in the unit cell, with 1 molecule per asymmetric unit. The
electron density map of the 9 (3-strands and an a-helix is very clear. However, N-
terminal, C-terminal and some loops that connect p-strands have ill-defined density,
especially the CD, EF and GH loops. Regions of disorder are commonly found in
BLG structures (Brownlow et al., 1997, Qin et al., 1998a). These loops are around
the open end of the p-barrel and are flexible, which resulted in difficulty in
interpretation of the electron density map. However, it is as a direct result of the
flexibility in these regions that the ligand is able to access the calyx without
obstruction.
The structure has good geometry as reported by SHELX97 with rms deviation of
bond length and angle distance, 0.004A and 0.018 A, respectively. The average B-
° "7 •
factor for all protein atoms is quite high, 47.17 A , but is in keeping with the values
usually obtained for BLG.
The stereochemical quality of the structure was checked by CCP4 program
PROCHECK (Laskowski et al., 1993). The Ramachandran Plot is shown in Figure 4-
8.
Essentially, all residues are in the allowed regions, expect Tyr99. Tyr99, which
adopts a typical y-turn conformation common to other lipocalin stmctures with the
sequence of TDY, is well defined in the density map and is also in the disallowed
region in the lattice X structure. One residue, Asn88, is in the generously allowed
region. This residue is in the mobile EF loop which is a portal loop to reveal the
interior of the calyx and the density map around this part is weak and poorly defined.
PROCHECK was also used to assess agreement between the main-chain and side-
chain parameters of the structure of palmitate bound to BLG with those of well-
refined structures at a similar resolution (See Figure 4-9 and Figure 4-10). The
structure of palmitate bound to BLG is represented by a solid square, while other
reference structures are represented by the dark band. The central line is a least-
squares fit to the mean trend as a function of resolution and the width of the band












Residues in most favoured regions [A,B,L] 116 78.9%
Residues in additional allowed regions [a,b,l,p] 29 19.7%
Residues in generously allowed regions [~a,~b,~l,~p] 1 0.7%
Residues in disallowed regions 1 0.7%
Number of non-glycine and non-proline residues 147 100.0%
Number of end-residues (excl. Gly and Pro) 2
Number of glycine residues (shown as triangles) 4
Number of proline residues 8
Total number of residues ] 61
Figure 4-8. Ramachandran plot of the structure of BLG with bound palmitate,
produced by PROCHECK (Laskowski et al., 1993). Square symbols represent
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Figure 4-9. Plots of the comparison of the main chain parameters of the
structure ofBLG with bound palmitate with other structures solved to a similar
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Figure 4-10. Plots of the comparison of the side chain parameters of the
structure of BLG with bound palmitate with other structures solved to a similar
resolution, produced by the program PROCHECK (Laskowski et al., 1993).
1.0 1.5 2.0 2.5 3.0 3.5 4 0
Resolution (Angstroms)
l!0 ~L5 23) 235 33) 3J 40
Resolution (Angstroms)
c. Chi-1 gauche plus
1.0 1.5 2.0 2.5 3.0 3A 4!0
Resolution (Angstroms)
e. Standard deviation of Chi-2 trans angle
50 6
a. Chi-1 gauche minus
4-18
The structure was of high quality since all main-chain and side-chain parameters are
in the average region; two main-chain parameters, bad contact check and overall G-
factor, are even better than the mean value.
4.2 Overall structure
The overall structure of palmitate bound to BLG is shown in Figure 4-11.
The structure of the host protein, BLG, is almost identical to the native BLG structure
solved in the different lattice forms, triclinic (lattice X) and orthorhombic (lattice Y).
The (3-barrel of BLG is open to ligand binding. At the open end of the (3-barrel, there
are three very mobile loops, CD, EF and GH loops, and their flexibility allows the
ligand to enter the binding site without obstruction. Inside the barrel is a hydrophobic
cavity or calyx formed by the side chains of LeulO, Ilel2, Vall5, Val41, Val43,
Leu46, Leu54, Ile56, Leu58, Ile71, Ala73, Ala80, Phe82, Ile84, Val92, Val94,
Leu 103, Phel05 and Met 107. The palmitate binds inside the calyx and lies parallel to
[3-strands E with the hydrophobic tail stretching into the bottom of the calyx. At the
open end of the barrel, the head of palmitate forms two hydrogen bonds with Lys60
and Lys69. The palmitate makes a total of 29 hydrophobic contacts with the 13
residues in the hydrophobic cavity over a distance of less than 4A. The interatomic
distances between palmitate and BLG are summarised in Table 4-G.
The distances between palmitate and BLG vary from 3.30 to 3.89A. In particular, the
side chain of Phel05 faces the tail of the palmitate and contributes most to the
hydrophobic interaction (see Figure 4-12). From the statistics in Table 4-G, it is clear
that the carbon atoms of the tail make more hydrophobic contacts with the protein
than those of the head. Therefore, the carbon atoms at the tail with lower B-factor are
stabilised by hydrophobic interactions while carbon atoms at the head with higher B-
factors are more mobile due to weaker hydrophobic interactions with the protein.
This phenomenon is also consistent with the density map of palmitate seen in Figure
4-2. The density of the tail is stronger and can be seen in the first (3Fo-2Fc) map (see










Figure 4-1 l.Ribbon diagram of the structure of palmitate bound to BLG.
Palmitate binds inside the calyx.
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Table 4-G. The interatomic distances between BLG and palmitate
Palmitate atoms BLG atoms Distance (A)





























Hydrogen bond interaction 01 NZ/Lys69 3.22
01 NZ/Lys60 2.72
There are also two strong hydrogen bonds involved in the ligand-protein binding.
One oxygen atom of the carboxyl group of palmitate is hydrogen bonded to Lys60
and Lys69 with distances of 2.72A and 3.22 A, respectively. As mentioned in Qin's
paper (Qin et al., 1998b), Lys60 and Lys69 seem to be very important in the ligand
binding affinity. The replacement of Lys69 with glutamate in pig BLG results in the
failure of fatty acid binding to BLG (Frapin et al., 1993). The replacement of Lys60
with glutamate in horse and donkey BLG also results in the failure of fatty acid
binding (Perez et al., 1993). It is thus tempting to speculate that any substitution of








Figure 4-12.Diagram of the binding site of BLG with bound palmitate, produced
by MOLSCRIPT (Kraulis, 1991). The residues formed the hydrophobic contacts
with palmitate are labelled. The carbon atoms of palmitate are shown in green.
The carbon atoms of Phel05 are shown in magenta.
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4.3 The conformation of paImitate
In its bound conformation, palmitate bends slightly from a fully extended all-trans
conformation in order to fit inside the calyx. There is a kink at C6. Careful
comparison of the B-factors of the palmitate carbons within the calyx (C8-C16) shows
they are similar in magnitude to those of the adjacent side chain atoms. Those nearer
the opening of the calyx increase, presumably reflecting the larger volume of the
cavity and hence the less specific nature of the binding in the region of the highly
flexible EF and GH loops. The electron density for both these loops is not well-
defined.
BLG contains two tryptophan, Trpl9 and Trp61. Trpl9, facing into the base of the
calyx, is essentially inaccessible to solvent. Trp61 in the extremely mobile loop at the
mouth of the hydrophobic calyx is exposed. As perturbation of the Trp fluorescence
can be used to monitor binding of hydrophobic ligands to BLG, the distances from
palmitate to the two Trp residues were determined directly in the program O. The
closest approach of C2 is 10.36A from Trp61 and C15 is 6.98A from Trpl9. It is
possible therefore that there is perturbation of fluorescence signals from both Trp
residues, although that at position 19 is in a significantly more restricted
environment. Some papers have proposed Trpl9 maybe be more important than
Trp61 for the changes in both fluorescence and CD intensity by site-direct
mutagenesis method (Cho et al., 1994) and CD (Creamer, 1995). This is probably
relative to the observation that Trp 19 makes closer contact with ligand than Trp61.
4.4 The structure for the second data set
The structure of BLG co-crystallised with palmitate was used as the starting model to
refine the structure from material produced by the alternative method as mentioned in
section 2.3.2.3. Firstly, only the protein structure was used in refinement; the
palmitate was omitted. Positional and B-factor refinement were performed using
SHELX97. After 10 cycles of positional and B-factor refinement, a (2Fo-lFc) map
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was calculated using SHELXPRO and displayed with O. In the (2Fo-lFc) map (see
Figure 4-13), some density appeared in the expected binding site inside the calyx.
The density of the tail of palmitate is visible, whereas that of the head is very weak.
100 H2O were added using SHEFXWAT and a (2Fo-lFc) map was calculated again.
The density map (see Figure 4-14) is clearer and the density around the head region
of palmitate is stronger.
The R-factor also decreased from 28.0% to 23.6%. Palmitate was then built into
density. After building, 20 cycles of positional and B-factor refinement were
performed again and another 30 H2O were added. The ligand density is very clear at
this stage (see Figure 4-15).
All palmitate atoms were fitted into the map and the density of the -COOH group
were well-defined. The structure was completed by manually building some residues
of the flexible loops, for examples, Asn88, Glu89 and Pro 113, into density.
The final R-factor is 23.3% and Rfree is 28.5% for all reflections to 2.3A resolution.
The result of the final round of refinement result is summarised in Table 4-H.
Table 4-H. Summary of the refinement statistics from the second data set


















Figure 4-13.The (2Fo-Fc) electron density map around the bound palmitate with
the refined structure superimposed. The map, contoured at 1.4 sigma, was
calculated by SHELXPRO (Sheldrick and Schneider, 1997) after positional and
B-factor refinement in SHELX and displayed in O (Jones et al„ 1991). Some
density appeared in the expected binding site inside the calyx.
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Figure 4-14.The (2Fo-Fc) electron density map around the bound palmitate with
the refined structure superimposed. The map, contoured at 1.4 sigma, was
calculated by SHELXPRO (Sheldrick and Schneider, 1997) after the addition of
water molecules in SHELX and displayed in O (Jones et al., 1991). Compared to
Figure 4-13, this map shows the improvement in density of palmitate after the
addition of water molecules.
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Palmitate
Figure 4-15.The (2Fo-Fc) electron density map around the bound palmitate with
the refined structure superimposed. The map, contoured at 1.4 sigma, was
calculated by SHELXPRO (Sheldrick and Schneider, 1997) after building
palmitate into the density and displayed in O (Jones et al., 1991). The density of
palmitate is very clear in this map. Note the discrete density for Met 107 and the
palmitate.
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The rms deviations of bond length and angle distance are 0.006A and 0.02 A,
0 2
respectively. The average B-factor for all protein atoms is 47.51 A . The
stereochemical quality of the complexed structure assessed by PROCHECK is very
similar to that of the structure from the first preparation. The geometry is again
acceptable, with Tyr99 and Asn88 again being the exceptions in the Ramachandran
plot.
It is clear that there is a bulge in the density associated with the position ofMet 107
(see Figure 4-15). The B-factors for the same palmitate C-atoms after refinement
with the second data set were significantly larger than those of the adjacent side-
chains but, when a single occupancy term for all ligand atoms was used in
refinement, the B-value became similar to those of the surrounding side-chains. In
the lattice Z crystal form, the two binding sites in the dimer are crystallographically
identical. Analysis by gas chromatography as mentioned in section 2.2.2 showed that
the complex had about 1 mol palmitate bound to 1 mol of dimeric protein. If the
stoichiometry was one ligand per dimer, the expected occupancy would be 0.5 since
on average, each site has half a palmitate molecule in it. The refined occupancy was
0.69. This is higher than 0.5, but because of the imprecise nature of the occupancy
determination and the high correlation that exists between occupancy and B-factor,
the result indicates a reasonable agreement with the solution study. In comparison, an
identical calculation of the occupancy of palmitate in the first data set gave a value of
0.96. The bulge in the electron density at Met 107 is thus explained as the addition of
two components for the Met 107 side chain - that of the native structure and that
with bound ligand (see Figure 4-16).
What is not clear is why the different preparation protocols used should produce
different palmitate to BLG dimer ratio. There is no obvious cooperativity between
the monomers, whose binding sites, some 35A apart, are approached from a direction
away from the dimer interface.
One possible explanation is that first data set was collected from the crystal which
was crystallised in the mother liquor super-saturated with palmitate as mentioned in
section 2.3.2.2 while the second data set was from the crystal crystallised in the
mother liquor containing no palmitate. Therefore, BLG was saturated with palmitate
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once crystallised during the first preparation whereas some palmitate was dissociated
from BLG to the mother liquor once crystallised during the second preparation. More
palmitate thus bound to BLG in the first data set, which consequently results in the
higher occupancy of palmitate compared to the second data set.
4.5 Comparison of the structure of Palmitate-bound BLG
with other native BLG structures
Comparison of the structure of palmitate-bound BLG at pH 7.5 with the structure of
the native lattice X at pH 6.5 reveals the major difference is in the movement of the
EF loop (see Figure 4-16). In the lattice X structure, the EF loop is folded toward the
calyx thus blocking the entrance to the calyx. In contrast, in the structure of palmitate
bound to BLG, the EF loop is folded back to allow access for the binding of
palmitate. It is the movement of the loop as the pH is raised from pH 6 to 7.5 that
opens up the entrance to the calyx (see Figure 4-16).
The occlusion of, or at least hindrance to, the binding site at low pH may provide an
explanation for the failure of the soaking experiments with the lattice X crystal form
at pH 6.5. This result may be also relevant to the lower affinity binding of BLG to
palmitate seen as the pH decrease from 8.7 to 6.5 (Spector and Fletcher, 1970).
Spector measured the strength of palmitate binding to BLG over different pH range.
This showed palmitate bound more tightly at pH 7.4 than pH 6.9. In addition,
titration of BLG with palmitic acid, myristic acid and oleic acid under acidic
conditions at pH 3.0 showed no binding of fatty acids as measured by the
fluorescence enhancement assay (Frapin et cil., 1993). Therefore, it is tempting to
conclude, at lower pH, the binding site is inaccessible to ligands because of
hindrance by the EF loop.
The pH-dependant movement of the EF loop is in agreement with the study by Qin
(Qin et al., 1998a) as mentioned in section 1.1.7.
Apart from the EF loop, the side chain of Met 107 near the kink at C6 also moves to
allow the occupancy of palmitate (see Figure 4-16).
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GH LOOP
Figure 4-16.(a) Diagram of the native structure at pH6.5 (lattice X) showing the
position ofMetl07 when palmitate is absent, (b) Diagram of the structure at
pH7.5 (lattice Z) showing the movement of side chain ofMetl07 when palmitate
binds. The movement of the EF loop can also be seen. There are no other
significant movements between the bound and free forms of the protein.
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Comparison of the structure of palmitate-bound BLG at pH 7.5 with the structure of
the native lattice Y at pH 7.5 shows the binding sites of these two structures are
identical (see Figure 4-17).
The exceptions are that the side chains of Lys60, Lys69, Ile71 and Metl07 adopt
different rotamers. As mentioned above, the side chain ofMetl07 moves away to
allow the occupancy of fatty acid once the ligand enters the binding site. Lys60 and
Lys69 are in the very mobile region. Their flexibility allows these two residues to
move so that the side chains can make better hydrogen bond contacts when ligands,
such as fatty acids, bind into the calyx.
Additionally, the EF loop in the lattice Y form also adopts the open conformation as
seen in the complexed structure. It is therefore tempting to speculate that fatty acid
will bind in the lattice Y form in the same manner as in the complexed structure in
the lattice Z form.
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Figure 4-17.Diagram of the superimposition of the binding site of BLGY and
that of palmitate bound to BLG structure (green). The labelled residues
represent the residues that adopt the different conformations in these two
structures.
4-32
4.6 Comparison of the structure of palmitate bound to BLG
with that of 12-bromododecanoic acid bound to BLG
12-bromododecanoic acid binds to BLG in a very similar way to palmitate (Qin et
al., 1998b). The carboxyl group of 12-bromododecanoic acid is associated with
Lys60 and Lys69 while the tail stretches into the interior of the calyx. Both adopt the
almost fully extended conformation with a kink at C6 in palmitate and C3 in 12-
bromododecanoic acid. By superimposing these two structures, it was found that the
head of palmitate is one C-C bond length longer to the mouth of the calyx and three
C-C bond lengths deeper into the base of the calyx. The palmitate makes a total of 29
hydrophobic contacts with the protein in a distance less than 4A while 12-
bromododecanoic acid makes a total of 12 hydrophobic contact with the protein over
the same distance. The fewer hydrophobic contacts of 12-bromododecanoic acid with
BLG provide the structural basis of the weaker binding strength of dodecanoic acid
(lauric acid) than that of palmitate observed by fluorescence (Frapin et al., 1993).
The association constant of palmitate is 7 times higher than that of lauric acid. It also
proved the assumption made by Perez (Perez et al., 1995) that hydrophobic
interactions are very important in the binding process. As for the structures of the
BLG, these two are very similar, except in some mobile loops. The rms between
corresponding backbone atoms of 145 residues in the structure of palmitate-bound
BLG and that of 12-bromododecanoic acid-bound BLG is 0.403A with the CD, EF
and GH loops excluded. In the structure of palmitate bound to BLG, two loops at the
mouth of the calyx, the EF loop and CD loop, slightly shift toward the ligand (see
Figure 4-18)
The shift in the CD loop will allow Lys60 and Lys69 to make better hydrogen bonds
with the carboxyl group of palmitate. The distances between Ol atom of palmitate
and the side chains of Lys60 and Lys69 are 2.12k and 3.22A, respectively while the
distances between 01 of 12-bromododecanoic acid and side chains of Lys60 and
Lys69 are 4.5A and 5.08A, respectively. There are also other subtle differences
between these two structures.
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CD LOOP
Figure 4-18.Diagram of the superimposition of palmitate bound to BLG and
12-bromododecanoic acid bound to BLG structures. The structure of BLG with
bound palmitate is shown in yellow while the structure of BLG with bound
12-bromododecanoic acid is shown in cyan. The carbon atoms of palmitate are shown
in black while the carbon atoms of 12-bromododecanoic acid are shown in orange.
4-34
The orientation of the carboxyl group of palmitate is different from that of 12-
bromododecanoic acid. The orientation of the head of palmitate allows the carboxyl
group to make better hydrogen bond contact with Lys60 and Lys69 along with the
shift of the CD loop as discussed above. Moreover, the side chains ofMetl07, Ile84
and Ile71 adopt the different rotamers.
4.7 Comparison of the structure ofpalmitate bound to BLG
with FABP structure
This gating of the inner binding site is in some way similar to that of the dynamic
portal hypothesis in FABP where ligand access and binding are mediated by flexible
regions of the protein backbone (Hodsdon and Cistola, 1997b). While in the structure
of palmitate bound to BLG, discrete arrangements of the 'portal' loop EF exist and
some nearby loops are very mobile. In the dynamic portal hypothesis, the disordered
region creates a dynamic portal to allow entry of the fatty acid. Once the fatty acid
binds to the protein, a variety of interactions induced by the ligand stabilise this
flexible region and close the ligand entry portal. This fatty acid-induced ordering
process may effectively lower the dissociation rate and increase the binding affinity.
Any reaction that destabilises this disordered region will release the fatty acid. This
hypothesis is relative to the observation by Qin (Qin et al., 1998b). When 12-
bromododecanoic acid binds to BLG, the EF loop is more rigid with smaller B-
factors compared to the native structure. It confirms that ligand binding stabilises the
flexible region in the entrance of the calyx. However, the phenomenon of the entry
portal closing once ligand was bound to protein is not observed in BLG. In BLG, the
EF loop adopts the open conformation with and without ligand binding.
The binding site in BLG is rather fully extended, but there is space for longer fatty
acid molecules such as stearate and oleate to be accommodated within the calyx, with
the carboxyl group making the same interactions with Lys 60 and Lys 69. The
association constants for both acids are similar (Perez et al., 1989, Frapin et al.,
1993). In the FABP family, palmitate is also observed in an extended form, although
alternative conformations of bound fatty acids have been observed (Hodsdon and
Cistola, 1997a, Sacchettini et al., 1992). It has been found that if the carbon chain is
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longer than 16 carbon atoms, the fatty acids, such as stearic acid or arachidonic acid,
are likely to adopt a horse-shoe conformation whereas if the carbon chain is equal or
shorter than 16 carbon atoms, the fatty acids always adopt the extended
conformation.
4.8 The existence of the second binding site?
Little can be said about the existence of the second binding site so far although
several lines of evidence point to the possibility of the existence of a second binding
site. Retinol, the other well-known ligand that can bind to BLG, has been proposed to
bind independently and simultaneously with fatty acid to BLG. For example, titration
of native BLG, as well as retinol-bound BLG, by palmitic acid enhances the
tryptophan fluorescence simultaneously and their association constants are quite
similar, Kd=l*10~7 M (n=0.93) and Kd=2.6*10~7 M (n=0.9) for native BLG and
retinol-bound BLG complex, respectively (Frapin et al, 1993). Also, using electron
spin resonance spectroscopy, Narayan and Berliner (1997) have found 5-doxylstearic
acid, a fatty acid analogue, binding at a site that is not perturbed by retinol and
proposed the presence of at least two strong hydrophobic binding sites on BLG.
Recently, Lange et al (1998) suggested the retinol and retinoic acid bind in the
surface cleft of BLG instead of the interior calyx, using data from fluorescence
resonance energy transfer (FRET) analysis. According to Lange's result, the
experimental efficiency of fluorescence resonance energy transfer calculated from the
two Trps (Trpl9 and Trp61) and the ligands, retinol and retinoic acid, are in excellent
agreement with the theoretical value calculated from the distances between each Trp
and Lysl41 as a reference point for the surface cleft. In contrast, the theoretical value
calculated from the distances between each Trp and Lys70 as a reference point for the
interior calyx is twice as large as the experimental value. It is needed to note that
Lys70 in the model (Papiz et al., 1986) used by Lange should be corrected to Lys69
in the revised model (Cabral, 1993; Brownlow et al., 1997; Qin et al., 1998a). The
result obtained by Lange is consistent with the crystallographic analysis of the
structure of retinol bound to BLG by Monaco (Monaco et al., 1987), which suggested
that retinol binds in the external groove. However, the proposed surface binding site
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of retinol is in contradiction to the report of Cho et al (1994), which found that the
residues of the central calyx contribute to the binding interaction as demonstrated by
fluorescence study together with site-directed mutagenesis. Thus, higher resolution
data from the retinol/BLG complex is required to facilitate further investigation into
the precise nature of the retinol binding site. This would also allow clearer
identification of second binding site of BLG.
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5. Structure determination of CYP3
This chapter will describe the crystallographic work on the native structure of CYP3
and the structure of Ala-Pro bound to CYP3. Section 5.1 will contain the refinement
of the CYP3 structure, the examination of the detail of the structure and the
comparison with the CYPA structure. Section 5.2 will contain the refinement of the
structure of Ala-Pro bound to CYP3, the analysis of the binding site and the
calculation of the dissociation constant "in crystallo " by x-ray crystallography.
5.1 Native Cyp3 structure
5.1.1 Refinement
The initial structure was solved by Dr. Paul Taylor in Prof. Walkinshaw's group in
Edinburgh (Taylor, 1998a) using molecular replacement with the refined human
CYPA structure (space group P2i2i2j: a=36.4A, b=60.7A, c=72.2A, a=P=y=90°,
PDB ID=1CWA) as the search model. Data used were to a resolution of 1.9A and
collected at the synchrotron. These data were from a crystal grown in the presence of
3.5%DMSO, which has been shown to bind to cyclophilin by x-ray crystallography
(Kontopidis, 1999). Native data to 1.8A was collected on the home source. This data
set was used for further refinement. The native stmcture produced from this data set
is discussed in this thesis.
The same refinement procedure mentioned in the section 2.7.3.2 was followed.
Positional and B-factor refinement were performed using SHELX97. After 15 cycles
of positional and B-factor refinement, H20 molecules were added using
SHELXWAT. 110 ITO molecules were added and the R-factor decreased from
30.62% to 23.67% while Rfree decreased from 36.07% to 29.45%. A (2Fo-Fc) map
was calculated using SHELXPRO and displayed with program O to ensure the model
is well-fitted in the density map. The density map was very clear and most of the
residues were well defined in the map, except some residues in the N-terminal
region, C-terminal region and the mobile loop, which will be discussed later. It was
shown in the map that the side chain of Vail40 adopted the different conformation
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from the original model. Therefore, the side chain of Vail40 was moved to fit into
the density. Following the reposition of the side chain of Vail40, several cycles of
positional and B-factor refinement were performed again and more H20 molecules
were also added. The R and Rfree of each refinement stage are summarised in Table 5-
A.
The final R-factor is 20.81% and Rfree is 28.47% to 1.8A. The results from the final
cycle of refinement are summarised in Table 5-B.
Table 5-A. The refinement process of CYP3
Refinement step Resolution
range(A)
R (%) Rfree (%)
Positional and B-factor refinement 10-1.8 30.62 36.07
Adding 111 H20 10-1.8 23.67 29.45
Positional and B-factor refinement after
moving side chain of Vail40 into density
10-1.8 23.27 29.17
Adding another 150 H2Q 10-1.8 20.81 28.47
Table 5-B. Summary of the refinement statistics of CYP3 structure














The solvent content of the crystal is 59.32 %, with a Matthews coefficient of
3.05A3/Da. The space group is P4i2i2 and the unit cell is a=b=60.60A and
c=123.1A. There are 8 molecules in the unit cell, with 1 molecule per asymmetric
unit. Most of the residues are well defined in the electron density map, the exceptions
being 2 residues in the N-terminal region (Metl-Ser2), 2 residue in the C-terminal
region (Lysl72-Alal73) and 2 residues in the loop (Gly87-Glu88). The B-factors of
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these disordered residues are very high and the electron density around these regions
is weak and discontinuous.
The structure has good geometry as reported by SHELX97 with rms deviations of
bond length and angle distance, 0.031A and 0.026 A, respectively. The average B-
factor for all protein atoms is 30.37 A2.
The stereochemical quality of the structure was checked by the CCP4 program
PROCHECK (Laskowski et al., 1993). The Ramachandran Plot is shown in Figure 5-
1.
No residues are in the disallowed regions. Two residues, Phe67 and Glu88, are in the
generously allowed regions. After carefully checking the density map, Phe67 is well
defined in the density map as shown in Figure 5-2 while Glu88 is disordered and the
density map is too weak to build this residue accurately.
PROCHECK was also used to assess the agreement between the main-chain and
side-chain parameters of the CYP3 structure with those of well-refined structures at a
similar resolution (See Figure 5-3 and Figure 5-4). In Figure 5-3 and Figure 5-4, the
CYP3 structure is represented by a solid square, while other reference structures are
represented by the dark band. The central line is a least-squares fit to the mean value
as a function of resolution and the width of the band corresponds to a variation of one
standard deviation about the mean.
From these statistics, it is clear the structure is of acceptable quality as the














Residues in most favoured regions [A,B,L] 112 81.8%
Residues in additional allowed regions [a,b,l,p] 23 16.8%
Residues in generously allowed regions [~a,~b,~l,~p] 2 1.5%
Residues in disallowed regions 0 0.0%
Number of non-glycine and non-proline residues 137 100.0%
Number of end-residues (excl. Gly and Pro) 2
Number of glycine residues (shown as triangles) 26
Number of proline residues 7
Total number of residues 172
Figure 5-1. Ramachandran plot of the structure of CYP3, produced by
PROCHECK (Laskowski et al., 1993). Sqaure symbols represent the non-
glycine residues while triangles represent the glycine residues
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Figure 5-2.The (2Fo-Fc) electron density map around Phe67 with the refined
structure superimposed. The map, contoured at 1.6 sigma, was calculated by
SHELXPRO (Sheldrick and Schneider, 1997) and display in O (Jones et al.,1991)
Phe67 is well defined in the density map although it is in a disallowed region.
a. Ramachandran plot quality assessment b. Peptide bond planarity - omega angle sd
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Figure 5-3. Plots of the comparison of the main chain parameters of CYP3
structure with other structures solved to a similar resolution, produced by the








































Figure 5-4. Plots of the comparison of the side chain parameters of CYP3
structure with other structures solved to a similar resolution, produced by the
program PROCHECK (Laskowski et al., 1993)
1:0 ~Ti 10 15 10 15 4 0
Resolution (Angstroms)
i:o ~T!5 10 15 10 15 4:0
Resolution (Angstroms)
c. Chi-1 gauche plus
1.0 1.5 2.0 2.5 3.0 3.5 4 0
Resolution (Angstroms)
e. Standard deviation of Chi-2 trans angle
50-






























1.0 1.5 2.0 2.5 3.0 3.5 4.0
Resolution (Angstroms)
1.0 1.5 2.0 2.5 3.0 3.5 4!0
Resolution (Angstroms)





The overall structure of CYP3 is very similar to that of hCYPA with the exception
of the inserted loop. The structural comparison of CYP3 with CYPA will be
discussed in section 5.1.3.
In CYP3, there are 4 free cysteine residues. Cysl22 and Cysl63 are too far apart to
form a disulphide bridge. However, Cys40 and Cysl68 are very close, with 5.38 A
between 2 sulphur atoms, but fail to form the expected disulphide bond. Torsion
angles Chil (N, CA, CB, S) of the 2 residues are -12° for Cys40 and 53° for Cysl68.
Modelling has shown that a rotation in the Chil torsion angle of both residues (-134°
for Cys40 and -167° for Cysl68), would enable the formation the disulphide bridge.
This rotation changes the original staggered conformation to an alternatively
favoured staggered conformation and leads to an S-S distance of 2.1A with
reasonable contacts with the surrounding residues.
From the clear electron density map around Cys40 and Cysl68 (see Figure 5-5), there
is no doubt CYP3 contains reduced cysteine residues. The reason why these two
cysteines do not form a disulphide bridge is still unknown although this phenomenon
is also seen in the cyclophilin from the parasitic nematode Brugia malayi (Taylor et
al., 1998b). It is probably that these unusual reduce forms of cysteine residues may
provide a signalling mechanism in response to oxidative stress. In an oxidising
environment, the formation of a disulphide bridge may induce a conformational
change and this conformational change may provide a dynamic signal to activate
other enzymes in the cell. Moreover, there is a metal ion coordinate site formed by
the sulphydryl groups of the reduced Cys40 and Cysl68 together with the imidazole
side chain of His54. Interestingly, His54 is conserved in all divergent loop




Figure 5-5.The (2Fo-Fc) electron density map around Cys40 and Cysl68 with
the refined structure superimposed. The map, contoured at 1.8 sigma, was
calculated by SHELXPRO (Sheldrick and Schneider, 1997) and displayed in O
(Jones et al., 1991). The clear density shows that both cysteines are present in the
reduced form.
5-9
5.1.3 Comparison of CYP3 with CYPA
CYP3 and CYPA have 67% sequence identity. The overall structures of both are very
similar (See Figure 5-6).
The rms deviation between the corresponding backbone atoms of the 162 residues in
CYPA and CYP3 is 0.469 A; the 7 residues in the additional loop and 3 residues in
N-terminal are excluded. The most distinctive structural feature between these two
proteins is the additional loop found in CYP3 (see Figure 5-7).
Sequence alignment shows this additional loop containing 7 inserted residues
(48KSGKPLH54), starting from Lys48 in CYP3 sequence. Comparison of these two
structures shows divergence actually begins at Gly45. The loop is held by a tight and
specific network of hydrogen bonds from the side chain of Glu83 (see Figure 5-8).
The carboxylate group of Glu83 forms three strong hydrogen bonds with Lys48 and
Ser49. The hydrogen bond distances are 2.19k, 3.10A, 3,57A between N/Lys48 and
OE2/Glu83, N/Ser49 and 0E1/Glu83, OG/Ser49 and 0E1/Glu83, respectively.
It is proposed that the role of Glu83 is to lock the loop into a particular p-turn
conformation. This is a very important feature of the protein structure since such
motifs are usually involved in protein-protein recognition, receptor binding and
postranslational modification (Rose et al., 1985). 4 residues (47GKSG50) of the loop
form the P-turn. Lys48 and Ser49 are hydrogen bonded to Glu83 as mentioned above.
In P-turns, the oxygen of the carbonyl group of the first residues is hydrogen bonded
to the nitrogen in NH group of the fourth residue. As shown in Figure 5-9, the
oxygen of Gly47 is hydrogen bonded to the nitrogen of Gly50 with a bond distance
2.77A. Moreover, because <(> and \|/ of Lys48 and Ser49 are (-58, -26) and (-71, -12),
this p-turn is assigned to type I, the most common P-turn type (Wilmot and Thornton,
1988).
The binding site of CYP3 is almost identical to that of CYPA, except that the side
chains of Arg62, Met68 and Lysl25 are slightly shifted (See Figure 5-10).
It is tempting to speculate that all ligands which bind to CYPA will bind to CYP3
and that the isomerase activity of CYP3 should be very similar to that of CYPA.
Actually, the isomerase activity of CYP3 inhibited by the immunosuppressive drug
cyclosporin has been determined with an IC50 value of 16nM (Dornan, 1999b) while
that of hCYPA is 19nM. (Liu et al, 1990).
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CYP3_CAEELMSRSKVFFDITIGGKASGRIVMELYDDWPKTAGNFRALC40 CYPH_TCRUZMRKINVPSKGERRRGIPVEVSRNPKVFFDISIDNKPSGRIKMELYADTVPKTAENFRALC60 CYP1_ARATHMAFPKVYFDMTIDGQPAGRIVMELYTDKTPRT ENFRALC40 CYPH_MAIZEMANPRVFFDMTVGGAPAGRIVMELYANEVPKTAENFRALC40 CYPH_SYNECMMSKVFFDITIGSDTAGRIVMELFDEVTPKTAENFRALC39 CYP4_BOVINMSHPSPQAKPSNPSNPRVFFDVDIGGERVGRIVLELFADIVPKTAENFRALC52 CYP1_BRMALMSKKDRRRVFLDVTIDGNLAGRIVMELYNDIAPRTCNNFL LC43 CYPH_ONCHOMSKKDRRRVFFDVTIDGNLAGRIVMELYNDIAPRTC NFLMLC43 CYPH_HUMANMVNPTVFFDIAVDGE LGRVSFELFADKVPKTAENFRALS40 CYP3_CAEELTGENGIGK-SGKPLHFKGSKFHRIIPNFMIQGGDFTRGNGTGGESIYGEKFPDENF96 CYPH_TCRUZTGEKGRGK-SGKPLHYKGCVFHRVIPGFWIQGGDITRGNgTGGESIYGMNFRDESFSGKA119 CYPl_ARATHTGEKGVGG-TGKPLHFKGSKFHRVIPNFWZQGGDFTAGNgTGGESIYGSKFEDENF96 CYPH_MAIZETGEKGVGK-SGKPLHYKGSTFHEVIPEFMCQGGDFTRGNGTGGESIYGEKFPD KFV96 CYPH_SYNECTGEKGVGKA-GKPLHFKGSHFHRVITDFmQGGDFTRGNgTGGESIYGEKFADENFQ95 CYP4_BOVINTGEKGIGPTTGKPLHFKGCPFHKIIKKFMIOGGDFSNONGTGGESIYGEKFEDENFH109 CYP1_BRMALTGMAGTGKISGKPLHYKGSTFHRVIKIiFTflQGGDFTKGD TG ESIYGGMFDDEEFV100 CYPH_ONCHOTGMAGIGKISGKPLHYKGSTFHRVIKNJFTJIQGGDFTKGDgT GESIYGGMFDDEEFV100 CYPH_HUMANTGEKGFGYKGSCFHRIIPGFMCCGGDFTRHNGTG KSIYGEKFEDENF189 CYP3_CAEELEKHTGPGVLSMAMAGPNTNGSQFFTiCTVKTEWLDGKHWFGRWEGLDWKAVESNGSQS156 CYPH_TCRUZGKHTGVGCLSMAMAG NTNGSCFFICTANTPWLDGKHVVFGRVTEGIDVVRRVERLGSES179 CYPl_ARATHRKHTGPGILSMANAGANTNGSCFFICTVKTDWLDGKHWFGQWEGLDWKAIEKVGSSS156 CYPH_MAIZERKQPA GVLSMA AGNTNGSQF.FTVATWLDGKHWFGQWEGMDWKAIEKVGTRN156 CYPH_SYNECLKHDRPGLLSMAWAGPNTNGSCFFLTFVPCPHTLDGKHWFGEWEGLEILEQLEANGSQS155 CYP4_BOVINYKHDKEGLLSMAMAGSNTNGSeFFITTVPTPHI/DGKHWFGQVIKGMGVAKILENVEVKG169 CYPl_BRMALMKHDEPFWSMAHKGPNTNGSCFFITTTPAPHLNNIHWFGKWSGQEWTKIEYLKTNS160 CYPH_ONCHOMKHDEPFLVSMAWKG NTNGSCFFITTTPAPffiNNIHWFGKWSGQEWTKIECLKTNS160 CYPH_HUMANLKHTGPGILSMAHAGPNTNGSCFFICTAKTEWLDGKHWFGKVKEGMNIVE MERFGSRN149 CYP3_CAEEL-GKPVKDCMIADCGQLKA17 CYPH_TCRUZ-GKTRGRIIIADCGEVWPEPK*200 CYP1_ARATH-GKPTKPVWADCGQLS172 CYPH_MAIZE-GSTSKWKVADCGQLS172 CYPHJ3YNEC-GQTKQAIVISDCGEIK171 CYP4_BOVIN-EKPAKLCVIAECGELKEGDDW*190 CYP1_BRMALKNRPLADWILNCGELVRRK*180 CYPH_ONCHOKNRPLADVIILNCGELVRRK*180 CYPH_HUMAN-GKTSKKITIADCGQLE165
Figure5-6.Sequencealignmentofth cyclophilins,producedbyCLUSTALW (Thompsonetal.,1994).Abbreviati n: CYP3_CAEELforYP3r m.elegans; CYPH_TCRUZforcyclophilinr mT.ruzi; CYP1_ARATHforYP1r mA.thaliana; CYPH_MAIZEforcyclophilinr mZ.mays; CYPH_SYNECforcyclophilinr m Synechocystissp;CYP4_BOVINforb vine CYP40;YPH_BRMALforcyclophilinfr m B.malayi;CYPH_ONCHOforYP1r mO. volvulus;CYPH_HUMANforhumanYPA. Insertedr siduesfo mingth"additional loop"seeninallthlignedsequ ncewith exceptionofhumanCYPAareinb ldn underlined.Cyst e,histidinandgl tamat residuesconserv dwithinth ssubgroupf cyclophilinarelsosh wninunderlinedbold. ResiduesinvolvedthC Abin ingitar inbolditalics.Thifiguresd nyMis JacquelineDornaithlaboratory.
Extra loop: Gly45-His54
N-term
Figure 5-7.Diagram of the superimposition of the structures of hCYPA (red)






Figure 5-8.Diagram of the additional loop held by Glu83. Three hydrogen bonds
formed by the side chain of Glu83 to Lys48 and Ser49 are shown as dashed lines.
The numbers represent the hydrogen bond distances.
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Lys48
Figure 5-9.Diagram of the beta-turn found in the additional loop of CYP3. The
hydrogen bond formed by the oxygen ofGly47 to the nitrogen ofGly50 with a
bond distance 2.77A is shown as dashed lines.
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Figure 5-10.Stereodiagram of the superimposition of the binding sites of CYP3
and hCYPA (green). The labelled residues represent the residues that adopt the
different conformations in these two structures.
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5.2 The structure ofAla-Pro bound to CYP3
5.2.1 Refinement
The CYP3 native structure was used as a starting model to refine the structure of
120mM Ala-Pro bound to CYP3 (120mM Ala-Pro/CYP3). Positional and B-factor
refinement were performed using SHELX97. After 10 cycles of positional and B-
factor refinement, H2O molecules were added using SHELXWAT. A (lFo-lFc) map
was calculated using SHELXPRO and displayed with the program O. There is a clear
density map within the expected binding site (See Figure 5-11).
The model of Ala-Pro was taken from the well-refined structure of Ala-Pro bound to
hCYPA (PDB ID 1CYH) and built into the density with O. Also, from the density
map, it is obvious Arg62 moves when Ala-Pro enters the binding site. Arg62 was
repositioned into the density as well. Repeated cycles of positional and B-factor
refinement were performed followed by the addition of H2O molecules. The R-factor
and Rfree of each refinement stage are summarised in Table 5-C.
The final R-factor is 18.38% and Rfree is 24.48% to 1.9A resolution.
Table 5-C. The refinement process of the structure of Ala-Pro bound to CYP3
Refinement step Resolution
range(A)
R (%) Rfree (%)
Positional and B-factor refinement 10-1.9 29.21 33.41
Adding 90 H2O 10-1.9 23.43 29.00
Positional and B-factor refinement after
building Ala-Pro and moving Arg62 into
density
10-1.9 22.52 28.01






Figure 5-11.The (Fo-Fc) electron density map around Ala-Pro with the refined structure
superimposed. The map, contoured at 1.5 sigma, was calculated by SHELXPRO (Sheldrick
and Schneider, 1997) after the addition of water molecules in SHELX and displayed in O
(Jones et al., 1991).
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The final rms deviations of bond length and angle distance are 0.030A and 0.028 A,
0 2
respectively. The average B-factor for all protein atoms is 32.13 A . The
stereochemical quality of the complexed structures assessed by PROCHECK is very
similar to that of the native structure. No residues are in the disallowed regions. Two
residues, Phe67 and Glu88, are in the generously allowed regions as they are in the
native structure.
5.2.2 Binding site
The binding site is located outside the (3-barrel and on the surface of the protein,
which is similar to that of hCYPA as mentioned in section 1.2.4.
The side chain of proline makes contact with the hydrophobic pocket, which is
composed of Phe67, Met68, Phel20, Leul29, Hisl33. Specifically, Phel20 makes
the most and strongest contact with the proline ring while the other residues only
contribute one to two hydrophobic contacts to Ala-Pro. In addition, there are seven
strong hydrogen bonds involved in the ligand-protein binding. The N-terminal
nitrogen (Nl) of Ala-Pro forms three hydrogen bonds with the carbonyl oxygen of
Asnl09 and two H20 molecules while carbonyl oxygen (Ol) of Ala-Pro forms one
hydrogen bond with the NH nitrogen of Asnl09. In addition, the two C-terminal
oxygens form three hydrogen bonds with Arg62 and Gln70 (See Figure 5-12). The
interatomic distances between Ala-Pro and CYP3 are summarised in Table 5-D.
The binding of Ala-Pro does not change the structure of the protein significantly. The
rms deviation value of backbone atoms of 170 residues between the native and the
o
t
complexed structure is 0.316A. All residues around the binding site with the
exception of Arg62 adopt an identical conformation to the native structure. In the
native structure, three H20 molecules occupy the binding position of Ala-Pro and the
guanidino group of Arg62 adopts the conformation toward the binding site. In the
structure of Ala-Pro bound to CYP3, when Ala-Pro approaches the binding site, the
guanidino group of Arg62 has to move away to accommodate the ligand and
consequently displaces the H20 near Arg62 (see Figure 5-13)
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Figure 5-12.Stereodiagram of the binding site of CYP3 with bound Ala-Pro,
produced by MOLSCRIPT (Kraulis, 1991). THe carbon atoms of Ala-Pro are
shown in green. The residues formed the hydrophobic pocket and hydrogen
bonded to Ala-Pro are labelled. Some of the hydrogen bonds are marked by
broken lines.
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Table 5-D. (a) Chemical structure of Ala-Pro
Table 5-D. (b) The interatomic distances between CYP3 and Ala-Pro
Ala-Pro atom CYP3 atom Distance
Hydrophobic CD2 CE1/Hisl33 3.68







CB2 CD 1/Leu 129 4.00
CG2 CE/Met68 3.91
Hydrogen bond N1 O/Asnl09 2.73
interactions N1 HOH (no.363) 2.84







Figure 5-13.(a) Diagram of the conformation of Arg62 (Arg(N)) when Ala-Pro is
absent. The binding site is occupied by water molecules (magenta) when Ala-Pro
is absent.(b) Diagram of the conformation of Arg62 (Arg(L)) when Ala-Pro binds
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5.2.3 Crystal dynamic study
Native crystals were soaked in solutions with different concentrations of Ala-Pro.
The complexed structures with different ligand concentrations were refined using the
same procedure as discussed above. The highest resolution of these structures varied
from 1.9A to 2.1A and the final R-factor varied from 0.176 to 0.225. The quality of
these structures is very similar while rms deviations of bond lengths are 0.031A, the
rms deviations of angle distance are around 0.026A and the mean B-factor is around
32 A2. The stereochemical quality of all the complexed structures as assessed by
PROCHECK is very similar to that of the native structure. No residues are in the
disallowed regions. Two residues, Phe67 and Glu88, are in the generously allowed
regions. The final refinement results for the complexed structures with different
ligand concentrations are summarised in Table 5-E.
Table 5-E. Summary of the refinement statistics of the structures of CYP3
complexed with different concentrations of Ala-Pro
Summary of the refinement
statistics



























Summary of the refinement
statistics



























1 Rfree is calculated with 5% of the data omitted from refinement for cross-validation
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After positional and B-factor refinement, fitting Ala-Pro and Arg62 into the density
and adding H20, the occupancy of Ala-Pro was refined using SHELX97. The
coordinates of Arg62(N), Arg62(L), three H20 molecules in the binding site, one H20
molecule near Arg62(N) and Ala-Pro were fixed during occupancy refinement.
Arg62(N) represents the Arg62 conformation without Ala-Pro binding to CYP3 while
Arg62(L) represents the Arg62 conformation with Ala-Pro binding to CYP3. The B-
factor of Arg62(N), 3 H20 molecules in the binding site and one H20 near Arg62(N)
were fixed to the same B-factor as that of the native structure. The B-factor of
Arg62(L) and Ala-Pro were fixed to the value as the same as the B-factor of those
obtained from the structure of 120mM Ala-Pro bound to CYP3. Since the binding
site is occupied by either ligand or H20, the sum of the occupancies of Ala-Pro and
H20 is 1. In addition, because Arg62 adopts either the native or binding
conformation, the sum of these two conformations is 1 as well. Further, the
occupancy of Ala-Pro is the same as that of Arg62(L) since the Arg62 adopts the
binding conformation only when the binding site is occupied by Ala-Pro. Moreover,
the occupancy of H20 is the same as that of Arg62(N) since the Arg62 adopts the
native conformation only when the binding site is occupied by H20. The restraints
applied in the occupancy refinement are summarised below:
where
Qh20 (a) : occupancy of H20 in the binding site while no Ala-Pro binding
Qh20 (b) : occupancy of H20 near NE/Arg62 while no Ala-Pro binding
QArg62 (N) • occupancy of Arg62 conformation while no Ala-Pro binding
qarg62 (l): occupancy of Arg62 conformation while Ala-Pro binding
QAia-Pro : occupancy of Ala-Pro
Qh20 (a) = Qh20 (b)
Qh20 (a) + QAla-Pro
QArg 62(N) + QArg62(L)
QArg62 (l) = QAla-Pro




The occupancy of Ala-Pro at different soaking concentrations is shown in Table 5-F.
The (2Fo-lFc) electron density maps around the binding site of CYP3 complexed
with different concentrations of Ala-Pro are shown in Figure 5-14.














Figure 5-14.The (2Fo-Fc) electron density map around the binding site of CYP3 complexed with different
concentrations of Ala-Pro. All maps were calculated by SHELXPRO (Sheldrick and Schneider, 1997) and displayed
in O (Jones et al., 1991). (a) The density map around the binding site of native CYP3 structure, contoured at 1.5
sigma. Water molecules are seen in the binding site when Ala-Pro is absent and Arg62 adopts the conformation
Arg62(N). (b) The density map, contoured at 1.5 sigma, around the binding site of the structure of CYP3 complexed
with 1.2mM Ala-Pro. The map is very similar to (a) and the electron density of Ala-Pro is too weak to be seen in the
map.(c) The density map, contoured at 1.5 sigma, around the binding site of the structure of CYP3 complexed with
6mM Ala-Pro. Similar to (b),the electron density of Ala-Pro is too weak to be seen in the map. (d) The density map,
contoured at 1.5 sigma, around the binding site of the structure of CYP3 complexed with 18mM Ala-Pro. The
density of Ala-Pro starts to show up although the shape is not well-defined. It also could be seen from the density
map that Arg62 adopts two conformations (Arg62(N) and Arg62(L))(e) The density map, contoured at 1.5 sigma,
around the binding site of the structure of CYP3 complexed with 36mM Ala-Pro. The density of Ala-Pro is very
clear. Similar to (d),Arg62 adopts two conformations (Arg62(N) and Arg62(L))(f) The density map, contoured at 1.7
sigma, around the binding site of the structure of CYP3 complexed with 60mM Ala-Pro. The density of Ala-Pro is
very clear. From the density map, it shows that Arg62 adopts the conformation (Arg62(L)). (g) The density map,
contoured at 1.7 sigma, around the binding site of the structure of CYP3 complexed with 120mM Ala-Pro. Similar to
(f), the density of Ala-Pro is very clear and Arg62 adopts the conformation (Arg62(L)).
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The (2Fo-lFc) maps around the binding site of 1.2mM and 6mM Ala-Pro/CYP3
complexed structure are very similar to that of the native. This indicates the electron
density of Ala-Pro is too weak to be seen in the map and only H20 molecules are
seen in the binding site, as the occupancy of Ala-Pro is very low in both structures.
With 18mM Ala-Pro, the density of Ala-Pro starts to show up although the shape is
not well-defined, especially the CA1, CB1 and N1 atoms of Ala. Also, the density
map shows the mixed-conformations adopted by Arg62 (Arg62(N) and Arg62(L)) and
indicates the occurrence of the Arg62(N) conformation is close to that of the Arg62(L)
conformation. As mentioned before, the sum of the occupancy of Arg62(N) and that of
Arg62(L) is 1. If the occurrence of these two conformations is equal, the theoretical
occupancy would be 0.5 for each. As might be expected, if the density map shows the
mixed-conformations adopted by Arg62, the occupancy of Arg62(L) and Arg62(N)
must be near 0.5. The density map is consistent with the occupancy calculated from
SHELX97 while the occupancy of Ala-Pro, equal to Arg62(L), is 0.396. in this
structure. When the concentration of Ala-Pro increases, the density map becomes
more interpretable. As shown in the density map of 36mM Ala-Pro/CYP3 complexed
structure, the map of Ala-Pro is very clear and the model fits perfectly into the
density. As for Arg62, the density map still shows the mixed conformations of
Arg62. The occupancy of Ala-Pro is greater than 0.5. While in the 60mM and
120mM Ala-Pro/CYP3 complexed structures, Ala-Pro fully occupies the binding site
and the liganded conformation of Arg62 dominates in the density map as shown in
Figure 5-14 (f) and (g). The occupancies of Ala-Pro in these two complexed
structures are 0.678 and 0.812, respectfully.
5-27
5.2.4 Calculation of the
[ PL ]
dissociation constant "in crystallo"
< > [P] + [L]
= [P ] [ L] / [ PL ]
Because [ Ptotal ] = [ PL ] + [ P ]
[PL] = [PtotaI] Q
[P ] = [ Ptotal ] ( 1" Q)
Thus, Kdc = { [ Ptotal ] (1- Q) } [L]/ [ Ptotal ] Q
= ( 1-Q ) * [ L ] / Q
where KdC : dissociation constant "in crystallo "
[ P ] : concentration of protein without ligand
[ L ] : concentration of ligand
[ PL ] : concentration of protein with ligand
[ Ptotal ] : total concentration of protein
Q : occupancy of ligand
It was assumed that the concentration of ligand is constant throughout the soaking
experiment. This is a reasonable assumption as the concentration of ligand is much
greater than that of protein, around lpM.
Re-arranging the equation as follows:
1/ Kdc is the proportionality constant for the plot of l/{ (1/Q)-1} versus [L],
This result is presented in Figure 5-15.
The experimental data fit the theoretical calibration curve with a high R2, 0.9981.
1/kdc is 0.036 from the calibration calculation. Therefore, the dissociation constant
"in crystallo", KdC, is 27.7mM.




Figure5-15.Theplotof1/{( /Q)-1}versus[L],solidlinrepre entst xp rim ntdatawh lsh representsthcalibrationurve.KdC,obtain dfr mr v rsefpropo tionalityonstantlis27.7 M
5.2.5 Discussion
According to the preliminary solution study, the dissociation constant of Ala-Pro
binding to CYP3 determined by PPIase assay is 31.23 mM (Dornan, 1999a). As can
be seen, the dissociation constant obtained by x-ray crystallography is comparable
with one obtained by solution studies.
The different values obtained from these two methods probably result from the
different experimental systems as one is in solution while the other is in crystal.
Moreover, the imprecise nature of the occupancy determination by the refinement
program, partially due to the high correlation that exist between occupancy and B-
factor may lead to the inaccuracy of the dissociation constant. In order to overcome
this problem, the B-factors are fixed during occupancy refinement as mentioned in
section 5.2.3. However, this fixation is valid only when the quality of each data is
similar as the B-factors decrease if the quality of data is better while the B-factors
increase if the quality of data is worse. In the model of Ala-Pro bound to CYP3, the
quality of each data is similar as the resolution and R-factor vary in a small range
between these data. Recently, the "frozen and unfrozen" method (Yeh & Hoi, 1998)
as mentioned in section 2.4.1 enable to collect more than one data set from the same
crystal. If this method can be applied successfully, it will improve the determination
of occupancy as the quality of each data will be expected to be very similar because
of the same crystal. In the current experiment, the CYP3 crystals cracked when
unfrozen. Therefore, different cryoprotectant solution can be tried in order to achieve
the goal.
Nevertheless, the structure of Ala-Pro bound to CYP3 provides a good model to
study the dynamic behaviour of ligand binding "in crystallo". Firstly, the data and
the protein structures are good enough to present the successive change of the density
map as the result of the increase of the ligand concentration, for example, the gradual
appearance of Ala-Pro, disappearance of the water molecules and the movement of
Arg62. Secondly, the occupancy of Ala-Pro can be determined more precisely as
more than one restraints are applied in the occupancy refinement (see section 5.2.3).
More restraints can provide more information to calculate the occupancy of ligand
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and consequently give rise to the more accurate determination of occupancy. As can
be seen, the occupancy of Ala-Pro calculated by SHELX are reasonable as the
occupancy increases when the concentration of Ala-Pro increases and the R2 of the
calibration curve obtained from the plot of 1/ { (1/Q)-1) versus [L] is very high (R2 =
0.9981), which shows the experimental data fit the theoretical value very well.
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6. Conclusion
This chapter will summarise the results of the work that came out of this thesis and
will bring together the various components previously discussed in earlier sections,
providing an overview of the work undertaken. Finally, some suggestions for future
studies will be given at the end of the chapter.
6.1 BLG
The structure of BLG co-crystallised with palmitate at pH 7.5 has been solved by
molecular replacement using a monomer of the dimeric BLG in lattice X form as the
search model. The complexed structure has been refined to 2.5A with R=0.204
(Rfree=0.240) for 6888 reflections. It has been shown that the palmitate binds in the
central cavity of the molecule, formed by the eight antiparallel p-strands. The
hydrophobic tail of palmitate stretches into the interior of the calyx while the
carboxyl group of palmitate make hydrogen bond contacts with both Lys60 and
Lys69 at the open end of the barrel. In addition to the hydrogen bonds, hydrophobic
interactions play an important role in the binding of palmitate to BLG. There are a
total of 29 hydrophobic contacts with the 13 residues in the hydrophobic cavity over
a distance of less than 4A. In particular, the side chain of Phel05 faces the tail of the
palmitate and contributes most to the hydrophobic interaction.
BLG does not undergo a dramatic change in conformation upon palmitate binding.
All residues in the hydrophobic cavity with the exception ofMet 107 remain in the
native conformation. The side chain ofMet 107 adopts an alternative rotamer to
accommodate the ligand. In order to fit inside the calyx, the conformation of
palmitate bends slightly from a fully extended all-trans conformation. There is a kink
at C6 of palmitate associated with the movement of the side chain ofMet 107.
Careful examination of the B-factors of the palmitate shows the carbon atoms of the
tail (Cg-Cie) have lower B-factors whereas those near the opening of the calyx have
much higher B-factors. The difference in B-factors can be explained by the distinct
interactions between ligand and protein. Firstly, the tail of palmitate makes strong
hydrophobic contacts with the surrounding residues and is thus stabilised by
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hydrophobic interactions, resulting in the lower B-factors seen. Secondly, the
significant increase of B-factors of the atoms near the entrance of the calyx is
presumably reflecting the larger volume of the cavity and hence the less specific
nature of the binding in the region of the highly flexible EF and GH loops.
By comparing the structure of palmitate-bound BLG at pH 7.5 with the structure of
the native lattice X at pH 6.5, it has been shown the EF loop moves when the pH is
increased from pH 6.5 to pH 7.5. In the lattice X structure, the EF loop is folded over
the entrance thus hindering the access to the calyx. However, in the structure of
palmitate binding to BLG, the EF loop is folded back to allow palmitate access to the
binding site. Therefore, it can be concluded that the movement of EF loop is essential
to open up the entrance to the calyx. The pH-dependant movement of the EF loop is
also responsible for the well-characterised Tanford transition (Tanford et al., 1959).
Qin and co-workers have refined the structures of the lattice Z form at 3 distinct pH
values (6.2, 7.1, 8.2) showing that there is a distinct movement of a loop as the pH is
raised (Qin et al., 1998a). This movement uncovers a buried carboxyl group,
observed during titration by Tanford et al (1959). This anomalous carboxyl group has
been confirmed as the side chain of Glu89 by a recent structural study (Qin et al.,
1998). The feature of the EF loop serving as a portal loop is somehow similar to that
of the dynamic portal hypothesis (Hodsdon and Cistola, 1997b) in fatty acid binding
protein (FABP). In FABP, the access and binding of fatty acid is controlled by a
flexible region that consists of several disordered loops. In BLG, discrete
arrangements of the 'portal' EF loop exist and some nearby loops (AB, GH and CD
loops) at the open end of the calyx are very flexible to allow the entry of the ligand
without obstruction.
The structure of BLG complexed with a fatty acid analogue, 12-bromododecanoic
acid, has been solved independently by Qin et al (1998b). The complexed structure
shows 12-bromododecanoic acid binds to BLG in a manner similar to palmitate with
the tail extended to the bottom of the calyx and the head located at the entrance of the
calyx. Comparison of the structure of 12-bromododecanoic acid-bound BLG and that
of palmitate-bound BLG reveals the major difference is that palmitate makes more
hydrophobic contacts with BLG. This observation of the greater degree of
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hydrophobic contact of palmitate with BLG is consistent with the result seen by
solution studies using fluorescence which shows that the binding strength of palmitic
acid is stronger than that of dodecanoic acid (lauric acid).
The binding site in BLG is fully extended, but there is space for longer fatty acid
molecules such as stearate and oleate to be accommodated within the calyx, with the
carboxyl group making the same interactions with Lys 60 and Lys 69. The
association constants for both acids are similar.
At this stage, little can be said about the existence of a second binding site. It is
surprising to find palmitate in the calyx, since the report of Narayan & Berliner
(1997) establishes fatty acid binding at a site which is not perturbed by retinol and the
report of Cho et al. (1994) implicates Lys 69 with retinol binding. Furthermore,
contrary to the findings of Narayan and Berliner, Puyol et al (1991) find that
palmitate and retinol bind competitively to BLG, the former displacing the latter.
Thus, the groove identified by Monaco et al. (Monaco et al., 1987) on the outer
surface of the protein has yet to be confirmed as a binding site for any ligand, despite
several strands of circumstantial evidence that point to its existence (Sawyer et al.,
1998). Thus, to collect a suitable data from the retinol/BLG complex is necessary to
reveal the retinol binding site.
6.2 CYP3
6.2.1 Native structure
The structure of cyclophilin 3 (CYP3) has been solved and refined to 1.8A with
R=0.208 (Rfree=0.284). The overall structure of CYP3 contains a P-barrel formed by
8 antiparallel (3-strands with 2 a-helices sitting on the top and bottom of the barrel.
The inside of the barrel is a hydrophobic core formed by the side chains of Val6,
Phe8, Ile20, Met22, Ile63, Ile69, Leul05, Phel 19, Leul21, Ilel65. These two a-
helices block the entrance to the core and consequently hinder the entrance of ligands
to the core. Moreover, inside the core, the hydrophobic residues pack tightly
excluding the possibility of ligand binding. Therefore, no ligands or substrates are
able to bind inside the P-barrel. Instead, ligands bind in a long and deep groove
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located on the surface of the protein between one face of the (3-barrel and the FG
loop.
The structure of CYP3 is very similar to that of human cyclophilin A, the best-
characterised member of cyclophilin family. The binding site, which is also the active
site, of CYP-3 is almost identical to that of CYPA. All residues important in ligand
binding are conserved, the only differences being that the side chains of Arg62,
Met68 and Lysl25 are slightly shifted. Therefore, it is not surprising to find that the
catalytic efficiency of CYP3 is comparable with that of CYPA as the IC50 value of
CYP3 determined by the inhibition of CsA is 16nM, which is in agreement with the
value of hCYPA, 19nM. It is therefore distinctly possible that ligands would bind to
CYP3 in a similar way to that seen with CYPA, and that the isomerase activity of
CYP3 should resemble that of CYPA although this conclusion can not be confirmed
until more experiments have been done.
Comparison of these two structures reveals the major difference is the additional loop
found in CYP3. This additional loop, located above the active site consists of 7
inserted residues (48KSGKPLH54). Interestingly, this loop is held in place by a tight
and specific network of hydrogen bonds from the side chain of Glu83, the
carboxylate group of Glu83 making three strong hydrogen bonds with Lys48 and
Ser49. The role of Glu83 is probably to lock the loop into a particular (3-turn
conformation, which in other structures is usually involved in protein-protein
interactions or receptor binding. Several cyclophilin homologues, for example,
Brugia malayi cyclophilin, human/bovine cyclophilin 40 and some plant
cyclophilins, have also this additional loop. It is particularly common in the
cyclophilin isoforms from the nematode C.elegans. Therefore, this inserted loop may
be used as an important recognition feature of this subclass of cyclophilins.
All proteins with the additional loop have a conserved glutamate while a lysine in the
homologous position is found in the cyclophilins without the additional loop. The
high degree of homology of this additional loop and the conserved glutamate residue
indicate both the loop structure and locking mechanism are likely to play an
important role although the actual role of this specific loop is still unclear.
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Another unusual feature of CYP3 is the unexpected presence of the reduced forms of
Cys40 and Cysl68. The two sulphur atoms of Cys40 and Cysl68 are very close,
separated by 5.38 A, but fail to form the expected disulphide bridge. Modelling
studies have suggested Cys40 and Cysl68 would be able to form a disulphide bridge
if the chi 1 torsion angle of both residues is rotated to the appropriate angle. The
biological roles these unusual cysteines play require further investigation although
some possible functions have been suggested in this thesis.
6.2.2 The structure of Ala-Pro bound to CYP3
The structure of CYP3 complexed with 120mM Ala-Pro has been refined to 1.9A
with an R-factor of 18.38% (Rfree = 24.48%). The density map around Ala-Pro has
clearly shown that the ligand binds in a deep groove on the surface of the protein.
Both hydrophobic and hydrogen bond interactions contribute to the ligand-protein
binding. The side chain of proline occupies the hydrophobic pocket of the protein
which consists of the following residues, Phe67, Met68, Phel20, Leul29 and
His 133, and makes strong contacts with the surrounding residues, especially Phel20.
Additionally, seven strong hydrogen bonds are formed by Ala-Pro with residues
Asnl09, Arg62, Glu70 and also two water molecules in the binding site. CYP3 does
not undergo a dramatic structural change upon Ala-Pro binding. All residues around
the binding site, with the exception of Arg62, adopt the conserved conformations to
the native structure. In the structure of Ala-Pro bound to CYP3, when Ala-Pro
approaches the binding site, the guanidino group of Arg62 has to move away to
accommodate the ligand and consequently displaces the H20 near Arg62.
Moreover, the structure of Ala-Pro bound to CYP3 was used as a model to study the
dynamic feature "in crystallo". A series of data from native crystals soaked in
different concentration of Ala-Pro have been collected. The occupancy of Ala-Pro in
each data has been determined using SHELX97. Once the occupancy of Ala-Pro has
been determined, the dissociation constant "in crystallo" can be calculated with the
application of the appropriate mathematic equations. The dissociation constant
obtained by x-ray crystallography is 27.7mM. This value is comparable with the




The most difficult problem in the study of BLG with hydrophobic ligands by x-ray
crystallography is how to introduce sufficient ligand into the protein without
damaging the crystal as the ligands are usually insoluble in water. The co-
crystallisation of BLG with palmitate has been successful in this thesis. Therefore,
the protocol of co-crystallisation developed here could be applied to introduce other
hydrophobic ligands into BLG.
Retinol will be the most interesting ligand in the future studies. Actually, a
crystallographic study of the binding of retinol to BLG has been carried out by Mr.
George Kontopidis in the laboratory. Crystals of retinol-bound BLG have been
obtained by modifying the protocols mentioned in section 2.3.2. The structure of
retinol bound to BLG has been refined using the protein structure of palmitate bound
to BLG as a starting model with the model of palmitate omitted. From the difference
map, it is clear that retinol binds inside the calyx. Once the refinement of the
structure of BLG complexed with retinol is complete, this complexed structure will
be compared with that of BLG complexed with palmitate. The similarity and
difference of these two complexed structures may provide more information about
the biological function of BLG.
In addition to retinol, other hydrophobic ligands as mentioned in section 1.1.6.3,
phosphate lipids and some vitamin analogues, for examples, vitamin D and D2 could
be examined by performing similar experiments to those described in this thesis in
order to investigate the existence of the other binding site and most important, to
understand the nature and the biological roles of BLG.
As for the future work of BLGY structure, it is clear that the type of buffer and
precipitant affect the crystallisation in a subtle way. Full refinement, probably of data
from crystals from several different batches, would be one way of trying to
understand the subtle variations of structure that lead to poor refinement and
variations in the achievable resolution in any given case.
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(b)CYP3:
The structure of Ala-Pro bound to CYP3 is the first model system that has allowed
determination of the dissociation constant "in crystallo " by x-ray crystallography. In
future studies, more ligands, for example, CsA, tetrapeptides and other dipeptides,
could be tested to investigate whether the structure or the size of the ligand affects
the accuracy of the determination of the dissociation constant "in crystallo".
Moreover, an alternative crystal form of CYP3 could be crystallised. Once the
crystals in a different crystal form are obtained, the same experiments on CYP3 as
performed in this thesis could be repeated to obtain the dissociation constant of Ala-
Pro bound to CYP3 in the alternative crystal form. The comparison of these two
dissociation constants determined from the different crystal forms will reveal whether
the crystal packing affects the ligand binding behaviour "in crystallo". Actually, the
other crystal form of CYP3 has been obtained at 4°C by the hanging drop vapour
diffusion method. The well solution contains 26% MPEG5000 as precipitant and
0.1M sodium citrate adjusted with citrate acid to pH 6.0. For a hanging drop, 2|il
21mg/ml CYP3 in 20mMHEPES/0.5MNaCl buffer was added to 2|il well solution.
The data have been collected and processed by Dr. Paul Taylor in the laboratory.
These crystals are orthorhombic with unit cell dimensions of a=58.9A, b=67.5A,
c=76.4A. However, no further studies of this crystal form were carried out as they are
very anisotropic. Therefore, the future work will be involved in modifying the
crystallisation conditions in order to improve the quality of the crystal in the
orthorhombic form.
Finally, other model systems of different proteins complexed with different ligands
could be examined to provide more information to insight into the dynamic
interactions between proteins and ligands and establish more precise methods to
determine the dissociation constant "in crystallo".
6.4 Conclusion
X-ray crystallography has been shown to be a useful and powerful technique in
molecular biology and biochemistry to understand the interaction between a protein
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and its ligands, receptors or inhibitors, at the atomic level. In this thesis, the
structures and ligand binding interactions of BLG and CYP3 have been studied.
The binding of BLG with a variety of hydrophobic ligands has been studied in
solution for many years. However, the actual binding site of these small molecules,
such as fatty acid, are arguable as there are two possible binding site to accommodate
a ligand; one is in the calyx inside the P-barrel and the other is in the groove on the
protein surface. The work presented here is the first direct observation of a ligand
binding to BLG. A detailed description of the interaction between a fatty acid
(palmitate) and BLG can therefore be examined. Moreover, the structure of
palmitate-bound BLG could provide an insight into the biological phenomenon
observed by other methods, such as fluorescence and site-mutagenesis study.
As for CYP3, this is the first structure of a cyclophilin from the free-living nematode
C. elegans to be solved. The structure of CYP3 has provided many informations to
understand the various biological roles that cyclophilin plays and may help the
development of targeted antiparasite drugs, for example, CsA analogues.
Furthermore, the structure of CYP3 complexed with Ala-Pro has been shown to be a
good model system to study the ligand binding behaviour "in crystallo". This is the
first report to obtain the dissociation constant "in crystallo" by x-ray crystallography.
This result has been shown to be in agreement with the result obtained from the
PPIase assay in solution. Therefore, this experimental system may provide a starting
point to develop a method to determine a dissociation constant by x-ray
crystallography when other techniques, for example, fluorescence, are insensitive or
unavailable.
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(1) Systematic absence of BLGY data ( C2221)
( absence)
Intensities of systematic absences
h k 1 Intensity Sigma I/Sigma
0 0 3 627 .3 113 .6 5.5
0 0 5 52 .7 130 . 0 0.4
0 0 7 625 .1 161.8 3.9
0 0 9 119 .2 114 . 9 1.0
0 0 11 65 .2 156.4 0.4
0 0 13 -155.7 209.5 -0.7
0 0 17 -72 . 0 185.6 -0.4
0 0 19 623 .2 270 . 8 2.3
0 0 21 33 . 9 195.9 0.2
0 0 23 463 . 5 219.2 2.1
0 0 25 276 . 5 423.4 0.7
0 0 27 474.1 217.6 2.2
0 0 29 452.4 427.3 1.1
0 0 31 -32 . 9 243 .4 -0.1
0 0 33 211.8 450.3 0.5
( present)
0 0 4 250472 29790
0 0 6 2607.9 175.2
0 0 8 12540.7 742 . 8
0 0 10 10936.7 553.6
0 0 12 32877.1 1383 .4
0 0 14 127262 4144
0 0 16 285866 13724
0 0 18 82921.8 4774.4
0 0 20 396.8 243 .2
0 0 22 4181.9 335.8
0 0 24 818.2 311.0
0 0 26 9971.3 1146.2
0 0 28 2646.0 377.6
0 0 30 1046.7 281.5
0 0 32 21811.2 5512.2
: > reflection condit
(2) Systematice absence of BLG co-crystallized with
Palmitic acid ( P3221)
(absence)
Intensities of systematic absences
h k 1 Intensity Sigma I/Sigma
0 0 13 -58.2 35 . 6 -1.6
0 0 14 -1.9 38.7 0.0
0 0 16 90.3 44.5 2.0
0 0 17 -25.4 33.3 -0.8
0 0 19 -74.2 57.1 -1.3
0 0 20 -35.1 62.9 -0.6
0 0 22 60.8 92.3 0.7
0 0 25 121.4 77.3 1.6
0 0 26 74.9 75.9 1.0
0 0 28 155.8 77.2 2.0
0 0 29 53 .3 61.2 0.9
0 0 31 -87 .7 57.8 -1.5
0 0 32 106.3 82 .1 1.3
0 0 34 -18.3 82 .1 -0.2
0 0 35 163 .1 87 . 8 1.9
0 0 37 12 . 9 90 . 5 0.1
0 0 38 6 .1 69.2 0.1
0 0 40 79 . 9 97.9 0.8
0 0 41 69.3 90.9 0.8
0 0 43 176 . 0 106.5 1.7
0 0 44 -154.4 113.8 -1.4
(present)
0 0 12 5896.1 392.5
0 0 15 16379 . 6 1030.2
0 0 18 3945.4 353.6
0 0 21 14225.1 1252.5
0 0 27 903 . 0 137 .2
0 0 30 4348.2 533 .7
0 0 33 1147.2 182 . 8
0 0 36 709 . 0 147.5
0 0 39 2920 .4 698.3
0 0 42 -48.0 87 .3
- > reflection condition
===> space group : p3121 or p3221
(1) Systematic absence of CYP3 data ( P41212)
systematic absence:
(a) absence:
Intensities of systematic absences
h k 1 Intensity Sigma I/Sigma
0 0 21 -22 .4 44.6 -0.5
0 0 22 -64.9 49.1 -1.3
0 0 23 -5 . 9 34.8 -0.2
0 0 26 23 .4 40.0 0.6
0 0 27 169 . 6 61.4 2.8
0 0 29 34.6 46.5 0.7
0 0 31 -34.4 57 . 0 -0.6
0 0 33 171.4 84.2 2.0
0 0 34 40.8 57.3 0.7
0 0 35 164.3 85.2 1.9
0 0 37 0.6 60.4 0.0
0 0 38 18 . 8 84.1 0.2
0 0 39 -60.1 84.2 -0.7
0 0 41 -153 .2 84.6 -1.8
0 0 42 -145.3 59 . 5 -2.4
0 0 43 -177.8 82.9 -2 .1
0 0 45 -65.7 71.3 -0.9
0 0 46 27.9 80.0 0.3
0 0 47 2.2 81.0 0.0
0 0 49 48.7 81.0 0.6
0 0 50 93 .2 59.1 1.6
0 0 51 7.5 78.9 0.1
0 0 53 -15.0 55.0 -0.3
0 0 54 54.0 82 .3 0.7
0 0 55 -28.0 81.7 -0.3
0 0 57 142.8 90.1 1.6
0 0 58 75.4 59.8 1.3
0 0 59 217 .1 102 .1 2.1
0 0 61 -145.3 78.3 -1.9
0 0 62 -55 . 8 79.5 -0.7
0 0 63 45.4 56.6 0.8
0 0 65 63 .9 77.5 0.8
0 0 66 39.8 52 .1 0.8
0 0 67 -5.4 79 . 8 -0.1
5 0 0 7.0 12 . 5 0.6
7 0 0 12 . 6 16 . 8 0.7
9 0 0 -19.2 22 .3 -0.9
11 0 0 33 . 9 25 . 9 1.3
13 0 0 -19.4 44 . 6 -0.4
17 0 0 145.6 69.2 2.1
19 0 0 -98.6 64.8 -1.5
21 0 0 -0.8 60 . 8 0.0
23 0 0 -65.5 59 . 5 -1.1
27 0 0 -44.6 62.2 -0.7
(b) present:
0 0 20 7457 .2 623.9
0 0 24 43631.1 3479.1
0 0 28 11081.0 1040.7
0 0 32 5932 .4 709.7
0 0 36 4962.0 580.8
0 0 40 33515.2 4328 . 8
0 0 44 9621.1 1635 .7
0 0 48 46902.0 8657 . 8
0 0 52 32118.0 6999.6
0 0 56 2131.5 566.7
0 0 60 311.6 139.8
0 0 64 183 .3 108.0
0 0 68 1563 .2 868.4
6 0 0 16036.1 993 .3
8 0 0 677.0 47.7
10 0 0 605.6 44.1
12 0 0 9846.0 788.1
14 0 0 324.4 62 .4
16 0 0 1167.6 151.9
18 0 0 3221.9 431.9
20 0 0 2261.3 343 .2
22 0 0 2051.4 355.9
24 0 0 2221.7 446.5
===> relection condition : ( 0 0 4n) & (2n 0 0 )
===> space group : p41212 or p43212
